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Abstract 
Copy number variation (CNV) is pervasive in the human genome and has been shown to contribute 
significantly to phenotypic diversity and disease aetiology. High-throughput sequencing (HTS) 
technologies have allowed for the systematic investigation of CNV at an unprecedented resolution. HTS 
studies offer multiple distinct features that can provide evidence for the presence of CNV. We have 
developed an integrative statistical framework that jointly analyses multiple sequencing features at the 
population level to achieve sensitive and precise discovery of CNV. First, we applied our framework to 
low-coverage whole-genome sequencing experiments and used data from the 1000 Genomes Project to 
demonstrate a substantial improvement in CNV detection accuracy over existing methods. Next, we 
extended our approach to targeted HTS experiments, which offer improved cost-efficiency by focusing 
on a predetermined subset of the genome. Targeted HTS involves an enrichment step that introduces 
non-uniformity in sequencing coverage across target regions and thus hinders CNV identification. To 
that end, we designed a customized normalization procedure that counteracts the effects of enrichment 
bias and enhances the underlying CNV signal. Our extended framework was benchmarked on 
contiguous capture datasets, where it was shown to outperform competing strategies by a wide margin. 
Capture sequencing can also generate large amounts of data in untargeted genomic regions. Although 
these off-target results can be a valuable source of CNV evidence, they are subject to complex 
enrichment patterns that confound their interpretation. Therefore, we developed the first normalization 
strategy that can adapt to the highly heterogeneous nature of off-target capture and thus facilitate CNV 
investigation in untargeted regions. All in all, we present a generalized CNV detection toolset that has 
been shown to achieve robust performance across datasets and sequencing platforms and can therefore 
provide valuable insight into the prevalence and impact of CNV. 
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Chapter 1 
Chapter 1  Introduction 
Introduction 
 
 
 
 
 
 
 
 
Copy number variants (CNVs) constitute an abundant class of genomic structural variation 
that has been shown to play a key role in phenotypic diversity. However, until recently, large-scale 
CNV detection has been hindered by technological limitations. The advent of high-throughput 
sequencing (HTS) platforms has transformed the field of genomics and provided the means for 
investigating CNV at an unprecedented resolution. This thesis describes novel statistical approaches 
designed to enable a systematic and comprehensive examination of CNV in HTS studies of the human 
genome.  
In this introductory chapter, we review the experimental and methodological aspects of CNV 
detection. We begin with a brief description of the mechanisms that underlie CNV formation. We then 
present a historical perspective of the technological developments that have catalysed the remarkable 
advances in human genomics over the last 40 years. We discuss the rise of sequencing technologies, 
with special emphasis on high-throughput platforms, which have transformed the study of CNV. We 
proceed by detailing certain technical properties of HTS protocols that can affect CNV discovery. This 
is followed by a concise account of the ground-breaking 1000 Genomes Project, which served as the 
starting point for our research. Lastly, we identify the distinct HTS features that can be harnessed for 
CNV detection and outline their individual characteristics. The chapter concludes with an extended 
restatement of our project’s aims and an overview of the thesis structure.  
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1.1 Structural Variation overview 
The initial analysis of the human genome attributed most of the genetic variation to DNA 
sequence variants known as single nucleotide polymorphisms (SNPs) [1, 2]. However, in recent years, 
structural variation (SV) has been shown to contribute significantly to human diversity [3] with the 
fraction of the genome affected by SV estimated to be larger than that affected by SNPs [4]. In the 
human genome, the term structural variation encompasses a multitude of variants, ranging from 
cytogenetically detectable to submicroscopic. 
Structural variants can be categorized on the basis of their size and their effect on genomic 
balance. Variants larger than 3 Mb were the first to be discovered using conventional microscopy and 
consist mainly of aneuploidies [5], large rearrangements [6], marker chromosomes and fragile sites [7]. 
Variants up to 3 Mb in size are too small to be observable by microscope and consist of copy number 
variants, translocations and inversions. CNVs are quantitative dosage-altering variants and comprise 
DNA segments that appear as lost (deletions) or gained (duplications, insertions) compared to a 
reference genome sequence [8]. Translocations are DNA segments that have changed position within a 
genome, while inversions are segments whose orientation has been reversed relative to the surrounding 
sequence. Both translocations and inversions are dosage-invariant rearrangements as they involve no 
change in total DNA content. 
CNVs represent the most abundant class of submicroscopic SVs and include events as small 
as 50 basepairs (bp). CNVs can be further grouped into common and rare according to their population 
frequency. Common CNVs are recurrent in the population (minor allele frequency >5%) and account 
for most inter-individual copy number differences. Rare variants can be sporadic or recurrent and tend 
to be larger in size (>50 kilobases). CNV follows the paradigm of Mendelian inheritance, with de novo 
rates estimated to be between 0.01 and 0.03 mutations per haploid genome per generation [9].  
1.2 CNV origins 
CNV formation is thought to be mediated by several distinct mechanisms, depending on the 
genomic context. In all cases, however, DNA repair mechanisms are largely responsible for the 
resulting rearrangements. When long stretches of paralogous DNA are misaligned –during meiosis or 
double-stranded break (DSB) repair– non-allelic homologous recombination (NAHR) can facilitate 
unequal crossovers resulting in recurrent deletions or duplications [10]. CNV may also arise through a 
different DSB repair pathway known as non-homologous end joining (NHEJ). In the event of multiple 
DSBs in close proximity, NHEJ may lead to aberrant non-reciprocal recombinations. Like NAHR, 
NHEJ can occur meiotically or mitotically. Unlike NAHR, however, NHEJ does not depend on 
sequence similarity and thus generates sporadic rather than recurrent variants [11]. To explain complex 
CNV patterns that are inconsistent with recombination-based mechanisms, a replication-based model 
has also been proposed. When replication forks collapse and homology-directed repair is unavailable, 
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the error-prone microhomology-mediated break-induced replication (MMBIR) pathway is enlisted, 
resulting in non-recurrent rearrangements with variable breakpoints [12]. Since the process is 
contingent on DNA replication, MMBIR-derived CNVs are mitotically generated. 
1.3 Uncovering CNV 
Although chromosomal abnormalities have long been implicated in human disorders, 
submicroscopic CNVs have been historically difficult to detect on a large scale. Traditionally, CNV 
identification has been achieved using targeted, microscopy-based techniques such as karyotyping and 
fluorescent in situ hybridization (FISH). Microscopy methods are bound by the limits of the visible 
light spectrum and can thus only resolve variants in the order of megabases [13]. Comparative genomic 
hybridization (CGH) was built upon the foundations of FISH to allow for efficient simultaneous 
investigation of multiple targets [14]. To overcome the inherent resolution limitation, CGH was then 
combined with emerging microarray technologies to create array CGH (aCGH). As microarrays were 
maturing into the preferred platform for SNP genotyping, it became apparent that they can also be used 
for genome-wide CNV detection [15]. A distinct class of low-plex assays relies on polymerase chain 
reaction (PCR) to provide more robust and sensitive CNV quantification than hybridization methods 
[16]. Finally, the development of massively parallel sequencing in the mid-2000s, revolutionized the 
field of genomics and facilitated CNV investigation at an unprecedented resolution. 
With the advent of high-throughput assays and high performance computing, it became 
possible to create genome-wide CNV maps at the population level. As a result, CNV has been shown 
to have a significant impact on many aspects of phenotypic variation, from the cellular level [17] to 
complex disease aetiology [18, 19] and evolutionary adaptation [20]. 
1.3.1  Microscopy-based technologies 
Karyotyping is one of the oldest methods for detecting gross chromosomal abnormalities. It 
involves staining metaphase-arrested chromosomes, arranging them into a standardized format and 
viewing them under a microscope [21]. Though karyotypes are still used in prenatal screening for 
aneuploidy-related disorders, such as Down syndrome and Klinefelter syndrome, their usefulness is 
limited by their low-resolution and very low-throughput. 
FISH is a more discriminative approach that allows localization and visualization of 
subchromosomal abnormalities. In FISH, genomic probes corresponding to a known target region are 
labelled and then hybridized to a chromosome of interest. If the probe binds successfully it produces 
distinctive fluorescence when viewed under the microscope that can be used to infer the presence of 
CNV. Although FISH offers a significant resolution improvement over karyotyping and allows for a 
certain degree of multiplexing, it does not have the capacity for genome-wide CNV screening. 
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CGH addresses the plexity constraints of FISH by competitively hybridizing fragmented 
DNA from a test and a control sample to a reference genome. The test and control samples are labelled 
with two different colours and the resulting fluorescence pattern will vary along each chromosome. The 
relative hybridization intensity for each fluorochrome can be used to infer copy number differences 
between samples. Due to its assumption-free and genome-wide nature, CGH was rapidly adopted for 
tumour CNV analysis [22, 23]. However, like FISH, CGH operates on metaphase-arrested cells, which 
imposes a limit on the resolution of detectable variants in the order of megabases [24]. 
1.3.2 Microarray-based technologies 
Microarray technologies, namely aCGH and SNP arrays, ushered cytogenetics away from 
microscopy and allowed for the characterization of the abundance of CNVs in the human genome [25, 
26]. The adoption of biochips uncoupled hybridization-based approaches from metaphase 
chromosomes and introduced the new era of computational genomics. 
1.3.2.1 Array CGH 
aCGH was the first platform that was developed to facilitate high-resolution genome-wide 
CNV detection. In aCGH, two differentially labelled genome samples (a sample of interest and a control 
sample) are co-hybridized to microarrays that are spotted with cloned DNA fragments. The fluorescent 
intensity ratio is used to detect copy number differences between the two samples. A positive log-
transformed ratio indicates a relative copy number gain, while negative values correspond to deletions. 
Initially, large-insert genomic clones, such as bacterial artificial chromosomes (BACs), were used [27], 
but have since been succeeded by oligonucleotide cDNA clones that drastically improve resolution [28]. 
Modern aCGH platforms comprise millions of oligonucleotide probes that cover large portions of the 
genome and enable higher breakpoint precision. Such high-density arrays also produce more confident 
CNV calls by leveraging information from consecutive probes with consistent intensity profiles. 
Since its inception in the late 1990s, aCGH technology has been extensively used to 
characterise cancer genomes. Both for discovering cancer genes and for unravelling the genetics of 
disease progression, aCGH has proven to be a powerful and reliable tool that has shaped our 
understanding of cancer aetiology [29]. aCGH has also been instrumental in uncovering associations 
between CNVs and autoimmune diseases such as psoriasis [18] and systemic lupus erythematosus [30]. 
1.3.2.2 SNP arrays 
In more recent years, SNP microarrays have superseded aCGH as they offer simultaneous 
genome-wide SNP and CNV profiling. SNP chips are spotted oligonucleotide arrays that were 
originally designed for genotyping sequence variants. Thus, unlike aCGH, only a single test sample is 
hybridized on each array and a direct control comparison is not available. CNV detection is achieved 
by comparing the hybridisation intensity signal to reference values (usually derived from independent 
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control samples or population averages). Significant deviation of the observed intensity signal from the 
reference is interpreted as evidence of a variant. To that end, a log ratio metric akin to that of aCGH is 
calculated for every hybridization probe. However, this ratio tends to be noisier for SNP arrays [31] and 
therefore less reliable for CNV detection on its own. This limitation is mitigated by orthogonal CNV 
signal contained in the SNP genotype information, known as B-allele frequency (BAF). 
BAF quantifies the proportion of allelic intensities at each SNP, which can then be matched 
to discrete copy number states. In addition to superior signal-to-noise discrimination, BAF offers the 
unique ability to identify loss of heterozygosity [32] and uniparental disomy [33], which are entirely 
undetectable with aCGH. The inherent weakness of BAF lies in the ambiguous copy number 
interpretation of certain allelic configurations (e.g. copy-neutral hemizygosity is indistinguishable from 
heterozygous deletions). Therefore, the optimal strategy for SNP array-based CNV discovery involves 
joint analysis of BAF and hybridization intensity. 
Due to their cost-efficiency and ubiquity, SNP microarrays have been used to reveal a plethora 
of evidence associating CNVs with both common [34] and rare disorders [35, 36]. Furthermore, the 
inclusion of non-polymorphic CNV-dedicated probes in later generation assays has led to increased 
coverage in previously unexplored regions. As a result, SNP arrays represent the first technology to 
enable systematic exploration of CNV in the human genome [37]. 
1.3.2.3 Limitations 
Despite their technical advancement and widespread adoption, microarray platforms are 
based on hybridisation principles that limit their scope of application. Both aCGH and SNP arrays are 
constrained by the scarcity of informative probes in CNV-rich loci such as repeat regions and segmental 
duplications. The probe density is another important factor that determines the minimum size of 
detectable CNVs and the breakpoint resolution. As the signal from multiple consecutive probes is 
required to avoid spurious CNV calls, microarrays tend to be more sensitive to variants larger than 1 
kilobase (kb). Finally, due to an established ascertainment bias [38], duplications are considerably 
under-represented in array-based CNV results, especially in the shorter size range. 
1.3.3 PCR-based technologies 
PCR has been established as the definitive platform for accurate DNA quantification [39]. 
Generally, PCR involves multiple cycles of temperature-controlled DNA replication to amplify a 
genomic region of interest. The main principle behind PCR-based quantification lies in the proportional 
relationship between the amount of starting DNA and the amplified product at the end of every cycle. 
The presence of CNV can be ascertained by comparing the amount of PCR product between a test 
sample (presumed to carry a variant) and a copy-neutral reference sample. Conventional PCR measures 
only the end-point product using gel electrophoresis and size-based discrimination, which suffer from 
low resolution. Also, towards the end of the reaction, the amplification rate slows down and the 
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proportionality assumption starts to collapse, resulting in low precision. Technological improvements 
have led to the development of quantitative real-time PCR (qPCR), which can monitor the PCR product 
throughout the amplification process using fluorescence [40]. Thus, qPCR obtains measurements at 
earlier stages of the reaction that yield constant amplification rates for increased precision. This 
technique avoids the caveats of gel-based post-processing and allows qPCR to achieve robust and 
sensitive detection of absolute copy number changes.  
At the crossroads between low-plex and medium-throughput, qPCR assays constitute the gold 
standard for CNV screening. As they don’t rely on hybridisation, PCR-based approaches are highly 
specific and exhibit a high dynamic range of quantification. Despite the advancement of various 
strategies that allow for a certain degree multiplexing [41, 42], qPCR remains a targeted approach that 
is reserved for validation of CNV predictions. 
1.3.4 Sequencing technologies  
At its inception in 1990, the Human Genome Project (HGP) set out to determine the full 
nucleotide sequence of human DNA. With automated chain-termination (Sanger) sequencing as the 
primary tool, the HGP took ten years to produce a draft sequence [43], involving interdisciplinary efforts 
from an international scientific consortium. The completion of the finished-grade human genome 
sequence in 2003 [44] marked not only the end of the HGP but also the beginning of a new era in CNV 
discovery and genotyping. 
While Sanger sequencing helped usher humanity into the post-genomic era, it proved to be 
too expensive and time consuming for extensive human variation studies. Despite significant 
improvements in the course of the HGP, automated Sanger sequencing remains a low-throughput 
process and has been largely supplanted by newer technologies collectively named next-generation 
sequencing (NGS). NGS is an umbrella term that encompasses a variety of protocols for DNA template 
preparation, sequencing and imaging. However, what all NGS technologies have in common is a high 
degree of parallelisation which confers the ability to produce very large amounts of sequence, faster 
and cheaper than Sanger sequencing. 
NGS generates data in the form of short sequence fragments (35bp to 300bp in length) known 
as reads. CNV detection can be accomplished either by directly aligning the reads to a reference genome 
or by de novo assembling them into much longer fragments and comparing the results to the reference.  
Although both strategies can achieve significantly improved CNV segmentation compared to older 
technologies, de novo assembly is computationally more demanding and thus prohibitive on a large 
scale. The high-quality human genome reference produced by the HGP facilitates alignment-based 
techniques and provides the means for efficient, high-resolution CNV discovery on a truly genome-
wide scale. 
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1.4 The sequencing revolution 
The first attempts at determining the base sequence of a DNA molecule [45] came a mere 15 
years after the description of its double-helical structure. However rudimentary, these early efforts laid 
the foundation for the extraordinary technological advances of the 1970s that transformed molecular 
biology and gave rise to modern sequencing. For the nascent field of genomics, sequencing the entire 
human genome may have seemed quixotic. In the era of the $1000 genome-in-a-day [46] the future 
seems boundless. 
1.4.1 Historical perspective 
The importance of biomolecular sequencing was first demonstrated in proteins by Frederick 
Sanger [47, 48] in the 1940s. The elucidation of DNA structure in 1953 [49] was the catalyst that shifted 
the focus towards nucleic acids and the coding problem. Given the substantial length of undigested 
DNA molecules and the limited repertoire of chemical properties, which made them difficult to purify, 
it is no surprise that the first nucleic acid to be sequenced was transfer RNA [50]. Short viral DNA from 
certain bacteriophages that were easy to isolate was soon to follow [45]. These initial methods were 
slow and labour-intensive, generating the sequence of a few nucleotides per year. Around the same 
time, the discovery of type II restriction enzymes [51] would prove to be crucial for the developing 
sequencing technologies. By cleaving DNA in a highly predictable fashion these enzymes allowed the 
partitioning of long DNA molecules into small fragments that were more amenable to sequencing. The 
first major breakthrough, however, would come in the mid-1970s, when Sanger introduced the “plus 
and minus” sequencing method [52] that was much faster and less laborious than previous methods. 
Although “plus and minus” was not perfectly accurate and could only be applied to single-stranded 
DNA (ssDNA), it led to the sequencing of the first complete genome in 1977 [53]. The genome 
belonged to a bacteriophage (ΦΧ174) and measured 5,386bp in length. To address the limitations of 
“plus and minus”, Sanger proposed the chain-termination method [54] as an accurate and efficient 
alternative that would become the precursor of modern sequencing. Over the next decade, Sanger 
sequencing –as chain-termination came to be known– saw wide adoption and minor refinements but 
remained an arduous, manual process. In the early 1980s, the coupling of chain-termination with a 
random (“shotgun”) fragmentation step achieved a substantial increase in speed and efficiency, 
facilitating the sequencing of larger viral genomes [55, 56]. It wasn’t until 1986 when a certain degree 
of automation was introduced into Sanger sequencing [57] that the focus started shifting towards more 
complex organisms. A decade of viral genomics culminated in the ambitious Human Genome Project 
that set out to generate the complete sequence of the human chromosomes. Using automated Sanger 
sequencing and a hierarchical shotgun approach, the HGP would prove to be an immense international 
undertaking that was projected to last 15 years and cost $3bn. In the meantime, however, the inception 
of pairwise sequencing [58] and the championing of whole-genome shotgun by Craig Venter [59, 60] 
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would challenge the strategies adopted by the HGP. As a result, in 1999, Venter announced a competing 
human sequencing project that advertised rapid results at a fraction of the cost. The ensuing race 
between Venter and the HGP ended with the simultaneous publication of separate draft human genomes 
in 2001 [61, 62]. By the time the HGP had generated the finished sequence of the last chromosome 
[63], the reign of Sanger sequencing was no longer undisputed. A plethora of next-generation 
technologies developed in the mid-2000s promised to dramatically increase throughput and reduce cost, 
at the expense of accuracy. Initially, there were three competing NGS platforms: pyrosequencing [64], 
cyclic reversible termination [65] and sequencing by ligation [66]. Although these methods are all based 
on massively parallel whole-genome shotgun, they exhibit different characteristics (such as read 
lengths, error rates and sequence output) that have largely determined their fates. Cyclic reversible 
termination (CRT), now marketed by Illumina, has established itself as the platform of choice for high-
throughput sequencing (HTS) and is currently the driving force behind large-scale genomic endeavours 
such as the 1000 Genomes Project [67] and The Cancer Genome Atlas (TCGA) [68]. Sequencing 
methods, however, are still in active development and the quest to improve performance is far from 
over. Emergent third-generation technologies such as SMRT [69] and nanopores [70] are focusing on 
real-time single-molecule sequencing, which promises faster turnaround times and ultimately lower 
cost [71]. Despite the astounding progress of the last 50 years, there may be a new sequencing revolution 
in the offing. 
1.4.2 Sanger sequencing 
Multiple innovations that were introduced throughout the 1970s compose what is now called 
Sanger sequencing. The individual elements were combined by Sanger into the ground-breaking 
dideoxy chain-termination method. Sanger sequencing relies on the inherent ability of DNA polymerase 
to synthesize DNA based on  a single-stranded template. Given a specific primer that is annealed to the 
template and provides the starting point, the polymerase extends the complementary chain using free 
nucleotides. Under optimum conditions and in the presence of only standard, naturally occurring 
deoxynucleotides (dNTPs), enzymatic synthesis proceeds uninterrupted. However, there are certain 
chemically altered nucleotide analogues called dideoxynucleotides (ddNTPs) that have the ability to 
irreversibly inhibit DNA synthesis. Dideoxynucleotides lack the 3´-hydroxyl group of deoxynucleotides 
and therefore prevent further extension of a growing chain, once they are incorporated by DNA 
polymerase. In Sanger sequencing, a mixture of dNTPs and low-concentration specially labelled 
ddNTPs is used as substrate for DNA polymerase. This leads to random but base-specific termination 
of synthesis, and if repeated multiple times, produces chains of variable length ending in ddNTPs. The 
final step is separating the chains by size using gel electrophoresis and reading the labelled ddNTPs 
from top to bottom to obtain the DNA sequence. In Sanger’s original version, ddNTPs were 
radioactively tagged and could therefore not be distinguished from each other. This meant that four 
parallel synthesis reactions containing only one of the ddNTPs were required and the results were 
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visualized in four different lanes on a gel. Eventually, radiolabelling was replaced by fluorescent dyes 
that tagged each ddNTP with a different colour, eliminating the need for separate reactions and allowing 
for faster optical readout on a single gel lane. 
Sanger sequencing is a highly accurate method that maintains very low error rates even in 
genomic regions of low complexity (such as repeats and homopolymer runs). Furthermore, the Sanger 
technique can read sequences of up to 1000bp in length from a single reaction. This extended read 
length is a major advantage for assembling large genomes without any a priori knowledge and explains 
why Sanger sequencing is associated with the success of the HGP. Despite several improvements over 
the years, Sanger sequencing remains low-throughput and time-consuming and has largely been 
replaced by cost-efficient next-generation technologies, particularly in large-scale re-sequencing 
projects. Nevertheless, its unmatched accuracy and read length render Sanger sequencing the gold 
standard for variant validation, de-novo assembly and gap closure. 
1.4.3 High-throughput sequencing 
Since the completion of the HGP, sequencing research has seen a departure from traditional 
chain-termination techniques. Inspired by the principles of whole-genome shotgun, next-generation 
sequencing platforms were designed to overcome the throughput limitation of Sanger sequencing. This 
is achieved by randomly shearing the DNA into millions of fragments that can be used as sequencing 
templates. The templates are then clonally amplified and immobilized on densely tiled surfaces that 
allow for simultaneous sequencing reactions to occur in a massively parallel fashion. Although multiple 
distinct NGS technologies vied to reinvent sequencing as an accessible and affordable tool, it was 
Illumina/Solexa’s cyclic reversible termination (CRT) that ended up prevailing as the de facto HTS 
platform.  
CRT is a conceptual descendant of chain-termination methods and thus shares certain features 
with Sanger sequencing. Like chain-termination, the main principle behind CRT is sequencing by 
synthesis using fluorescently-labelled nucleotides. However, instead of using ddNTPs, CRT employs 
specially modified 3´-O-azidomethyl-dNTPs that act as reversible terminators. In their initial form, the 
3´-O-blocked-dNTPs are similar to ddNTPs in their chain-terminating properties. The difference with 
ddNTPs is that once a modified dNTP has been incorporated and thus arrested DNA synthesis, the 
blocking group can be cleaved (along with the fluorescent tag) to allow for chain elongation to proceed. 
This renders termination reversible and eliminates the need for mixtures of standard and modified 
nucleotides as substrates for DNA synthesis. The drawback of reversibility lies in the inability of regular 
DNA polymerases to accept 3´-modified nucleotides. To that end, CRT utilizes mutant polymerases 
that exhibit improved efficiency and fidelity for reversible terminators. Illumina sequencing is a step-
wise approach [65] that relies on a proprietary 9oNm polymerase to extend the chain one nucleotide at a 
time, followed by the removal of unincorporated nucleotides and optical detection of the current 
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fluorochrome. The cycle is completed by cleavage of the blocking group which allows synthesis to 
resume. 
Due to limitations in imaging technology, NGS platforms require PCR-amplified templates 
that are sequenced concurrently to obtain strong aggregate fluorescent signals. This is responsible for 
most of the shortcomings typically associated with Illumina sequencing. PCR can introduce mutations 
in the amplified templates, which decrease the quality of the generated sequence and increase the error 
rate. Furthermore, PCR is known to be affected by GC content, which may explain why certain genomic 
regions tend to be underrepresented in NGS results [72]. Finally, the relatively short read lengths that 
can be obtained by Illumina platforms can be attributed to the requirement for synchronicity across 
amplicon clones. When template clones fall out of sync, the detected fluorescent intensity does not arise 
solely from the expected cycle, but also includes lagging and leading clones. This dilutes the true signal 
with noise from preceding and succeeding cycles, known as pre-phasing and phasing respectively. As 
the number of cycles increases and more sequence is synthesized, a larger proportion of the clones is 
affected by this de-phasing phenomenon, which results in increasing interference. Thus, the effective 
read length is limited by the decreasing signal-to-noise ratio which eventually renders base 
identification infeasible.  When it first became available, CRT could only generate 35bp of reliable 
sequence from a given DNA fragment. Subsequent improvements in optical instrumentation and 
chemistry preparation have ameliorated the effects of de-phasing and allowed for incremental increases 
in read length. As a result, CRT can nowadays routinely produce 150bp-long reads, while some systems 
promise maximum lengths as high as 300bp.  
Despite their shortcomings, NGS platforms share certain advantageous features that set them 
apart from first-generation platforms. By sacrificing accuracy on the altar of efficiency, HTS can 
produce a very large number of short reads at a much lower cost than Sanger sequencing. This allows 
a high degree of redundancy, with NGS experiments designed to have multiple overlapping reads 
covering each genomic position. The high depth of coverage achievable by NGS can be leveraged by 
dedicated algorithms – such as Velvet [73] and ALLPATHS [74] – to enable de novo assembly despite 
the reduced read length and increased error rate. The true strength of NGS, however, lies in its capacity 
for rapid and comprehensive variant discovery in large-scale re-sequencing experiments. The inherent 
redundancy of NGS facilitates the detection of CNV and acts as an error correction mechanism to help 
eliminate spurious SNP calls. The adoption of pairwise sequencing protocols has also provided the 
means for identifying balanced structural variants. As a result, NGS is currently the platform of choice 
for exploring all types of genomic variation when a reference genome is available. 
1.4.4 Third-generation sequencing 
Since its inception, NGS has undergone incremental improvements owing to advancements 
in sequencing chemistry and instrumentation. Meanwhile, third generation technologies (TGS) that 
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started to emerge towards the end of the 2000s, are now vying for their place as the rightful heirs of 
NGS. While NGS’s primary contribution was increased efficiency through parallelization, TGS 
embodies an entirely novel paradigm of single molecule sequencing.  
Various transitional sequencing technologies have been developed to address the limitations 
of NGS. The most notable examples are Ion semiconductor sequencing, which offers a significant speed 
enhancement over NGS, and Helicos Genetic Analysis Platform which was the first commercial 
application of single molecule sequencing. Both of these platforms, however, suffer from some of the 
shortcomings associated with previous-generation technologies and therefore lie on the verge between 
NGS and TGS. The two leading technologies that have crossed the TGS boundary are single-molecule 
real-time (SMRT) sequencing and nanopore sequencing. SMRT was designed to track the elongation 
of a DNA strand by a single molecule of polymerase. In nanopore systems, a single DNA strand is 
guided through an aperture that is inserted into a membrane of high electric resistivity. As the ssDNA 
passes through this pore, it causes a characteristic disruption in the current flowing through the aperture, 
which can be used to identify individual nucleotides. Although these technologies are based on entirely 
different principles, what they have in common is the ability to process single DNA molecules and 
generate sequence faster, and cheaper than NGS. 
One of the primary weaknesses of NGS is the PCR amplification step that is required to 
strengthen the fluorescent signal. TGS supersedes NGS in its ability to operate on unamplified DNA, 
thereby avoiding the caveats traditionally associated with sequencing by synthesis, such as de-phasing 
and PCR bias. As a result, TGS can theoretically generate reads that are much longer than NGS (in the 
order of kilobases), without deterioration in accuracy. TGS also abolishes the need to pause the 
sequencing reaction after each reading cycle, which offers significant advantages in terms of throughput 
and turnaround time. Finally, TGS involves simpler sample preparation and requires minimal amounts 
of starting genetic materials and reagents compared to NGS. Consequently, it has the potential to lower 
the overall cost of sequencing and directly compete with NGS both in terms of performance and 
efficiency. 
As with all sequencing technologies in their infancy, TGS currently suffers from high error 
rates and relatively underwhelming read lengths. If the history of NGS is any indication, however, it 
won’t take long for TGS to deliver on its promises. 
1.5 Single-end vs pairwise sequencing 
In the early days of shotgun sequencing, the DNA templates derived from the fragmented 
genome were “read” in a single direction. This strategy was effective for sequencing short viral 
genomes, but posed challenges for more complex eukaryotic genomes. As a result, the sequencing 
community started to embrace the concept of pairwise sequencing, which involved “reading” both ends 
of a DNA fragment and tracking the paired results throughout the experiment. Two pairwise sequencing 
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protocols have been developed to address distinct sequencing challenges: paired-end sequencing and 
mate-pairs. Although pairwise approaches are more laborious than single-end sequencing, they provide 
significant benefits for downstream analyses and have therefore become standard practice for NGS 
platforms. 
1.5.1 Single-end sequencing 
Single-end sequencing is a uni-directional approach that generates one read from each DNA 
fragment in a sequencing library. It was historically the first protocol to be used for whole-genome 
shotgun sequencing, but required a cumbersome hierarchical approach to accommodate large genomes 
with repetitive structure. Consequently, in the mid-1990s, research started shifting towards pairwise 
sequencing protocols, culminating in the publication of the fruit fly genome [75], which relied on a 
mate-pair strategy. Despite its drawbacks, single-end sequencing is still in use with modern NGS 
platforms, mainly due to its lower cost.  
1.5.2 Paired-end protocol 
Paired-end strategies constitute a fundamental extension to the initial shotgun sequencing 
paradigm. The process begins by shearing the genome into short fragments, which are then size-selected 
to ensure that the resulting sequencing libraries will be homogeneous. Next, the linear fragments are 
sequenced from both sides to obtain paired reads in an inward-facing orientation. The distance between 
the paired reads, known as insert size, is typically a few hundred bases and it rarely exceeds 1kb. Due 
to the tightly controlled fragment length (which determines the insert size) and the predictable 
orientation of the reads, paired-end protocols are better equipped to resolve repetitive sequence, 
especially in the presence of pre-assembled reference genome. If at least one of the reads can be 
uniquely mapped to its original genomic position in the reference, it may be used as an anchor to 
“rescue” its ambiguously mapped pair. Thus, by jointly considering paired reads, this strategy can help 
reconstruct complex genomic regions that would have been problematic for single-end protocols. In 
view of the highly repetitive nature of most eukaryotic genomes, paired-end sequencing has become 
the standard protocol for NGS re-sequencing projects. 
1.5.3 Mate-pair protocol 
Mate-pair sequencing was initially devised as a refined approach to aid de novo assembly of 
complex genomes. In the mate-pair protocol, large DNA fragments are labelled at both ends with a 
biotin marker and then circularized. The circular fragments are then sheared to much shorter lengths 
and the unlabelled sub-fragments are washed away. Subsequently, the remaining biotinylated sub-
fragments are sequenced from both ends to obtain read pairs in an outward facing orientation. The 
circularization process adjoins the two labelled ends that are physically remote, without increasing the 
size of the fragment to be sequenced. As a result, the mate-pair insert size can be much larger than for 
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paired-end reads, spanning up to several kilobases. This provides long-range information that is 
essential for linking and orientating assembled contigs. Thus, it is no surprise that mate-pairs played a 
major role in the original human genome assembly and remain an indispensable tool for sequencing 
new species.  
1.5.4 Mixed strategies 
Although both pairwise protocols constitute substantial improvements over single-end 
sequencing, they each have distinct strengths and weaknesses. From a technical point of view, paired-
end libraries are easy to generate and require small amounts of starting DNA. On the other hand, mate-
pair libraries are low yield and tend to be more cumbersome. Functionality-wise, paired-ends are better 
suited for filling assembly gaps and resolving repeat structures, while mate-pairs excel at bridging gaps. 
Another consideration is the ability of pairwise protocols to elucidate different types of structural 
variation depending on the underlying insert size. Consequently, the ideal scenario for pairwise 
sequencing is to employ a mixture of paired-end and mate-pair libraries with different insert sizes. This 
strategy combines the best of both worlds, achieving the broadest coverage across the genome and 
detecting the widest range of structural variants. 
1.6 Short-read alignment 
NGS technologies have the capacity to generate millions of short reads per run, amounting to 
gigabases worth of sequence. In re-sequencing experiments, where the main goal is to detect and 
catalogue differences from a reference genome, mapping the sequenced reads to their original genomic 
position is the first and arguably the most crucial step for downstream analyses. 
With the rise of NGS, it became obvious that pre-existing tools designed for Sanger 
sequencing would pose an exorbitant computational burden when applied to short-read data. Therefore, 
the research community set out to develop new, efficient algorithms that could align vast numbers of 
short reads in a fast and accurate manner. To that end, alignment algorithms employ data transforms 
and heuristics to minimize the time complexity and render the process computationally feasible without 
the need for supercomputers. The majority of the established alignment algorithms rely on two distinct 
auxiliary data structures to achieve the desired time-efficiency: hash tables and substring indices. 
1.6.1 Hash table-based algorithms 
Hash tables were the driving force behind the pioneering BLAST algorithm [76] and were 
therefore the first to be adapted for short-read alignment. This class of methods was built upon a 
heuristic known as seed-and-extend and includes popular aligners such as Eland [A. J. Cox, 
unpublished], MAQ [77] and SOAP [78]. In its simplest form, the seed-and-extend approach attempts 
to match short sub-sequences (seeds) of the NGS reads against the reference. Either the reads or (in the 
case of SOAP) the reference itself are split into oligomers of predetermined length, which are then 
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hashed and stored in memory. The resulting hash table allows for fast look-up and elimination of 
mismatches, offering significant speed benefits at the expense of sensitivity. Although hash table-based 
alignment has improved considerably over the years, both in terms of functionality and of computational 
complexity, the focus has shifted towards fundamentally more efficient string matching algorithms that 
are based on substring indices. 
1.6.2 Substring index-based algorithms 
Substring indices represent a family of data structures that allow for ultra-fast retrieval of 
query patterns within a long reference string. This is usually achieved by enumerating all the suffixes 
(or prefixes) of the reference and storing them either in a tree or in an array structure to facilitate efficient 
query search. Unlike hash tables, substring indices guarantee a time complexity that is directly 
proportional to the length of the query and independent of the reference length. Another significant 
advantage of these data structures pertains to queries with multiple identical copies in the reference. 
Substring indices can retrieve all such matches with a single alignment operation, while hash tables 
need to repeat the process for each copy. 
Where substring indices and hash tables converge, however, is in their space complexity. 
Traditional substring structures can be considerably larger than the reference itself, thus requiring vast 
amounts of memory for large eukaryotic genomes. This limitation was addressed by the introduction of 
improved structures known as FM-indices, which scale linearly with reference length [79]. Although 
FM-indices share some principles with suffix arrays, their distinguishing feature is the use of the 
Burrows-Wheeler Transform to obtain a compressed output without sacrificing performance. FM-
indices are the cornerstone of modern alignment algorithms, such as BWA [80], Bowtie [81] and 
SOAP2 [82], which have been universally adopted for large resequencing projects. 
1.7 Next-generation sequencing: from genomes to exomes 
Since NGS was built upon the tenets and principles of the HGP, it initially adopted whole-
genome shotgun strategies. Despite its unparalleled potential to elucidate both sequence and structural 
variation, the cost of whole-genome sequencing (WGS) remains a limiting factor for its widespread 
application in population genomics. To address this limitation, NGS technologies have evolved to allow 
for targeted sequencing of specific subsets of the genome at a fraction of the time and cost required for 
WGS. As a result, targeted sequencing has seen wide adoption, particularly in disease cohorts where 
the required sample sizes would be prohibitive for WGS. 
1.7.1 Whole-genome sequencing 
The original paradigm of NGS was inextricably linked to whole-genome sequencing. By 
randomly fragmenting the input DNA material prior to sequencing, WGS offers an unbiased and 
comprehensive view into genomic variation. Furthermore, WGS ensures that the generated data will 
27 
 
not be convoluted by unquantifiable pre-processing steps and that the resulting noise profile will only 
be determined by the underlying sequence composition. These advantages have established high-
throughput WGS as the leading technology for studies exploring the breadth of intra-species genetic 
polymorphism, such as the 1000 Genomes Project [83] and the 3000 Rice Genomes Project [84]. The 
benefits of WGS, however, come at a price. Despite a dramatic 5-order-of-magnitude decrease in DNA 
sequencing costs in the last decade [85], human-sized genomes still pose a major expense for 
population-wide research. 
1.7.2 Targeted sequencing 
The initial enthusiasm that surrounded the advent of NGS was soon followed by the 
realization that it would be largely inaccessible to budget-constrained researchers. The ability to 
sequence pre-specified portions of a genome has rendered NGS affordable and thus contributed 
significantly to the democratization of the field. Specialized techniques have been developed for 
enriching (or capturing) certain genomic target regions prior to sequencing. The amount of the genome 
to be targeted satisfies a delicate equation that attempts to balance thoroughness against efficiency. The 
selection of the target regions depends highly on the a priori hypothesis and may comprise contiguous 
regions or disjoint genomic fractions. A common practice is to target only the protein-coding regions, 
which span 30 megabases (Mb) and constitute approximately 1% of the human genome. This strategy 
is known as whole-exome sequencing (WES) and is especially effective for elucidating rare Mendelian 
disorders that tend to be disproportionately affected by coding mutations [86]. Contrariwise, when prior 
knowledge indicates the need for in depth exploration of a candidate region in large sample sizes, it is 
preferable to target contiguous sequence that encompasses the region of interest. 
1.8 1000 Genomes Project 
The 1000 Genomes Project is a ground-breaking international research effort that set out to 
create the most detailed catalogue of human genetic variation using high-throughput sequencing. At the 
project’s conception in 2007, a diverse academic consortium was formed under the vision of 
characterizing the full spectrum of DNA polymorphism in multiple human populations. The original 
goal of the consortium was to collect, sequence and analyse at least 1000 samples within 3 years. To 
facilitate this immense undertaking, the project launched in 2008 with a pilot phase that aimed to inform 
the design of the main project. 
The pilot phase comprised three relatively small studies, which were intended to investigate 
the project’s primary experimental configurations: low-coverage WGS of unrelated individuals, high-
coverage WGS of trios and high-coverage targeted sequencing of ~1,000 genes. Furthermore, the pilot 
employed various NGS technologies, including 454’s pyrosequencing, SOLiD’s sequencing-by-
ligation and Illumina’s CRT. Sequencing library construction was also interrogated by comparing 
single-end versus pairwise protocols and considering differential insert sizes and variable read lengths. 
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The analysis of the pilot phase [87] reported more than eight million novel sequence and structural 
variants and demonstrated the project's vast potential for elucidating genomic variation. The results of 
the pilot also indicated that low-coverage WGS could efficiently identify common variants, while deep 
targeted sequencing was ideal for uncovering rare variants of functional interest. Thus, for the main 
project, the trio approach was deemphasised, while the targeted strategy was expanded from a gene 
subset to the whole-exome. Also, single-end libraries were gradually eliminated in favour of pairwise 
protocols. 
The main project commenced in late 2009 with the expanded goal of sequencing 2,500 
geographically diverse samples, in 3 phases. Phase 1 represented the initial round of exome and low-
coverage WGS, which comprised 1,092 individuals from 14 different populations. The completion of 
phase 1 in mid-2011 surpassed the project’s eponymous milestone, while the accompanying analysis 
[67] reported major methodological advances. Phases 2 and 3 examined an additional ~1,500 
individuals from 12 new populations, bringing the total number of sequenced samples to 2,504. These 
latter phases relied exclusively on Illumina sequencing platforms and adopted newer protocols that 
generated longer and higher-quality reads. The final release of phase 3 results in the summer of 2014 
signified the culmination of a monumental 5-year endeavour that revolutionized the field of genomics.  
The legacy of the 1000 Genomes Project is broad and multifaceted. First, it represents the 
largest repository for open-access human genomic data. True to its roots as a community resource, the 
1000 Genomes Project prioritized the rapid and unrestricted release of both raw and analysed 
sequencing results. Thus, it granted the scientific community unprecedented access to nascent NGS 
technologies and established an extensive reference dataset for future studies. Moreover, in the process 
of generating this vast collection of data, the 1000 Genomes Project has create the tools and procedures 
that drive modern genomics. It determined the best experimental protocols and explored their capacity 
for variant detection. It also developed a plethora of computational analysis techniques and defined 
standardized file formats. As a result, the 1000 Genomes Project has provided an arsenal of transferable 
strategies that continue to inspire and facilitate genomics research the world over. 
1.9 Sequencing-based CNV detection 
The advent and ensuing dissemination of NGS platforms signalled a new era in the study of 
CNV. NGS combines the high throughput of microarrays with the fine resolution of Sanger sequencing 
to facilitate unparalleled CNV detection. At the same time, NGS offers an extremely high degree of 
multiplexing that allows for truly unbiased CNV discovery throughout the genome. A single NGS 
experiment generates multiple features that can provide evidence of underlying CNVs. Two 
complementary approaches have been developed to extract information from these features based on 
the existence of a reference genome: de novo assembly and short-read alignment. De novo assembly 
carries a heavy computational burden and is thus better suited for organisms without a reliable reference 
genome. The human genome, on the other hand, has the highest quality reference of any mammalian 
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species and is thus more amenable to alignment-based approaches. Our project focuses on human 
sequencing datasets and was therefore developed on the foundation of short-read alignment. 
1.9.1 Alignment and CNV detection 
Alignment algorithms were originally devised as tools for “reversing” the effects of shotgun 
fragmentation and reconstructing the underlying sequence. However, the alignment output is also a rich 
source of auxiliary information that can be exploited for the purposes of CNV detection. There are 3 
main features of a paired-end NGS alignment that can elucidate the presence of CNV: read depth, read 
pair inconsistency and split reads. These features arise through different mechanisms and thus provide 
independent CNV signals. 
1.9.2 Read Depth  
Read depth (RD) is a unique measurement assigned to every genomic position that represents 
the number of times it has been sequenced during an NGS experiment. RD is calculated by counting 
the number of reads aligning to a specific position and is thus theoretically proportional to the 
underlying copy number. Moreover, for each sequenced sample there is an associated summary statistic 
that quantifies the expected value of RD and is known as depth of coverage (DOC). Formally, DOC 
can be defined as the average number of reads representing any base in the reconstructed sequence, and 
is calculated as follows: 
𝐷𝐷𝐷𝐷𝐷𝐷 = 𝑛𝑛𝑛𝑛𝑛𝑛𝑛𝑛𝑛𝑛𝑛𝑛 𝑜𝑜𝑜𝑜 𝑛𝑛𝑚𝑚𝑚𝑚𝑚𝑚𝑛𝑛𝑚𝑚 𝑛𝑛𝑛𝑛𝑚𝑚𝑚𝑚𝑟𝑟 ∗ 𝑚𝑚𝑎𝑎𝑛𝑛𝑛𝑛𝑚𝑚𝑎𝑎𝑛𝑛 𝑛𝑛𝑛𝑛𝑚𝑚𝑚𝑚 𝑙𝑙𝑛𝑛𝑛𝑛𝑎𝑎𝑙𝑙ℎ
𝑙𝑙𝑛𝑛𝑛𝑛𝑎𝑎𝑙𝑙ℎ 𝑜𝑜𝑜𝑜 𝑛𝑛𝑛𝑛𝑜𝑜𝑛𝑛𝑛𝑛𝑛𝑛𝑛𝑛𝑟𝑟𝑛𝑛 𝑟𝑟𝑛𝑛𝑠𝑠𝑛𝑛𝑛𝑛𝑛𝑛𝑟𝑟𝑛𝑛  (1.1) 
Based on the proportionality hypothesis, substantial deviations of RD from the DOC are indicative of 
CNV. FIGURE 1.1 demonstrates the RD alignment signatures generated by deletions and duplications. 
 
FIGURE 1.1 Illustration of read depth alignment signatures generated by CNV. 
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1.9.3 Read Pair Inconsistency 
Read Pair (RP) analysis takes advantage of the “coupled” reads generated by pairwise 
sequencing protocols to deduce the presence of structural variation. The first step in this process 
involves joint mapping of read pairs to a reference genome. Inconsistencies in the distance or the relative 
orientation of the mapped pairs can subsequently be used as evidence for detecting both dosage-altering 
and dosage-invariant SVs. 
CNVs can be inferred by comparing the actual distance of a mapped RP to the expected insert 
size. The insert size is an intrinsic property of every sequencing library and should, in theory, be fixed 
and constant. Pairs that align significantly farther apart than anticipated by the library insert size 
correspond to potential deletions. Conversely, pairs that align too close are likely due to insertions or 
duplications. The resulting RP alignment signatures are demonstrated in FIGURE 1.2. 
 
 
FIGURE 1.2 Illustration of read pair alignment signatures generated by CNV. 
 
1.9.4 Split Reads 
Split Reads (SR) represent a category of atypical alignments that are uniquely capable of 
resolving CNV with basepair precision. There are two main scenarios that give rise to split reads: either 
a read happens to span the breakpoints of a deletion or it encompasses an entire (albeit small) insertion. 
As a consequence, these reads can be “split” into subsegments originating from distinct and 
discontiguous genomic regions of the reference.  
Traditional techniques attempt to align sequencing reads in their entirety and thus usually fail 
to map split reads with sufficient confidence. However, by utilizing dedicated algorithms, split read 
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analysis can yield an invaluable tool for fine-mapping CNV breakpoints. A schematic of SR alignment 
signatures is presented in FIGURE 1.3. 
 
FIGURE 1.3 Illustration of split read alignment signatures generated by CNV. 
 
1.9.5 Motivation of feature integration 
Since CNV is distinctly manifested in all of the aforementioned alignment features, they can 
conceivably be analysed independently and in isolation. Nevertheless, each component has unique 
strengths and weaknesses that renders it more suitable for CNVs with specific properties. 
Read depth is readily obtainable from both single-end and pairwise sequencing libraries and 
plays an essential role in determining absolute copy numbers [88]. However, it suffers from low 
breakpoint resolution and limited sensitivity for small variants (<500bp), especially in low-coverage 
contexts. Read pairs, on the other hand, are less susceptible to depth of coverage fluctuations and tend 
to be more sensitive to CNVs caused by retrotransposable elements [89]. Yet, the interpretation of read 
pair inconsistencies is often confounded by ambiguous alignments, which have an adverse effect on the 
detection of variants flanked by repetitive sequence. Finally, split reads can achieve incomparable 
breakpoint resolution but require longer sequencing reads and remain practically undetectable in 
repetitive regions. 
Given the performance profile of each alignment feature, it becomes apparent that they are 
individually inadequate for exhaustive CNV detection. Therefore, a thorough investigation of the entire 
CNV spectrum can only be achieved by incorporating information from multiple features and 
leveraging their synergistic relationships. 
1.10 Aims and structure of thesis 
The primary aim of this project was to develop a novel statistical framework that takes 
advantage of all available NGS alignment features to allow for an accurate and thorough investigation 
of CNV in the human genome. 
The origins of the project lie in the conceptualization of an integrative schema that could 
combine evidence from disparate sources, while maintaining a high degree of modularity. In this 
paradigm, each alignment feature would constitute a separate module that could be processed and 
modelled individually, but would then be assessed jointly with the other modules to identify CNV. 
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Chapter 2 describes the statistical strategies that were developed for each alignment feature, as well as 
the unifying CNV calling framework. 
This work has been inextricably linked with the 1000 Genomes Project, closely mirroring its 
progress. The development stages outlined in chapter 2 were based on data from the Project’s pilot 
phase [87]. The publication of the first phase of sequencing results [67] prompted the systematic 
application of our new framework to whole-genome data, which is described in chapter 3. This chapter 
also includes an extensive benchmarking study that demonstrates the substantial benefits of integrative 
CNV detection. 
As the focus of the genomics community started shifting away from WGS, we set out to 
explore the applicability of our framework to targeted sequencing datasets. Chapter 4 examines the 
challenges posed by the target capture process and introduces the extensions to our framework that were 
developed to address them. These extensions comprise customized strategies for handling the alignment 
features along with a refined CNV calling component. Building on the principles laid out in chapter 4, 
we developed an application of our extended framework for contiguous capture sequencing data. 
Chapter 5 details the implementation of this application and illustrates its significant advantages over 
existing methods. 
Targeted sequencing experiments can also generate large amounts of data in untargeted 
regions. Such off-target results, however, are highly irregular in nature and can therefore not be analysed 
with traditional techniques. Chapter 6 describes a further extension of our statistical framework that 
facilitates off-target CNV detection. This involves an adaptive normalization strategy designed to 
counteract off-target heterogeneity. Our novel approach was benchmarked using phase 1 WES data 
from the 1000 Genomes Project and was found to outperform competing algorithms by a wide margin. 
The final chapter summarizes the milestones of the thesis and offers perspective on the results. 
Moreover, it discusses potential future extensions and applications for our statistical methods.  
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Chapter 2 
Chapter 2 Statistical Framework for CNV detection 
Statistical Framework for CNV detection 
  
In Chapter 1, we gave a historical and technical overview of CNV detection, emphasizing the 
significant improvements afforded by NGS technologies. Furthermore, we outlined the NGS alignment 
features that harbour evidence of CNV as well as the rationale behind integrating these features instead 
of analysing them independently. In this chapter, we will describe how information is extracted from 
alignment features and how this information is transformed into a numerical format amenable to CNV 
segmentation. We also provide a concise review of notable NGS-based CNV methods designed to 
exploit different features. The chapter concludes with the description of the statistical framework that 
was developed to combine individual features into a comprehensive CNV detection algorithm. This 
framework is derived from a Hidden Markov model (HMM) that was previously described for inferring 
CNV in microarray experiments [90]. The parametric nature of the HMM allows us to employ tailored 
probability distributions to link each alignment feature with the unobserved copy numbers. For narrative 
purposes, the statistical modelling aspects of our algorithm are detailed prior to the formal definition of 
the HMM, in the sections dedicated to each feature. 
This chapter presents the conceptual underpinnings of the project and thus remains abstract 
and detached from practical applications. The contents of this chapter lay the foundation for the thesis 
and comprise the methodological aspects of the following published article: 
E. Bellos, M. R. Johnson and L. J. M. Coin (2012). "cnvHiTSeq: integrative models for high-resolution copy 
number variation detection and genotyping using population sequencing data." Genome Biol 13(12): R120. 
 
Our algorithm was developed using pilot phase datasets from the 1000 Genomes Project. Although 
multiple sequencing technologies were initially considered, the 1000 Genomes Consortium eventually 
adopted Illumina’s solution. This arguably cemented Illumina’s fate as the platform of choice for NGS 
applications and was thus the only technology considered in our project. Furthermore, the sequencing 
community adopted a unified format for NGS alignment results, known as Binary Alignment Map 
(BAM) [91], which constitutes the input of our algorithm and will therefore be referenced throughout 
this thesis.     
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2.1 Read Depth 
Read depth is the only alignment feature that has a direct and evident relationship with CNV. 
RD is an implicit measure of the starting DNA dosage and thus localized RD fluctuations usually 
correspond to genomic regions deviating from euploidy. Considering the inherent redundancy of NGS 
experiments, a comparison of RD to the overall depth of coverage can be used to estimate absolute copy 
numbers: 
𝑚𝑚𝑙𝑙𝑜𝑜𝑝𝑝𝑚𝑚𝑝𝑝 ∗
𝑅𝑅𝐷𝐷
𝐷𝐷𝐷𝐷𝐷𝐷
= 𝑚𝑚𝑛𝑛𝑟𝑟𝑜𝑜𝑙𝑙𝑛𝑛𝑙𝑙𝑛𝑛 𝑟𝑟𝑜𝑜𝑚𝑚𝑝𝑝 𝑛𝑛𝑛𝑛𝑛𝑛𝑛𝑛𝑛𝑛𝑛𝑛 (2.1) 
All the necessary information for calculating and analysing RD are contained in the standardized output 
of established read alignment tools, such as BWA and Bowtie.  
2.1.1 Pre-processing 
The RD pre-processing begins by filtering the BAM alignment files to discard unmapped 
reads, low quality alignments and duplicate reads, which would artificially inflate the results. To 
facilitate downstream analyses, the results are then reformatted into BAM files. Next, the filtered files 
are sorted by coordinate and converted to the pileup format using the SAMtools software package [91], 
which provides a set of utilities for manipulating alignments. The pileup format comprises a summary 
of the alignment by genomic position, including a count of aligned reads. This count constitutes the raw 
RD measurement and is extracted from the pileup file to minimize its memory footprint. Nevertheless, 
even in this reduced representation, the raw RD is of prohibitive size both for storage and for analysis. 
Therefore, we split the files up by chromosome and developed a compression scheme that combines 
run-length encoding and ASCII-to-binary conversion to achieve a 60-fold decrease in file size. 
2.1.2 Statistical Modelling 
RD shares certain similarities with microarray fluorescent intensity. As a result, RD is often 
treated as a successor to intensity ratios, which are generally assumed to arise from a normal 
distribution. This hypothesis stems from the fact that the variance in microarray intensities is lowest for 
copy-neutral states and increases in the presence of both deletions and duplications [92]. In RD signal, 
however, the variance is lowest for deletion states and increases with increasing copy number, thus 
violating the assumption of normality. 
Since RD is calculated by piling up the mapped reads, it occurs in the form of discrete counts. 
Count data has traditionally been modelled using the Poisson distribution, with a probability mass 
function: 
𝑜𝑜(𝑘𝑘; 𝜆𝜆) = 𝜆𝜆𝑘𝑘
𝑘𝑘! 𝑛𝑛−𝜆𝜆 (2.2) 
where 𝑘𝑘 ∈ {0,1,2, … } and the λ parameter corresponds to the expected value of the count variable. An 
important limitation of the Poisson distribution is that the mean of the underlying data is assumed to be 
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equal to its variance, as quantified by its single parameter. The standard metric used to assess the 
relationship between the mean (μ) and the variance (σ2) of a dataset is the dispersion index: 
𝐷𝐷 = 𝜎𝜎2
𝜇𝜇
 (2.3) 
The dispersion index can be used to classify datasets as described in TABLE 2.1. 
Dispersion Index value  Interpretation  
D=0 constant 
0<D<1 underdispersed  
D=1 equidispersed  
D>1  overdispersed  
TABLE 2.1  Interpretation of dispersion index. 
There has been a documented overdispersion in RD data [65] due to the non-uniform distribution of 
mapped reads across the genome. We verified this observation by calculating the RD dispersion index 
in a 60-sample dataset obtained from the low-coverage pilot phase of the 1000 Genomes Project. These 
samples are invariably overdispersed, with an average variance-to-mean ratio of 1.7 and values reaching 
up to 3.6. Consequently, RD appears to fail the equidispersion assumption of the Poisson model. To 
overcome this limitation of Poisson we considered fitting specialized alternative distribution that can 
accurately capture the excess variance. 
2.1.2.1 Negative Binomial Distribution 
The Negative Binomial Distribution (NBD) has been extensively used to model overdispersed 
data. We followed the parameterization adopted in [93] according to which, if Y is a negative binomial 
random variable, with mean parameter m and dispersion parameter c, its probability  mass function is 
given by: 
𝑜𝑜(𝑝𝑝 | 𝑛𝑛, 𝑟𝑟) = 𝛤𝛤(𝑝𝑝 + 𝑟𝑟−1)
𝑝𝑝!𝛤𝛤(𝑟𝑟−1) � 𝑟𝑟𝑛𝑛1 + 𝑟𝑟𝑛𝑛�𝑦𝑦 � 11 + 𝑟𝑟𝑛𝑛�𝑐𝑐−1 (2.4) 
where 𝑝𝑝 ∈ {0,1,2, … }. The c parameter can take both negative and positive values, to model 
underdispersion and overdispersion respectively, and it has been shown that lim
𝑐𝑐→0
𝑁𝑁𝑁𝑁(𝑛𝑛, 𝑟𝑟) =
𝑃𝑃𝑜𝑜𝑝𝑝𝑟𝑟𝑟𝑟𝑜𝑜𝑛𝑛(𝑛𝑛). 
Following the results of Saha and Paul [93] regarding bias and efficiency, we considered three 
estimators for the parameters of NBD: 
• the Method of Moments (MM) estimator, which is the simplest and least computationally intensive. 
• the Maximum Likelihood (ML) estimator, which requires numerically maximizing the log 
likelihood equation. 
• the Double-Extended Quasi-Likelihood (DEQL) estimator, which was introduced in [94]. 
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The MM estimator simply equates the first two sample moments with the corresponding population 
moments so that 𝑛𝑛� = 𝑝𝑝� and ?̂?𝑟𝑀𝑀𝑀𝑀 = (𝑟𝑟2 −  𝑛𝑛�) 𝑛𝑛�2�  , where 𝑝𝑝� is the sample mean and 𝑟𝑟2 is the sample 
variance. 
ML estimates of m and c can be obtained by setting 𝑛𝑛� = 𝑝𝑝� and solving the following equation for ?̂?𝑟𝑀𝑀𝑀𝑀: 
��
1
𝑟𝑟2
ln(1 + 𝑟𝑟𝑛𝑛�) − 𝑝𝑝𝑖𝑖 − 𝑛𝑛�
𝑟𝑟(1 + 𝑟𝑟𝑛𝑛�) − � 1𝑟𝑟(1 + 𝑟𝑟𝑐𝑐)𝑦𝑦𝑖𝑖−1
𝑗𝑗=0
�
𝑛𝑛
𝑖𝑖=1
= 0 (2.5) 
DEQL estimates were obtained by setting 𝑛𝑛� = 𝑝𝑝� and then solving the following equation for ?̂?𝑟𝐷𝐷𝐷𝐷𝐷𝐷𝑀𝑀: 
��
1
𝑟𝑟2
ln �1 + 𝑟𝑟𝑛𝑛�1 + 𝑟𝑟𝑝𝑝𝑖𝑖� + 𝑝𝑝𝑖𝑖 − 𝑛𝑛�𝑟𝑟(1 + 𝑟𝑟𝑛𝑛�) − 2𝑟𝑟𝑝𝑝𝑖𝑖 + 2 − 𝑟𝑟2𝑟𝑟2(1 + 𝑟𝑟𝑝𝑝𝑖𝑖) + 2 − 𝑟𝑟2𝑟𝑟2 − 𝑟𝑟𝑝𝑝𝑖𝑖(2 + 𝑟𝑟𝑝𝑝𝑖𝑖)12(1 + 𝑟𝑟𝑝𝑝𝑖𝑖)2�𝑛𝑛𝑖𝑖=1 = 0 (2.6) 
Numeric solutions to the above equations were computed using Brent's root-finding algorithm [95], 
which is a combination of the bisection, the secant and the inverse quadratic interpolation methods. 
According to the simulation study conducted in [93], MM and DEQL are the most efficient estimators, 
while ML tends to have the smallest bias. 
2.1.2.2 Generalized Poisson Distribution 
We also considered the two parameter 𝜆𝜆1, 𝜆𝜆2 Generalized Poisson Distribution (GPD), which 
was devised as a limiting form of the generalized NBD [96]. The probability mass function of this 
distribution is: 
𝑜𝑜(𝑝𝑝 | 𝜆𝜆1, 𝜆𝜆2) = 𝜆𝜆1(𝜆𝜆1 + 𝑝𝑝𝜆𝜆2)𝑦𝑦−1𝑛𝑛−(𝜆𝜆1+𝑦𝑦𝜆𝜆2)𝑝𝑝!  (2.7) 
where 𝑝𝑝 ∈ {0,1,2, … }, 𝜆𝜆1 > 0 and |𝜆𝜆2| < 1. 𝜆𝜆2 controls the variance of the distribution, and the classical 
Poisson distribution is just a special case of GPD with 𝜆𝜆2 = 0. 
The parameters of GPD were estimated using the method of moments, and can thus be 
expressed in terms of the sample mean 𝑝𝑝�, and variance 𝑟𝑟2 as follows: 
𝜆𝜆2 = 1 − � 𝑝𝑝�𝑟𝑟2�12 , 𝜆𝜆1 = 𝑝𝑝�  ∗ (1 − 𝜆𝜆2) (2.8) 
2.1.2.3 Weighted Poisson Distribution 
Finally, we considered the three parameter Weighted Poisson Distribution (WPD) [97], which 
generalizes Poisson by weighting it with 𝑤𝑤(𝑘𝑘) = (𝑘𝑘 + 𝑚𝑚)𝑟𝑟, where α is a positive displacement 
parameter and r is a dispersion parameter that can take both positive and negative values to account for 
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underdispersion and overdispersion respectively. The probability mass function of WPD can be defined 
as: 
𝑜𝑜(𝑝𝑝 | 𝜆𝜆, 𝑛𝑛, 𝑚𝑚) = 𝑛𝑛𝑘𝑘𝑘𝑘𝑘𝑘𝑘𝑘𝜆𝜆+𝑟𝑟𝑘𝑘𝑘𝑘𝑘𝑘(𝑘𝑘+𝑎𝑎)
𝑝𝑝!𝐷𝐷(𝜆𝜆, 𝑛𝑛,𝛼𝛼)  (2.9) 
where 𝑝𝑝 ∈ {0,1,2, … } and 𝐷𝐷(𝜆𝜆, 𝑛𝑛,𝛼𝛼) = ∑ 𝜆𝜆𝑦𝑦(𝑝𝑝 + 𝑚𝑚)𝑟𝑟 𝑝𝑝!�∞𝑦𝑦=0 . It is shown in [97] that series C converges 
for all λ > 0, α > 0 and 𝑛𝑛 ∈ ℝ. In the special case when r = 0, WPD collapses to the classical Poisson 
with parameter λ. 
Due to the high computational burden of estimating three parameters, we instead chose to 
work with a two-parameter model by fixing the value of parameter α. Thus, the log-likelihood function 
of WPDα for a random sample 𝑝𝑝 = (𝑝𝑝1,𝑝𝑝2, … , 𝑝𝑝𝑛𝑛) can be expressed as: 
𝑙𝑙𝑎𝑎(𝜆𝜆, 𝑛𝑛 | 𝑝𝑝) = 𝑛𝑛[𝑙𝑙𝑜𝑜𝑎𝑎(𝜆𝜆)𝑝𝑝� + 𝑛𝑛𝑙𝑙2 − 𝑙𝑙𝑜𝑜𝑎𝑎𝐷𝐷(𝜆𝜆, 𝑛𝑛,𝛼𝛼)] (2.10) 
where 𝑝𝑝� is the sample mean and 𝑙𝑙2 is the log-geometric mean of the sample shifted by the value of α: 
𝑙𝑙2 = 1𝑛𝑛∑ log (𝑝𝑝𝑖𝑖 + 𝛼𝛼)𝑛𝑛𝑖𝑖=1  (2.11) 
The log-likelihood equation 2.10 is highly non-linear and therefore needs to be solved numerically. We 
followed the scoring method proposed in [97] to study the profile log-likelihood while varying 
parameter α and finally selected the parameter triplet that yields the highest log-likelihood. 
Unfortunately, the scoring method requires inverting the Fisher Information Matrix, which is not always 
trivial and can prove detrimental to the estimation process. In the instances when the scoring method 
fails, we resorted to conjugate direction search to maximize the log-likelihood function. 
2.1.2.4 Best fit Model 
In order to determine the appropriate model for the observed read depth, we fitted each of the 
proposed distributions to chromosome 1 data obtained from the same 60 samples used in our dispersion 
calculations. Pericentromeric and telomeric regions were excluded from this analysis. The goodness of 
fit of each distribution was measured separately for each sample using Pearson's χ2 test: 
𝜒𝜒2 = � (𝐷𝐷𝑘𝑘 − 𝐸𝐸𝑘𝑘)2
𝐸𝐸𝑘𝑘
𝑛𝑛
𝑘𝑘=1
 (2.12) 
where Ok is the empirical frequency for read depth observation k calculated from the data, and Ek is the 
expected frequency for the same observation as determined by each of the examined distributions. The 
read depth was sampled every 100bp resulting in ~2,252,800 observations per sample. We then 
calculated five-number statistics for χ2 across all samples and the results of this analysis are depicted in 
the form of boxplots in FIGURE 2.1. 
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FIGURE 2.1 Goodness of fit for the distributions proposed to model read depth 
 
As observed in FIGURE 2.1, the Weighted Poisson Distribution provides the best fit to our overdispersed 
read depth data, with a much lower mean χ2 and a lower variance than the rest. It is also evident that the 
Maximum Likelihood NBD estimator performs almost identically to the DEQL NBD estimator, 
providing the second best fit to the data. The Method of Moments NBD estimator is ranked third only 
marginally ahead of the Generalized Poisson Distribution. 
Despite the apparent superiority of WPD, it suffers from two substantial weaknesses. First, 
the WPD parameter estimation process failed in 20 of the 60 samples either due to singular Fisher 
Information Matrices or due to convergence failure. This may exclude samples that would be modelled 
poorly by WPD, thus biasing the results. Second, since WPD is a 3-parameter model, the estimation 
process is very computationally demanding and therefore prohibitive for real applications. Furthermore, 
the increased complexity of the WPD model could lead to overfitting, which would account for its 
seemingly strong performance. On the other hand, the MM NBD estimation is the fastest, since it only 
requires the calculation of the mean and variance of the sample, but the resulting distribution is a 
relatively poor model for the real data. Therefore, read depth was ultimately modelled using ML NBD 
which provides a good compromise between complexity and goodness of fit. 
2.1.3 Notable RD-based methods 
Read depth is easily interpretable and can be unambiguously ascertained using standard 
alignment algorithms. As a result, multiple solely RD-based approaches have been proposed for 
detecting CNVs, the most notable of which are briefly reviewed below. 
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Event-wise testing (EWT) [92] was one of the earliest RD methods to attempt high-resolution 
CNV segmentation and relies heavily on significance testing. EWT first calculates windowed RD 
counts and performs bias correction. The adjusted counts are then converted into z-scores by subtracting 
the mean of all windows and dividing by the standard deviation. Finally, EWT uses this z-score to 
calculate upper- and lower-tail probabilities from a normal distribution. However, as we have 
demonstrated, this normality assumption is unrealistic for RD data. To address this issue, EWT resorts 
to larger RD window sizes, which allow for better normal approximation at the expense of resolution 
and small-variant sensitivity. 
CNVnator [98] borrows the mean-shift technique from image processing in order to 
iteratively partition the genomic sequence according to copy number. The mean-shift algorithm 
partitions the sequence into bins of equal length and then "shifts" each bin towards the local density 
maximum of the underlying RD probability distribution. By assigning the direction of each bin to point 
towards the local maximum, this procedure effectively segments the RD signal into neighbourhoods of 
local modes. Breakpoints designated by neighbouring bins have opposite directions. Both the strength 
and the weakness of this method stem from the fact that it does not require any prior knowledge 
regarding the RD signal and its probability distribution. This allows CNVnator to achieve a high 
breakpoint resolution depending only on the bin size and not on read length or DOC. However, this 
non-parametric approach also means that the partitioning process has to be followed by separate CNV 
calling and significance testing steps, which ultimately involve normality assumptions. 
2.2 Read Pairs 
Read pair inconsistencies are strong indicators of CNV, but require a more nuanced approach. 
A direct comparison between the mapped distance of a pair and the expected insert size would be 
sufficient if the insert size was constant. However, the construction of paired-end sequencing libraries 
involves a size-selection step which is subject to experimental noise. Consequently, libraries include 
fragments of variable length and the observed insert size is distributed around the target value. RP-
based CNV detection is contingent on distinguishing between CNV-associated distance inconsistencies 
and insert size variability. This is especially critical for identifying small variants that cause only small 
perturbations in the mapped RP distance and can be difficult to separate from noise. To address these 
challenges we developed a custom framework for normalizing and enhancing RP signal. 
2.2.1 Pre-processing 
Read pair data is extracted from BAM alignment files after a rigorous filtering process. In 
addition to duplicate and unaligned reads, we also filter out reads with non-unique alignments as they 
introduce ambiguity. Both reads of a pair are required to have a high mapping quality (phred-scaled 
score > 20) and originate from a distinct sequencing library. Reads fulfilling the aforementioned criteria 
are split into separate files according to the sequencing library from which they originate. This is to 
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ensure that libraries with dissimilar insert sizes will be processed appropriately. Since all the necessary 
information for CNV detection is contained in the observed RP distance, each pair is represented by 
two variables: 
• a single set of genomic coordinates defined by the end coordinate of the “upstream” read and the 
start coordinate of the “downstream” read. 
• the corresponding observed RP distance. 
 
2.2.2 Inter-library Normalization 
In high coverage samples, each sequencing library contains enough reads to be analysed 
individually. On the other hand, in low-coverage samples, data from all the libraries need to be pooled 
in order to obtain enough overlapping read pairs. When pooling, we account for potential inter-library 
differences by quantile-normalizing the observed RP distances to a reference distribution. Since insert 
size has been shown to be approximately normally distributed [99] we use an arbitrary Gaussian 
N(200,15) as a reference. Traditionally, sample quantiles are estimated using the empirical distribution 
function. However, if a library contains only a small number of read pairs, the inherent variability of 
read pair distance may lead to biases, which could severely affect CNV detection. Therefore, we use a 
kernel quantile estimator which has been shown to have a higher efficiency than the empirical 
distribution estimator [100]. A standard Gaussian kernel function was chosen, while the bandwidth was 
determined in each case by the formula [101]: 
ℎ = 𝑚𝑚𝑘𝑘 ∙ 1.36374 ∙ min �𝑟𝑟, 𝐼𝐼𝐼𝐼𝑅𝑅 1.34� � ∙ 𝑛𝑛−1 5�  (2.13) 
where αk is a constant that depends on the kernel (αk = 0.7764 for Gaussian kernels), s is the standard 
deviation of the observations, IQR is the interquartile range and n is the number of observations in the 
sample. 
2.2.3 Summarizing RP evidence 
The normalization process alters the mapped RP distance but leaves the alignment coordinates 
unaffected. This allows us to treat each pair as a single "pseudo-read" carrying an extra weight quantity 
equal to the normalized RP distance. Following the RD paradigm, the pseudo-reads are piled up across 
the genome and each position is assigned two metrics: an average normalized distance of all spanning 
read pairs (RPS) and a spanning read pair count (RPC). RPS is the primary source of RP evidence, 
which can be used to identify local deviations from the expected insert size. RPC provides an auxiliary 
measure of coverage that may differ from the overall RD either due to the exclusion of non-unique 
alignments or due to the presence of both single-end and paired-end libraries.  
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2.2.4 Statistical Modelling 
As described previously, RP distance is generally well approximated by the normal 
distribution. In some rare cases the distribution of distances appears to be bimodal. This is due to 
molecular artifacts that produce chimeric inserts and indicate poor quality control. Therefore, we 
disregard such occurrences and model RPS as a normal distribution. The Gaussian parameters for the 
copy-neutral state are set to reflect the size and random variation of the insert library (in our case 200 ± 
15bp, as determined by the inter-library normalization reference). The mean RPS for homozygous 
(heterozygous) deletions is expected to be 3 (2) standard deviations above the library insert size, and 
conversely for insertions. 
The spanning RP count is closely related to RD and thus displays signs of overdispersion. 
Contrary to RD, however, RPC omits reads with multiple alignments, which account for a large portion 
of the variance. As a result, RPC is expected to be more weakly overdispersed than RD. This hypothesis 
is verified in our 60-sample test dataset, which exhibits an average RPC dispersion index of 1.3 (versus 
1.7 for RD). Therefore, we employ the negative binomial distribution to model RPC, but adopt lower 
values for the dispersion parameter. 
The individual probabilities of RPS and RPC are multiplied to obtain a single read pair 
measurement. This can be interpreted as “weighting” the RPS evidence using evidence from RPC and 
allows us to assign more confidence to RP distances stemming from sufficient RP coverage. Thus, we 
overcome an important limitation of competing methods, which use hard thresholds on the number of 
read pairs supporting a CNV. This is especially important for detecting deletion events in low-coverage 
data, as the scarcity of RPs should not be equated with absence of CNV. On the other hand, our approach 
also downweights regions that appear to have extremely high RP counts, as they most likely correspond 
to sequencing artifacts or highly redundant segments of the reference. 
2.2.5 Notable RP-based methods 
The capacity of read pair inconsistencies to elucidate structural variation was first explored 
using early-generation BAC sequencing technologies [102]. The advent of paired-end NGS signalled a 
renewed interest in RP-based CNV detection, which led to significant advances in method development. 
The strategies employed by existing algorithms fall into two main categories: clustering approaches and 
parametric methods. 
A general framework for clustering-based RP analysis was first proposed by Tuzun et al. 
[103], which also introduced the standard nomenclature. In this context, a read pair is considered 
"concordant" if the observed mapped distance falls within a pre-specified range, and if both reads are 
aligned to the expected chromosome in the correct orientation. Various CNV discovery methods have 
since been designed to take advantage of "discordant" RP information. The most notable algorithm that 
relies solely on clustering principles is VariationHunter [104]. VariationHunter takes into account 
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multiple alignments and considers a RP as discordant if none of its mappings can be classified as 
concordant. It then clusters the discordant pairs into sets that can potentially support the same variant. 
However, since reads are allowed to have multiple alignments, some pairs may belong to more than one 
cluster. The algorithm adopts a maximum parsimony approach to solve this problem as it tries to assign 
a unique mapping to each discordant RP such that the total number of resulting CNVs is minimized. As 
with all clustering-based methods, the resolution of VariationHunter largely depends on how the 
concordant range of RP distances is defined. The method's main shortcoming, however, stems from the 
fact that the specified maximum parsimony problem is NP-hard, which means that a solution can only 
be approximated in polynomial time. 
Parametric methods, on the other hand, do not impose strict distance cut-off points in order 
to classify RPs as discordant. Instead, the local distribution of distances for a given genomic region, is 
compared to a genome-wide insert size distribution in search of significant differences that will provide 
evidence of CNV. Parametric algorithms are largely complementary to those based on clustering, since 
they appear to be more suitable for detecting smaller CNVs. BreakDancer [105] is a unique 
computational tool that addresses this limitation by incorporating both a clustering and a parametric 
component. First, BreakDancer utilizes a clustering approach, by searching for genomic regions that 
contain significantly more discordant RPs than expected and assigning them with a confidence score 
based on a Poisson model. Then, BreakDancer focuses on the unused RPs and applies a sliding-window 
to determine if the local RP distances are significantly different from the “global” distribution. In an 
effort to minimize false positive calls, both components require at least two discordant pairs to support 
each putative CNV call. Despite its more comprehensive nature, the resolution of BreakDancer depends 
highly on DOC and the size of the insert library. According to simulations, for a typical 200bp insert 
library, BreakDancer requires coverage higher than 20x in order to achieve a high sensitivity for short 
deletions. 
2.3 Split Reads 
Split reads constitute a powerful alignment feature that can facilitate unparalleled breakpoint 
resolution in CNV detection. Split reads contain the exact fingerprints of CNV and thus their existence 
provides the most conclusive evidence of any alignment feature. Deletions are especially amenable to 
SR analysis as they generate a distinctive “broken” alignment, with the gap between the resulting 
fragments corresponding to the deleted reference sequence. Thus, deletions of any size can be 
characterized in fine detail by identifying the boundary of the split along the read and the remote 
locations where the two fragments align. Conversely, insertions generate “fused” alignments that 
involve splitting a read into three consecutive fragments. The middle fragment corresponds to the novel 
inserted sequence and thus remains unaligned, while the two remaining fragments align contiguously 
to the reference. As a result, SR analysis can only identify insertions smaller than the read length, which 
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renders them unsuitable for short-read NGS experiments and prompted us to focus on deletions. Despite 
the invaluable role of split reads in CNV detection, their identification poses a non-trivial computational 
problem that is related to sequence alignment. Thus, we developed a statistical pipeline that harnesses 
the power of existing short-read aligners to achieve accurate and efficient detection of split reads. 
2.3.1 Pre-processing 
Unlike RD and RP measurements, split read data cannot be readily extracted from standard 
alignment files. Established short-read alignment algorithms, such as BWA and Bowtie, were designed 
and optimized for end-to-end alignment and, therefore, cannot accommodate split reads. Such reads are 
impossible to align in their entirety as they exhibit multiple partial local alignments. Depending on the 
aligner configuration, a split read with partial matches to the reference either produces a low-quality 
alignment or it is classified as altogether unmapped. When faced with split reads, some tools may also 
generate “soft-clipped” high-quality alignments. Soft-clipping corresponds to sequence on either end 
of a mapped read that has been disregarded (clipped) as it doesn’t support the reported alignment. Thus, 
the first step in discovering split reads is to scan the BAM files for unaligned reads, as well as reads 
with poor alignment scores or extensive soft-clipping.  
Next, we split the unmapped and poorly mapped reads in all plausible combinations, while 
maintaining an adequate split fragment length to facilitate subsequent analysis. Soft-clipped reads do 
not need to be split exhaustively, as the clipping information can be used to define the boundary between 
the aligned and unaligned fragments with high precision (±3bp). The split fragments resulting from this 
process are stored in paired FASTQ files. This essentially treats a split read as a read pair. Since some 
of the split fragments may be quite short, we eliminate those that exhibit low complexity (e.g. 
homopolymers runs) using the DUST algorithm [106]. The "paired" split fragments are then aligned to 
the reference using BWA, allowing up to two mismatches. All the alternative mappings generated by 
BWA are retained in order to find the best combination. This comprises the final SR discovery set. Note 
that this discovery set may contain alternative splits of the same read, which are used to fine-map the 
breakpoints of a deletion. 
2.3.2 Summarizing SR evidence 
Similarly to our read pair approach, we create pseudo-reads from the gap between aligned 
split fragments. Thus, the coordinates of the pseudo-reads correspond to potential deletion breakpoints. 
The pseudo-reads are then piled up to obtain counts of the actual splits that span any given genomic 
position. Alternative splits of the same read are independently piled up and normalized so that they 
collective contribute as a single read to the count. The final count constitutes the split read count (SRC) 
summary statistic. 
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2.3.3 Split read anchoring 
The genome-wide alignment of exhaustively split read fragments is a computationally 
intensive task that relies on the efficiency of modern short-read aligners. When dealing with single-end 
sequencing protocols, there is no information regarding the true origins of a split and we therefore have 
to consider all the potential alignments that arise. In paired-end protocols, however, if the  
mate of a split read is uniquely mapped, it can define a relatively narrow genomic region of interest. In 
those instances, the mapped read is used as an “anchor” to limit the search space for potential splits. 
The anchoring strategy lightens the computational burden and helps eliminate false positive alignments. 
Another benefit of this approach stems from the fact that the anchor read was originally orphaned but 
becomes properly paired if a split can be detected. These newly rescued pairs are especially informative 
in repetitive regions, where there is a higher chance of splits occurring. Thus, rescued pairs are extracted 
from the SR pipeline and incorporated into the previously described RP framework. 
2.3.4 Statistical Modelling 
Since SR events can provide unambiguous evidence for the existence of CNV, a few 
overlapping splits are usually sufficient to make confident CNV calls. However, SR detection remains 
challenging, as it relies on inherently imperfect realignment algorithms that are not guaranteed to be 
exhaustive. Consequently, split read counts tend to be underestimated and thus exhibit lower 
overdispersion than RD and RPC. Moreover, the variance of SRC is not expected to vary significantly 
with copy number. Therefore, instead of the negative binomial distribution, we model the SR count 
using a positively skewed normal distribution with location and scale parameters depending on the 
depth of coverage. The skewness captures the slight overdispersion of SRC, while reflecting our rapidly 
increasing confidence in CNV existence when split reads are present. As with RP, our parametric 
approach eliminates the need for a minimum number of supporting split reads and models the SRC 
directly. By avoiding hard thresholds and allowing for alignment mismatches, our method achieves 
higher flexibility than existing methods, especially for low-coverage samples where SRs are infrequent. 
Also, the fact that our model incorporates information contained in alternative splits improves 
breakpoint resolution, even when the supporting evidence is sparse. 
2.3.5 Notable SR-based methods 
Split reads analysis is highly contingent on read length and was therefore initially devised for 
Sanger sequencing technologies. In that context, it was only used to detect short insertions and deletions 
(indels) mediated by transposable elements [107]. Later the basic principles were extended to 
accommodate short-read data and adapted for detecting larger CNVs. The most notable SR analysis 
method for NGS is Pindel [108]. 
Pindel is based on a pattern growth algorithm that has been successfully employed in 
sequential pattern mining [109]. Pindel is only applicable to paired-end data, as it requires one of the 
read of the pair to function as an anchor point and the other to be unmapped. Pattern growth is used to 
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search for minimum and maximum unique substrings from both ends of the unmapped read, within a 
genomic sub-region predetermined by the anchor. A deletion will be called when a complete read can 
be reconstructed from the substrings, while partial reconstruction will provide evidence of a possible 
insertion. Despite its strengths, Pindel has limited usefulness due to its strict requirements. While the 
presence of an anchor point significantly reduces the search space, it also prevents Pindel from 
discovering reads that are split across larger distances, corresponding to larger deletions. Increasing the 
search space, may help detect such events, but it may also result in a high number of false positive 
matches, especially for shorter reads. Finally, the absence of mismatches, which is inherent in pattern 
growth, may result in low sensitivity. 
2.4 Feature integration for CNV detection 
Although alignment features are individually capable of elucidating CNV, each of them 
provides an incomplete view of the full picture. A common solution to this problem involves analysing 
features separately and then combining the results. As expected, this post-hoc analysis yields better 
results than any feature alone, but still fails to realize the full potential of alignment-based CNV 
detection. True variants that are marginally undetectable using a single feature need to amass supporting 
evidence from complementary features to rise above the noise. Conversely, false positive variants 
identified by a single feature can be eliminated due to lack of corroboration from other features. To that 
end, we envisioned a unified framework that integrates information from all features in an organic way.  
This joint analytical approach amounts to more than the sum of its parts and has the potential to achieve 
the most comprehensive examination of CNV in the human genome.  
The seeds of our statistical framework can be traced to an algorithm designed for  microarray-
based CNV detection, called cnvHap [90]. cnvHap attained superior performance by utilizing a hidden 
Markov model (HMM) to combine information from both fluorescent intensity and B-allele frequency 
data. This provided the inspiration for incorporating distinct NGS alignment features into a single 
probabilistic model. Thus, our framework relies on a HMM to integrate multiple features and capture 
the spatial correlations of the input data. Following the paradigm of cnvHap, we also implemented a 
population training component that takes advantage of large sample sizes to correct for sample-
independent variation. 
2.4.1 Hidden Markov Model 
The use of a HMM is motivated by the hypothesis that the observed sequence data are 
generated by discrete hidden states corresponding to the unknown copy numbers at each genomic 
position. Our framework models the probability of every data point conditional on this hidden copy 
number using emission distributions tailored to each alignment feature. The HMM can then be used to 
calculate the likelihood of different paths (corresponding to different CNV segmentations) through the 
model, and thus perform an integrated analysis of the underlying features. 
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2.4.1.1 Description 
Our HMM comprises one hidden state per haploid copy number at each measured position m, 
denoted by 𝑙𝑙𝑚𝑚 ∈ {0, 1, 2, … ,𝐷𝐷𝑁𝑁𝑚𝑚𝑎𝑎𝑚𝑚} (FIGURE 2.2a). The hidden states of the diploid HMM (denoted by 
𝑟𝑟𝑚𝑚) constitute pairs of states from the haploid model, so that 𝑟𝑟𝑚𝑚 = {𝑙𝑙1𝑚𝑚, 𝑙𝑙2𝑚𝑚} (FIGURE 2.2b). For 
convenience we will drop the m subscript on the haploid states. The diploid HMM states have emission 
distributions specific to the data source measured at a given position (FIGURE 2.2c), thus interweaving 
different alignment features in the same model. The transition probabilities of the model are determined 
using the combination of a global transition rate matrix and a local transition parameter that can capture 
variation in CNV frequency across the genome. 
2.4.1.2 Emission probabilities 
Since the observations of our HMM at any position m comprise read depth, read pairs and 
split reads, we denote the emission data for sample j as 𝐼𝐼𝑚𝑚
𝑗𝑗 = �𝑅𝑅𝐷𝐷𝑚𝑚𝑗𝑗 ,𝑅𝑅𝑃𝑃𝑆𝑆𝑚𝑚𝑗𝑗 ,𝑅𝑅𝑃𝑃𝐷𝐷𝑚𝑚𝑗𝑗 , 𝑆𝑆𝑅𝑅𝐷𝐷𝑚𝑚𝑗𝑗 �. As discussed 
previously, RD and RPC were modelled using the negative binomial (NB) distribution, while RPS and 
SRC were modelled with the normal and skew normal (SN) distributions respectively. We assume that 
RPS and RPC are independent, conditional on the hidden copy number, and hence the joint conditional 
RP probability is the product of their individual probabilities. The emission probability of an unordered 
list states 𝑟𝑟𝑚𝑚 = {𝑙𝑙1, 𝑙𝑙2} depends only on the total copy number: 
𝑃𝑃�𝐼𝐼𝑚𝑚
𝑗𝑗 �𝑟𝑟�𝑟𝑟𝑚𝑚
𝑗𝑗 = {𝑙𝑙1, 𝑙𝑙2}�,𝜃𝜃𝑚𝑚� = �𝑁𝑁𝑁𝑁�𝑅𝑅𝐷𝐷𝑚𝑚𝑗𝑗 �𝜅𝜅𝑚𝑚𝑐𝑐 , 𝜂𝜂𝑚𝑚𝑐𝑐�                                       𝑛𝑛𝑛𝑛𝑚𝑚𝑚𝑚 𝑚𝑚𝑛𝑛𝑚𝑚𝑙𝑙ℎ𝑁𝑁�𝑅𝑅𝑃𝑃𝑆𝑆𝑚𝑚𝑗𝑗 �𝜇𝜇𝑚𝑚𝑐𝑐 ,𝜎𝜎𝑚𝑚𝑐𝑐� ∗ 𝑁𝑁𝑁𝑁�𝑅𝑅𝑃𝑃𝐷𝐷𝑚𝑚𝑗𝑗 �𝜅𝜅𝑚𝑚𝑐𝑐 , 𝜂𝜂𝑚𝑚𝑐𝑐� 𝑛𝑛𝑛𝑛𝑚𝑚𝑚𝑚 𝑚𝑚𝑚𝑚𝑝𝑝𝑛𝑛
𝑆𝑆𝑁𝑁�𝑆𝑆𝑅𝑅𝐷𝐷𝑚𝑚
𝑗𝑗 �𝜉𝜉𝑚𝑚𝑐𝑐 ,𝜔𝜔𝑚𝑚𝑐𝑐 ,𝛼𝛼𝑚𝑚𝑐𝑐�                            𝑟𝑟𝑚𝑚𝑙𝑙𝑝𝑝𝑙𝑙 𝑛𝑛𝑛𝑛𝑚𝑚𝑚𝑚  (2.14) 
where 𝑟𝑟(𝑟𝑟𝑚𝑚) represents the total copy number of a haploid state pair, so that 𝑟𝑟(𝑟𝑟𝑚𝑚) = 𝑙𝑙1 + 𝑙𝑙2, and θm 
represents the parameters of the emission distributions at position m. 
2.4.1.3 Transition probabilities 
The transition probabilities were defined using continuous time Markov chain theory. Thus, the 
transition between unordered pairs of states can be expressed as: 
𝑚𝑚(𝑟𝑟𝑚𝑚 = {𝑙𝑙1, 𝑙𝑙2}|𝑟𝑟𝑚𝑚−1 = {𝑘𝑘1, 𝑘𝑘2}) = � � � 𝑚𝑚�𝑟𝑟𝑚𝑚𝑛𝑛 = 𝑙𝑙𝜏𝜏(𝑛𝑛)�𝑟𝑟(𝑚𝑚−1)𝑛𝑛 = 𝑘𝑘𝑛𝑛� 
𝑛𝑛=1…𝑁𝑁 �𝜏𝜏∈𝑇𝑇(𝑠𝑠𝑚𝑚)  (2.15) 
where 𝑇𝑇(𝑟𝑟𝑚𝑚) represents all possible permutations of 𝑟𝑟𝑚𝑚. For the haploid HMM, the transition probability 
from hidden state k to state l can be calculated as follows: 
𝑚𝑚�𝑟𝑟𝑚𝑚𝑛𝑛 = 𝑙𝑙|𝑟𝑟(𝑚𝑚−1)𝑛𝑛 = 𝑘𝑘� = �𝑛𝑛𝐷𝐷𝑟𝑟𝑚𝑚�𝑑𝑑(𝑚𝑚)−𝑑𝑑(𝑚𝑚−1)��𝑘𝑘,𝑘𝑘 (2.16) 
where Q is a global reversible transition rate matrix between copy number states, rm is a scalar 
representing the local rate of transitions at position m, and 𝑚𝑚(𝑛𝑛) represents the base-pair coordinate of 
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position m. In other words, 𝐼𝐼𝑘𝑘𝑘𝑘 is the per-base rate of transition from state k to state l, and the probability 
of transition between two states is the matrix exponential of this rate matrix. 
To derive this result, we require that the rows of the transition rate matrix sum to zero. This 
condition is satisfied by the fundamental property of transition rate matrices that defines their diagonal 
elements as 𝐼𝐼𝑘𝑘𝑘𝑘 = −∑ 𝐼𝐼𝑘𝑘𝑘𝑘𝑘𝑘≠𝑘𝑘 . Following from continuous Markov chain theory, we assume that there 
exists a unique equilibrium probability distribution π, such that 𝜋𝜋𝐼𝐼 = 0. This assumption holds, 
providing there is a non-zero probability of transitioning between any two states for some positive 
distance d, and that the probability of visiting each state a finite number of times over an infinite distance 
is 1. We also make the simplifying assumption that the genome is in an equilibrium state, meaning that 
the frequency distribution of deletions, duplications and copy neutral states is equal to the equilibrium 
distribution. This is essentially equivalent to assuming that the genome is close to “infinite” size. 
Finally, if we denote by 𝑃𝑃𝑘𝑘(𝑚𝑚𝑚𝑚) the probability of being in state k at genomic distance dm and by 𝑃𝑃(𝑚𝑚) 
the vector of these probabilities, then the evolution of P over genomic distance d is described by the 
matrix differential equation d𝑃𝑃 d𝑚𝑚� = 𝑃𝑃𝐼𝐼𝑛𝑛 (where r is an arbitrary scaling constant). The solution of 
this differential equation is the matrix exponential of Q multiplied by the initial probability distribution, 
such that 𝑃𝑃(𝑚𝑚) = 𝑃𝑃(0)𝑛𝑛𝐷𝐷𝑟𝑟𝑑𝑑. From this result we obtain the transition probabilities described in (2.16). 
The transition model was initialized via a user-definable equilibrium probability distribution. 
To that end, we assume that the rate matrix Q is reversible, which implies that the “flux” of transitions 
between states is the same in both directions, that is, 𝜋𝜋𝑘𝑘𝐼𝐼𝑘𝑘𝑘𝑘 = 𝜋𝜋𝑘𝑘𝐼𝐼𝑘𝑘𝑘𝑘. In our case, this would indicate 
that the transition rate from a deletion or duplication state (for which the equilibrium frequency is 
smaller) to a copy neutral state (for which the equilibrium frequency is greater) will be much larger than 
in reverse. This is consistent with the deletions or duplications being much shorter than copy neutral 
regions. Thus, given a target equilibrium distribution π, we followed [110] in constructing a symmetric 
initial 𝐼𝐼𝑖𝑖𝑗𝑗 matrix: 
𝐼𝐼𝑖𝑖𝑗𝑗 =
⎩
⎪
⎨
⎪
⎧     −1 ∗ �𝜋𝜋𝑗𝑗 𝜋𝜋𝑗𝑗�     𝑝𝑝𝑜𝑜 𝑝𝑝 = 𝑐𝑐    �𝜋𝜋𝑗𝑗 𝜋𝜋𝑖𝑖�
𝐷𝐷𝑁𝑁𝑚𝑚𝑎𝑎𝑚𝑚          𝑜𝑜𝑙𝑙ℎ𝑛𝑛𝑛𝑛𝑤𝑤𝑝𝑝𝑟𝑟𝑛𝑛
 (2.17) 
The default equilibrium probability distribution was defined as follows: 
𝜋𝜋(𝐷𝐷𝑁𝑁) = �0.01 𝑝𝑝𝑜𝑜 𝐷𝐷𝑁𝑁 = 00.98 𝑝𝑝𝑜𝑜 𝐷𝐷𝑁𝑁 = 10.01 𝑝𝑝𝑜𝑜 𝐷𝐷𝑁𝑁 = 2 (2.18) 
Finally, the rate scalar rm, which allows the model to capture difference in local rates of copy number 
variation, was initially set to 1. 
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 2.4.2 Population modelling 
An important aspect of our framework is the ability to process multiple samples 
simultaneously and thus model CNV at the population level. For each alignment feature, the emission 
distributions are initialized to reflect the expected location and scale of every copy number state. Based 
on these initial distributions, we can generate clusters of observed population data at each genomic 
position reflecting the preliminary copy number assignment for each sample. In a typical HMM, this 
clustering would be used to infer the most likely copy number segmentation. In our case, however, the 
observations are iteratively re-clustered and the results are used to update the emission parameters. This 
process essentially trains position-specific emission distributions on real data and allows our HMM to 
capture and ameliorate population-wide deviations that do not correspond to CNV. Such deviations are 
usually due to the local sequence composition, but may also arise from batch effects and other technical 
artifacts. 
2.4.3 Model training 
Model training is accomplished via a generalized Expectation Maximization (EM) algorithm. 
In the expectation step, we apply the forward-backward algorithm to each sample separately to calculate 
the expected counts of transitions between states k and l of the haploid HMM 𝐸𝐸𝑚𝑚𝑘𝑘𝑘𝑘𝑡𝑡 , as well as the 
posterior probability of each copy number at each position 𝑚𝑚�𝑟𝑟𝑚𝑚
𝑗𝑗 �𝐼𝐼𝑗𝑗�. The parameters of the transition 
model are updated using an EM variant that was designed for maximum-likelihood training of rate 
matrices [110]. 
If we assume that only a single transition can happen between adjacent examined positions, 
then we can directly update the rate matrix Q, by calculating a counts matrix 𝐷𝐷𝑘𝑘𝑘𝑘, representing the 
expected count of per-base transitions. The update procedure first estimates 𝐷𝐷𝑘𝑘𝑘𝑘 by dividing the expected 
number of transitions over the base distance  𝐷𝐷𝑘𝑘𝑘𝑘 = 𝐷𝐷𝑘𝑘𝑘𝑘𝑡𝑡(𝑑𝑑(𝑚𝑚)−𝑑𝑑(𝑚𝑚−1)) and then updates 𝐼𝐼𝑘𝑘𝑘𝑘 ← 𝐶𝐶𝑘𝑘𝑘𝑘∑ 𝐶𝐶𝑘𝑘𝑘𝑘𝑘𝑘 . This 
approach could theoretically be applied to sequencing datasets, if we considered observations at every 
genomic position. However, this remains impracticable in terms of computational efficiency, 
compelling us to sample the genome at a pre-specified frequency. As a result, we cannot directly 
estimate the count of all transitions between states k and l, unless the sampling windows are small 
enough to preclude any unobserved transitioning. Thus, to maintain generality and accommodate larger 
sampling windows, for which the single transition assumption is unrealistic, we followed Klosterman 
et al. [111] in accumulating the transition counts in the eigenvector space. Once the global rate matrix 
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has been updated, we use the 𝐸𝐸𝑚𝑚𝑘𝑘𝑘𝑘𝑡𝑡  to update the scalar rate parameter rm as the value which maximises 
the log posterior: 
�𝐸𝐸𝑚𝑚𝑘𝑘𝑘𝑘
𝑡𝑡 ∗ 𝑙𝑙𝑜𝑜𝑎𝑎�𝑚𝑚(𝑟𝑟𝑚𝑚𝑛𝑛 = 𝑙𝑙|𝑟𝑟𝑚𝑚𝑛𝑛 = 𝑘𝑘)�
𝑘𝑘𝑘𝑘
∗ 𝛤𝛤 �
𝑛𝑛𝑚𝑚5 ∗ 10−5 , 1 + (5 ∗ 10−5)� (2.19) 
using equation (2.16).  The gamma distribution hyperpriors encourage the rate scalars to remain close 
to one unless there is strong evidence for transition between copy number states at that position.  This 
has the added effect of encouraging different samples in a population to transition at exactly the same 
position, rather than at very close positions, thus pooling information about the copy number breakpoint 
of a recurrent CNV across multiple samples. 
The posterior probability of each copy number state at each position is also recorded as 
𝑤𝑤𝑚𝑚
𝑗𝑗 (𝐷𝐷𝑁𝑁) = 𝑚𝑚�𝑟𝑟𝑚𝑚𝑗𝑗 = 𝐷𝐷𝑁𝑁�𝐼𝐼𝑗𝑗�, and can be thought of as the assignment weight of the data at position m 
to state CN, using the current parameterization of the model. 
We optimize the parameters 𝜃𝜃�𝑚𝑚𝑐𝑐 of the emission distribution for copy number c based on 
maximization of the log-likelihood: 
𝐻𝐻�𝜃𝜃�𝑚𝑚𝑐𝑐� = � 𝑤𝑤𝑚𝑚𝑗𝑗 (𝑟𝑟) ∗ log �𝑚𝑚�𝐼𝐼𝑚𝑚𝑗𝑗 |𝑟𝑟,𝜃𝜃�𝑚𝑚𝑐𝑐��
𝑗𝑗
 
(2.20) 
where equation 2.14 is used to calculate the emission probabilities given the new set of parameters. The 
maximization is carried out using a gradient descent algorithm.  
To utilize the population modelling capabilities of our framework, the above process can be 
repeated for multiple training iterations. The resulting probability distributions are then averaged over 
iterations to obtain the final model. In order to avoid overfitting, we introduce a pre-defined 
pseudocount λ to our observed data, which defaults to 20. Thus, the clusters of observations for each 
copy number state at each position are augmented with ψ pseudo-observations 𝐼𝐼′𝑚𝑚
𝑗𝑗 , sampled from the 
initial emission distributions (equation 2.14). These pseudo-observations are weighted by 𝜆𝜆 𝜓𝜓�  so that 
they contribute to their cluster proportionally to the pseudocount. With each training iteration, λ is set 
to decrease by 0.9, thus allowing the data to slowly overcome the prior. A pseudocount of 20 will 
counteract the inherent variability of small sample sizes, by not allowing the clusters to shift 
substantially from their initial position. However, this relatively small pseudocount will only have a 
small effect on the cluster training when analyzing sufficiently large datasets. 
Once the HMM has been trained, the Viterbi algorithm is used to calculate the most likely 
CNV segmentation (conditional on the trained parameters) for each sample. FIGURE 2.2d,e presents 
examples of the trained haploid HMM for the two characteristic CNVs. 
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 FIGURE 2.2 Schematic diagram of our integrative model 
(a) State diagram of the haploid HMM. Vertices represent haploid copy number states (0, red; 1, gray; and 2, green) and edges 
represent transitions from one state to another. The thickness of the edges is proportional to the transition probabilities of the 
model. More haploid states can be used to model higher copy numbers. (b) By pairing two haploid copy number states our 
framework derives the final diploid model (0, dark red; 1, red; 2, gray; 3, green; 4, dark green). (c) Each observed variable is 
modelled using a customized emission distribution. Here, as an example, we present the emission distributions for Read Depth 
and Read Pair Span conditional on the copy number state. Read Depth is modelled using the Negative Binomial distribution, 
while Read Pair Distance is modelled using the normal distribution. The color scheme corresponds to the diploid copy number 
states presented in (b). (d) The trained haploid HMM that corresponds to a characteristic homozygous deleted region on 
chromosome 8.  The rows represent copy number states and the columns represent genomic location. Positions are given in 
megabases (Mb). Bubble size corresponds to the probability of assignment to each state at each position. The lines between 
bubbles indicate possible transitions between states. The annotated positions indicate the start and the stop of the CNV call. 
(e) The trained haploid HMM that corresponds to a characteristic heterozygous duplicated region on chromosome 8. 
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2.4.4 Existing integrative methods 
Despite the significant benefits that can be derived from combining alignment features, there 
has been a paucity in integrative CNV detection methods. To the best of our knowledge, there are no 
algorithms that incorporate evidence from all three available features. The few existing tools that 
consider two features, adopt step-wise approaches that begin by analysing a single feature and then 
attempt to strengthen the results using a different one. The most notable method in this category is 
Genome STRiP [57], which was adopted by the 1000 Genomes Project. 
Genome STRiP utilizes RP and RD information to improve the sensitivity and specificity of 
CNV discovery. This is achieved through the principles of coherence, population heterogeneity and 
allelic substitution. Coherence is aimed at exploring shared variation across genomes and is investigated 
by identifying "aberrant" read pairs, preferably from multiple samples. However, coherence is not 
enough to distinguish real variants from artifacts, which compels Genome STRiP to assess coherent 
evidence for population heterogeneity. Heterogeneity is determined by examining the deviation of the 
observed read distribution from a null model using a χ2 statistic. Finally, the algorithm incorporates RD 
information by applying the allelic substitution principle. In essence, this step uses coherent and 
heterogeneous candidate deletion sites as input and compares the average RD of genomes supporting a 
deletion with genomes that don't. Even though Genome STRiP achieves comparatively higher 
sensitivity and lower false discovery rate (FDR) than single feature methods, its piecemeal approach 
does not allow the different features to contribute equally, with RD information being significantly 
underutilized. As a result, it cannot be classified as truly integrative. 
2.5 Summary 
In this chapter we presented the statistical methodology that we developed to detect CNV in 
NGS datasets. We described the procedures that were established for analysing different alignment 
features, as well as the population model that was used to integrate the features into a coherent 
framework. Our approach was designed to enable an accurate and comprehensive examination of CNV 
in the human genome. Therefore, we implemented a WGS application of our framework called 
cnvHiTSeq, which we tested on data obtained from the 1000 Genomes Project. Details of the 
implementation and extensive benchmarking of cnvHiTSeq are showcased in the next chapter. 
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Chapter 3 
Chapter 3 Application to Whole-Genome Sequencing: cnvHiTSeq 
Application to Whole-Genome Sequencing: 
cnvHiTSeq 
 
In the past decade, whole-genome sequencing (WGS) has undergone substantial technical 
improvements and has thus been established as the technology of choice for in-depth investigation of 
genomic variation. Furthermore, WGS constitutes the driving force behind human population re-
sequencing efforts, such as the pioneering 1000 Genomes Project. Despite the continually decreasing 
cost of sequencing, high-coverage WGS remains prohibitive in large sample sets. As a result, there has 
been an increased interest in developing algorithms to identify CNVs from low-coverage WGS 
experiments [112]. Existing CNV methods, however, do not incorporate all available information into 
a unified model. In this chapter, we present cnvHiTSeq, an application of our integrative CNV detection 
framework to WGS datasets. 
cnvHiTSeq jointly models all available alignment features at the population level to achieve 
sensitive and precise discovery of all CNV classes even from low-coverage WGS data. Furthermore, 
the probabilistic model employed by cnvHiTSeq allows it to pool information across individual samples 
and reconcile copy number differences among features, thus achieving a high CNV genotyping 
accuracy. cnvHiTSeq was tested on both low-coverage and high-coverage WGS data from the 1000 
Genomes Project.  
This chapter illustrates the practical utility of our theoretical framework, as realized in the 
form of the cnvHiTSeq algorithm. It also includes an assessment of cnvHiTSeq’s performance under 
various conditions designed to establish its robustness. Concepts and results from this chapter have been 
published in the following article: 
E. Bellos, M. R. Johnson and L. J. M. Coin (2012). "cnvHiTSeq: integrative models for high-resolution copy 
number variation detection and genotyping using population sequencing data." Genome Biol 13(12): R120. 
 
We begin with a brief description of the datasets used in the analyses. Then, we introduce the technical 
and algorithmic aspects of cnvHiTSeq, including adaptations to our original framework that were 
motivated by specific properties of WGS. Finally, we present an extensive benchmarking study of 
cnvHiTSeq against existing algorithms described in chapter 2.  
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3.1 Materials and datasets 
Development and testing of cnvHiTSeq were accomplished using publically available data 
from the 1000 Genomes Project [87]. In the absence of a true gold standard against which to assess 
cnvHiTSeq’s performance, we used a collection of CNV callsets obtained with different technologies. 
These include array-CGH, capillary read data, fosmid sequencing and PCR-based experiments 
performed independently on 1000 Genomes samples. 
3.1.1 1000 Genomes Project data 
The core sequencing dataset that was used in our analyses comprises a subset of the results 
generated by phase 1 of the 1000 Genomes Project [67]. Specifically, we focused on samples of 
Northern and Western European ancestry (CEU population group), which were also part of the HapMap 
project [113] and have thus been extensively studied for the past 10 years. For legacy reasons, phase 1 
included sequence data generated by various technologies. Eventually, Illumina’s CRT technology was 
adopted by the entire consortium, which motivated us to consider only phase 1 samples sequenced (at 
least partly) using Illumina platforms. Thus, our final sequencing dataset consisted of 94 low-coverage 
(2x – 6x) CEU samples and a high-coverage (30x – 42x) mother-father-child trio. The samples were 
collectively sequenced by various academic institutions, which resulted in slightly variable sequencing 
protocols [67] (TABLE 3.1).  
Sequencing protocol Broad Institute BGI 
Max Planck 
Insitute 
Washington 
University 
Sanger 
Institute 
Read 
length 
50 bp   ✓ ✓     
75 bp   ✓       
100 bp  ✓     ✓ ✓ 
Insert 
size 
100 bp     ✓      
200 bp  ✓  ✓ ✓ 
300 bp ✓  ✓    ✓   
Illumina 
Instrument 
Genome Analyzer   ✓       
Genome Analyzer II ✓   ✓ ✓ ✓ 
HiSeq2000 ✓ ✓       
TABLE 3.1 1000 Genomes Project Phase 1 sequencing protocols by institution 
Sequencing data from the 1000 Genomes pilot phase were also incorporated into phase 1 results if they 
passed quality control. Thus, in the instances when the same sample had been processed using more 
than one protocol, the resulting sequencing libraries were merged before analysis. Due to the inclusion 
of previous generation sequencing results, the merged dataset includes both single-end and pair-end 
data. Our 97 samples were aligned to the GRCh37 reference genome using BWA. The resulting 
alignments, encoded in the BAM format, comprise the input of cnvHiTSeq. 
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3.1.2 Benchmarking datasets 
Since their inclusion in the HapMap project, the CEU samples have been meticulously 
analysed and universally adopted as control data. As genomic technologies have evolved, CEU samples 
have been re-examined from every angle, thus providing a trove of publically available datasets. This 
allowed us to compare cnvHiTSeq’s results with CNV calls generated by different types of assays. Each 
of these assays has distinct advantages that render it more suitable for benchmarking particular aspects 
of our algorithm.  
Sanger sequencing is ideal for detecting CNVs in the sub-kilobase range, using split read 
approaches. Thus, our benchmark includes the results of an early split read study [114] that was based 
on long capillary reads. This study generated ~300 short CNV calls (median = 200bp) for two of our 
CEU samples (NA12878, NA12156).  
Microarrays, on the other hand, provide lower resolution and are therefore more attuned to 
medium-sized CNVs. To that end, we considered two complementary array-based analyses of the 
HapMap samples: the High Resolution CNV Discovery study [4] and the Hybrid SNP-CNV study 
[115]. The former utilized a custom array-CGH that was designed to genotype approximately 5,000 
CNV regions. The latter introduced a new type of array that supplemented traditional SNP probes with 
CNV-only probes to allow for large-scale CNV interrogation. The High Resolution CNV Discovery 
study generated high-quality absolute copy number calls and was thus used to benchmark the 
genotyping accuracy of cnvHiTSeq. The Hybrid SNP-CNV study constructed an extensive CNV map 
(median = 2kb) and was therefore used to assess cnvHiTSeq’s ability to detect variants of intermediate 
size. 
Our benchmark was also expanded to include the outcomes of a clone-based study [116]. This 
study employed a fosmid pairwise sequencing approach to detect variants larger than 1kb. It 
investigated a subset of the HapMap population, including two of the CEU samples (NA12878, 
NA12156) in our dataset. The resulting ~110 CNV calls (median = 6kb) served to evaluate cnvHiTSeq’s 
performance for CNVs on the larger end of the spectrum.  
Finally, we used an independently validated CNV callset [117] to further explore our 
algorithm’s genotyping accuracy. This dataset includes 18 common deletion sites ranging from 6kb to 
120kb in size. The deletions have been genotyped in all our CEU samples using qPCR and comprise an 
integral component of our benchmark.  
3.2 Statistical considerations for WGS 
Our framework was designed to be an all-encompassing solution and thus remains 
independent of specific sequencing applications. Each sequencing dataset, however, presents with 
unique challenges that need to be thoroughly addressed so as not to confound the results. Here we 
55 
 
present the general solutions that we developed to counteract the biases encountered during WGS 
analysis. These biases are predominantly due to the underlying sequence composition, which has a 
strong impact on the observed read depth.  
3.2.1 GC correction 
In WGS, and Illumina datasets in particular, there is a pronounced dependence between the 
localized read coverage and the GC content. This documented bias translates to lower read depth in 
GC-rich and GC-poor regions [118, 119] and could be mistaken for CNV evidence. To demonstrate 
this bias we evaluated the genome-wide distribution of RD as a function of the GC content for a single 
CEU sample (NA11832). The results verify the underrepresentation of both GC-rich and AT-rich 
regions in the sequencing results (FIGURE 3.1).  
 
FIGURE 3.1 Relationship between depth of coverage and GC-content. 
Therefore, we normalized the observed RD by regressing the read count on GC content. To that end, 
we used a polynomial regression approach of user-definable degree. 
3.2.2 Alignability correction 
Another type of bias that needs to be accounted for is sequence “uniqueness". This uniqueness 
bias arises from portions of the reference sequence that exhibit a high degree of paralogy and is 
especially pronounced in repetitive regions. The standard metric used by the ENCODE pilot project 
[120] to quantify sequence uniqueness is the alignability score. This score is calculated by mapping 
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sliding windows of k-mers to the genome allowing up to 2 mismatches and assigning a score to each 
window equal to the inverse of the number of matches across the genome. Thus, alignability ranges 
from 0 for redundant sequences to 1 for perfectly unique sequences. Regions with alignability scores 
lower than 0.05 (corresponding to at least 20 genomic matches) were entirely masked out. In the 
remaining sequence, RD is corrected for alignability using polynomial regression. 
We also used the DAC blacklist to exclude 9.8Mb from further analysis. This list was 
designed to complement the alignability metric with pathological elements such as pericentromeric and 
subtelomeric repeats that have proven troublesome for short read alignment. In total we excluded 
~13.6% of the reference sequence, which is in almost perfect accordance with the “accessible genome” 
for low-coverage analysis as defined by the 1000 Genomes Pilot study [121].  
3.2.3 LOESS smoothing 
Even after the aforementioned corrections, read depth data exhibits spatial autocorrelation 
patterns, known as "wave artifacts", which cannot be fully explained by the GC content and alignability 
bias [122]. To minimize the effects of such artifacts we fit a LOESS curve to the RD data using second 
degree local polynomials. The choice of LOESS smoothing parameter α sets the lower limit for CNV 
breakpoint resolution. Given the noisy nature of low-coverage WGS, we set α so that a subset of 25bp 
is used in each local regression. This generates smooth RD, largely devoid of artifacts, but prevents 
cnvHiTSeq from reliably detecting variants shorter than 50bp. 
Finally, in order to account for differences in DOC among samples and facilitate comparison 
of the results, read depth is normalized by the average chromosome depth for each sample separately. 
3.3 cnvHiTSeq implementation 
cnvHiTSeq examines evidence from three distinct and complementary alignment features: 
read depth, read pairs, and split reads. Read depth (RD) corresponds to the number of reads aligning to 
a specific genomic position and is proportional to the underlying copy number. In our model, RD is 
represented by a single measurement of the read count at a given position (FIGURE 3.2a,d). Read pair 
(RP) analysis utilizes discrepancies between the observed and the expected distance of mapped paired-
end reads to infer the presence of CNVs. RP is incorporated into cnvHiTSeq using a pair of 
measurements, the first being the number of read pairs that span a given position, and the second being 
the average insert size of these reads (FIGURE 3.2b,e). Finally, split read (SR) analysis involves detecting 
single reads that happen to encompass the breakpoints of a CNV and thus appear to be split between 
two genomic locations when mapped to the reference. SR is summarized by the count of split reads that 
span a given genomic position (FIGURE 3.2c). 
57 
 
 FIGURE 3.2 Two characteristic CNVs and their corresponding sequencing signatures. 
Grey reads give rise to read depth measurements, represented as black circles. Blue reads correspond to discordant read pairs 
and contribute to read pair measurements denoted as blue squares. Split reads and their corresponding counts are represented 
in green. Hybrid green/blue reads provide evidence of split reads combined with abnormal read pair distance. (a) Read Depth 
signature for well described homozygous deletion on chromosome 8. Reads are absent inside the deleted region. (b) Read Pair 
signature for the same deletion as (a). The distance of the pairs spanning the deletion is significantly increased compared to 
the expected insert size. (c) Combination of Read Depth, Read Pair and Split Read signatures. Two split reads that span the 
breakpoints of the deletion were identified. The joint analysis of all the sources improves the breakpoint detection. (d) Read 
Depth signature for tandem duplication on chromosome 8. Significantly more reads are present inside the duplicated region. 
(e) Read Pair signature for the same duplication as (d). The read pair distance appears significantly decreased compared to the 
expected insert size. (f) Combination of Read Depth and Read Pair signatures provides improved breakpoints. The split reads 
detected in the region are used to rescue their orphaned pair and are thus incorporated into the Read Pair signature. 
 
The first step of our pipeline is to calculate normalized summary statistics for each of these three data 
sources across the genome, which form the input to the HMM (FIGURE 3.3). The summary statistics are 
sampled at a user defined frequency (with a default of 20bp) across each chromosome. Different data 
sources are offset by 1bp to avoid obtaining measurements from different sources at the same position.  
cnvHiTSeq utilizes the previously described population-haplotype framework to combine the 
diverse data sources into a single model. cnvHiTSeq’s HMM was designed to generate CNV 
segmentations consistent with all the alignment features, while capturing the spatial properties of CNV 
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across a single chromosome copy. The localized smoothing provided by the HMM allows cnvHiTSeq 
to detect events from low coverage data at a much finer resolution than sliding window methods without 
concomitant loss of power or increase in false positives due to small window noise. 
 
FIGURE 3.3 cnvHiTSeq pipeline. 
cnvHiTSeq is implemented as a collection of Java command-line tools and UNIX helper 
scripts. Our algorithm carries out separate data pre-processing steps for each alignment feature and each 
sample independently. The processed alignment features are integrated at runtime to perform CNV 
calling and genotyping. cnvHiTSeq assigns a confidence score to each detected variant based on the 
posterior probability distribution.  It also produces segmentation plots to facilitate visual inspection of 
the results. 
The pre-processing pipelines carry the highest computational burden, but are also highly 
amenable to parallelization, both on the feature and on the sample level. Thus, cnvHiTSeq was designed 
to take advantage of parallelism principles and reap the benefits of high-performance computing. The 
computational requirements of the pre-processing pipelines are outlined in TABLE 3.2. 
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Memory 
(GB) 
Time 
(CPU hours) Temporary Disk Space 
Final Disk Space 
Coverage Coverage Coverage 
Pipeline Low High Low High Low High 
RD 3 3 1.5 2 2 * BAM size 2 * BAM size 131 * 
𝑐𝑐ℎ𝑟𝑟𝑘𝑘𝑚𝑚𝑘𝑘𝑠𝑠𝑘𝑘𝑚𝑚𝑟𝑟 𝑘𝑘𝑟𝑟𝑛𝑛𝑘𝑘𝑡𝑡ℎ
𝑠𝑠𝑎𝑎𝑚𝑚𝑠𝑠𝑘𝑘𝑖𝑖𝑛𝑛𝑘𝑘 𝑤𝑤𝑖𝑖𝑛𝑛𝑑𝑑𝑘𝑘𝑤𝑤 𝑠𝑠𝑖𝑖𝑠𝑠𝑟𝑟 
RP 4 4 1.5 3 2 * BAM size 2 * BAM size 135 * 
𝑐𝑐ℎ𝑟𝑟𝑘𝑘𝑚𝑚𝑘𝑘𝑠𝑠𝑘𝑘𝑚𝑚𝑟𝑟 𝑘𝑘𝑟𝑟𝑛𝑛𝑘𝑘𝑡𝑡ℎ
𝑠𝑠𝑎𝑎𝑚𝑚𝑠𝑠𝑘𝑘𝑖𝑖𝑛𝑛𝑘𝑘 𝑤𝑤𝑖𝑖𝑛𝑛𝑑𝑑𝑘𝑘𝑤𝑤 𝑠𝑠𝑖𝑖𝑠𝑠𝑟𝑟 
SR 4 5 3 4 3 * BAM size 3* BAM size 125 * 
𝑐𝑐ℎ𝑟𝑟𝑘𝑘𝑚𝑚𝑘𝑘𝑠𝑠𝑘𝑘𝑚𝑚𝑟𝑟 𝑘𝑘𝑟𝑟𝑛𝑛𝑘𝑘𝑡𝑡ℎ
𝑠𝑠𝑎𝑎𝑚𝑚𝑠𝑠𝑘𝑘𝑖𝑖𝑛𝑛𝑘𝑘 𝑤𝑤𝑖𝑖𝑛𝑛𝑑𝑑𝑘𝑘𝑤𝑤 𝑠𝑠𝑖𝑖𝑠𝑠𝑟𝑟 
TABLE 3.2 Computational requirements of the pre-processing pipelines 
Memory, time and disk space requirements of the three pre-processing pipelines of cnvHiTSeq. The reported disk space 
requirements are relative to the input BAM file and the size of the chromosome that is being analyzed. The results were 
obtained from a single low-coverage (6x) and a single high-coverage (30x) sample. The pipelines are fully parallelizable and 
optimized for use on a computer cluster. 
 
3.4 cnvHiTSeq benchmark 
cnvHiTSeq offers a novel approach to CNV interrogation and represents a marked departure 
from existing methods. Therefore, we set out to explore cnvHiTSeq’s performance in the context of 
popular sequencing-based CNV detection algorithms. To ensure a broad basis for comparison, our 
benchmark includes methods that rely on a variety of principles. First, we sought to demonstrate the 
power of feature integration by considering algorithms that rely on single features. These comprise two 
prominent RD-based algorithms (EWT and CNVnator), as well as the leading RP- and SR-based 
methods (BreakDancer and Pindel respectively). At the time of cnvHiTSeq’s development, the leading 
multi-feature algorithm was Genome STRiP. As one of the primary tools of the 1000 Genome Project, 
Genome STRiP sets the bar for cnvHiTSeq and plays an important role in our assessment. All competing 
algorithms included in our analyses have been described in detail in chapter 2. 
Furthermore, we explore the effect of sequencing coverage on cnvHiTSeq’s performance and 
the potential for low-coverage WGS to replace microarray-based CNV detection. Our benchmark relies 
on three fundamental performance metrics: false discovery rate (FDR), sensitivity and genotyping 
accuracy. 
3.4.1 FDR estimation 
An important performance criterion for any classification algorithm is the proportion of false 
positive calls it produces. This is quantified by the FDR and relies on the existence of a gold standard. 
In our case, however, the CNV callsets that have been previously generated for the CEU samples cannot 
be considered exhaustive. Thus, a CNV that is called by cnvHiTSeq but is absent from our surrogate 
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gold standard does not necessarily correspond to a false positive. To overcome this obstacle, we obtain 
estimates of our method’s FDR using two indirect approaches.  
3.4.1.1 Mendelian inconsistency analysis 
First, we evaluated our FDR using data from the HapMap CEU trio. This trio was sequenced 
by the 1000 Genomes Project to high coverage (30x), but we also randomly downsampled the data to 
medium (10x and 20x) and low coverage (6x). We applied cnvHiTSeq separately to the child (sample 
NA12878) and the parents (samples NA12891 & NA12892) of the trio in order to approximate the false 
discovery rate (FDR) via the rate of Mendelian inconsistency in CNV prediction. This method doesn't 
utilize the population modelling capabilities of cnvHiTSeq, but provides a good genome-wide FDR 
estimate in absence of a gold standard. Throughout our analyses we focus on CNVs larger than 100bp. 
Using a standard inconsistency criterion, we classified the CNVs that were detected in the 
child as true positive only if they overlapped CNVs of the same class in at least one parent to be 
classified as true positive. At low coverage, cnvHiTSeq detected 2910 deletions and 2994 duplications 
in the child at a FDR of 4.3% and 9.8% respectively. The FDR was calculated using a 1bp overlap 
criterion and was found to decrease with increasing coverage (FIGURE 3.4a). 
 
FIGURE 3.4 FDR analysis of cnvHiTSeq. 
(a) FDR of our method for different depths of coverage. FDR determined using segregation analysis on the HapMap CEU trio. 
(b) FDR of cnvHiTSeq versus the number detected CNVs. Our method maintains a low FDR even when calling twice as many 
deletions as competing methods. 
When using a stricter 50% reciprocal overlap criterion between the child and the parents we report a 
FDR of 5.3% and 12.6% for deletions and duplications respectively. Genome STRiP, which was the 
best competing method, achieved a 8.2% (50% reciprocal overlap) FDR for this sample when calculated 
in exactly same way, although a lower FDR of 3.7% has been reported [112] based on experimental 
validation, demonstrating the conservative nature of our validation approach (TABLE 3.3). Typically, 
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we exclude cnvHiTSeq results with posterior probabilities lower than 80% from further analysis. 
However, by adjusting this posterior probability threshold we show that our method maintains a low 
FDR even when making twice as many calls as other methods [92, 108, 123] (FIGURE 3.4b). 
TABLE 3.3 Comparison of detected deletions between cnvHiTSeq and Genome STRiP. 
Since estimation of FDR using Mendelian inconsistency may be prone to sequencing biases 
potentially affecting all 3 samples in the trio, we also repeated our analysis using a stricter inconsistency 
criterion. For this strict criterion, we consider CNVs that have been detected in all 3 members of the 
trio as candidate false positive calls corresponding to systematic biases. The child CNV is required to 
have at least 50% overlap with both parents’ to be included in this category. This candidate false positive 
list is filtered to exclude common CNVs that were present in the Database of Genomic Variants (DGV) 
[26] as these are likely to recur in the population. We also required that a DGV variant covered at least 
90% of our corresponding CNV call. Thus, after this filtering step, we designated CNVs present in both 
or neither parent as false positive to obtain an FDR upper bound. Even with this very conservative 
approach, cnvHiTSeq achieves an FDR of 15.2%, which remained better than of Genome STRiP when 
calculated the same way (TABLE 3.4) 
Method 
Mendelian inconsistency 
Deletions Deletions(strict) Duplications 
Duplications
(strict) 
cnvHiTSeq 4.3% 15.2% 9.8% 18.9% 
Genome STRiP 8.2% 25.9% − − 
TABLE 3.4 Mendelian inconsistency comparison. 
 
3.4.1.2 Array-based estimation 
We also obtained an independent estimate of FDR using array-CGH data from the High 
Resolution CNV Discovery project [4]. We identified 166 deletions predicted by cnvHiTSeq for 
NA12878, which encompassed at least 4 CGH probes and were thus considered for validation. CGH 
analysis validated 155 of these 166 regions (FDR = 6.8%, APPENDIX TABLE 1), while 101 of the 166 
deletions were also identified by Genome STRiP. The validated deletions range from 541bp to 
143,379bp in length, with a median of 4,170bp and cnvHiTSeq maintains a low FDR across CNV 
lengths, while being slightly more accurate for longer variants (FIGURE 3.5). 
 
Number of 
detected 
deletions 
Average 
deletion 
length (bp) 
Genome STRiP 
overlap 
cnvHiTSeq 
overlap 
Mendelian 
inconsistency 
cnvHiTSeq 2910 2809 50% 100% 4.3% 
Genome STRiP 1753 2737 100% 80% 8.2% 
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 FIGURE 3.5 Cumulative length distribution of cnvHiTSeq calls that overlap aCGH data. 
166 deletions detected by cnvHiTSeq were covered by at least 4 probes on the array-CGH dataset. These deletions cover a 
wide range of lengths (541bp to 143,397bp) and the false positives are equally distributed across the length spectrum. The 
corresponding accuracy for each length bin is depicted in red. The last interval has been truncated for display purposes. 
3.4.2 Sensitivity analysis 
In order to estimate the sensitivity of our method, we applied cnvHiTSeq to the low-coverage NA12156 
sample and then compared the results to the gold standard dataset used by the 1000 Genome Structural 
Variant discovery study [112]. This gold standard comprises 3 heterogeneous CNV call sets for sample 
NA12156 that were obtained using different technologies and are therefore more sensitive to CNV 
events of different sizes, covering a wide range of the CNV spectrum. Smaller CNVs are examined 
using capillary read data [114], medium-sized CNVs are examined using hybrid SNP-CNV arrays [115] 
and larger variants using fosmid sequencing [116]. Both our reported sensitivity results and those of 
competing methods are based on a 1-bp overlap criterion. Using low-coverage WGS data, we achieved 
an overall sensitivity of 80.1%, with cnvHiTSeq performing consistently better than competing methods 
on the same data [112] (FIGURE 3.6). Specifically, on the fosmid dataset cnvHiTSeq achieves a 
sensitivity of 88%, compared to 63% for Genome STRiP. For array-CGH we report a sensitivity of 
86%, while the next best result of 70% is achieved by EWT. cnvHiTSeq also outperforms other methods 
on the capillary read data, for which we report a sensitivity of 48% compared to Genome STRiP's 21%.  
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 FIGURE 3.6 Sensitivity analysis of cnvHiTSeq across gold standard datasets. 
To provide context for our FDR results we also estimated our method's sensitivity on the 
downsampled CEU trio. The previously used gold standard datasets contain CNV calls for the child of 
the trio (NA12878). For this sample we report an overall sensitivity of 78.4% and individual results 
consistent with those for sample NA12156 (TABLE 3.5). Furthermore, we created a CNV call set for 
the entire trio by analysing the raw array-CGH intensity data from the High Resolution CNV Discovery 
project [4] using cnvHap. On this set, which contains both duplication and deletion events as small as 
100bp, cnvHiTSeq achieves an overall sensitivity of 87.8%. 
Sample Overlap criterion Method Capillary Read Data array-CGH 
Fosmid 
Sequencing 
NA12878 1-bp cnvHiTSeq 87% 88% 50% 
NA12156 
1-bp 
cnvHiTSeq 88% 86% 48% 
Genome STRiP 63% 40% 21% 
EWT 46% 70% 6% 
CNVnator 20% 31% 9% 
BreakDancer 20% 18% 17% 
Pindel 13% 13% 10% 
50% reciprocal cnvHiTSeq 67% 71% 34% 
TABLE 3.5 Sensitivity analysis on low-coverage samples.  
3.4.3 Genotyping accuracy 
In order to explore the extra benefits available from population level modelling of NGS 
features, we applied cnvHiTSeq to 94 low-coverage CEU samples at the sites of 18 common deletions 
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characterized by PCR, which have been previously used to benchmark CNV genotyping accuracy [90, 
117]. We used cnvHiTSeq in two different configurations: single-sample, in which each sample is 
analyzed separately, and population-aware, in which the model parameters are updated via 10 iterations 
of expectation maximization. The population-aware mode achieved perfect genotyping concordance 
with the reference in 14 of 18 deletions (98.2% genotyping accuracy, 0.5% missing rate) and 
outperforms the single-sample mode at all deletions. Furthermore, the population-aware mode is shown 
to be as good as, or superior to, the results obtained from Illumina 1M genotyping arrays in 16 of 18 
deletions (APPENDIX TABLE 2). 
We also tested the genotyping accuracy of population-aware cnvHiTSeq on a larger 
genotyping dataset obtained from the High Resolution CNV Discovery study [112]. This dataset 
consists of ~5000 CNV regions genotyped for 450 HapMap samples and was created using a custom 
array-CGH. We applied cnvHiTSeq on a randomly chosen subset of 150 CNVs for 91 CEU samples 
that were common with the low-coverage phase of the 1000 Genomes Project. These CNVs range from 
462bp to 48,748bp in length, with a median of 2550bp. We report a genotyping concordance of 96.0% 
percent (2.7% missing rate), which is consistent with our previous results considering the limitations of 
array-CGH platforms in identifying complex and nested copy number events (APPENDIX FIGURE 1). 
3.5 Discussion 
In this chapter, we have demonstrated that our CNV detection framework maintains a low 
FDR and high sensitivity while identifying considerably more variants than other methods in low-
coverage WGS data. By adopting a unifying approach we are able to detect both deletions and 
duplications across a wide range of sizes, without deviating from previously reported length 
distributions [112] (FIGURE 3.7). 
Our results indicate that almost all CNVs that are detectable by microarray technologies can 
also be identified using low-coverage sequencing with similar, if not greater, genotyping accuracy. And 
since the proportion of the genome that can be interrogated by sequencing is much higher than that by 
microarrays, low-coverage NGS constitutes a natural choice of platform for CNV association studies. 
Our method's modular framework makes it readily extendible to additional data sources as 
they become available. Furthermore, as cnvHiTSeq constitutes a natural extension of cnvHap, it can 
take full advantage of cnvHap's microarray-based CNV detection framework. Synthesizing the two 
technologies will achieve the most comprehensive results and allow us to impute sequencing-derived 
CNVs onto existing genotyped datasets. 
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 FIGURE 3.7 Length Distribution of CNV calls. 
Size-range of CNV calls produced by cnvHiTSeq for the CEU trio. The deletion peak around 300bp most likely corresponds 
to ALU elements. The duplication size distribution is driven by two separate forces. The read pair data source mainly 
contributes to duplications smaller than the sequencing library insert size. In our case the insert size was 200bp, which explains 
the duplication peak around 100bp. On the other hand, the read depth data source contributes to larger duplications which 
explains the long tail of the distribution. 
High throughput sequencing technologies are still in active development. Over the course of 
the last few years, there has been tremendous progress that allowed for faster, more affordable 
sequencing on a genome-wide scale. As a result, we are now in an era in which hundreds of animal and 
plant species have been, or are being sequenced, while thousands are being planned. NGS is the driving 
force behind population re-sequencing projects, which rely on existing reference genomes to identify 
and catalogue genetic variation, construct the pan-genome [124], and make inference on population 
structure and demographic history. Population re-sequencing projects are underway in multiple human 
populations, in Arabidposis thaliana [125], as well as rice [126] and soybean [127]. Such projects 
typically attempt to sequence more individuals by lowering the coverage per individual to between 4x-
8x. As these low-coverage re-sequencing cohorts become available, cnvHiTSeq will provide the means 
for interrogating the role of both deletions and duplications on the phenotypic diversity of multiple 
species. Considering the added ability to accurately distinguish between homozygous and heterozygous 
events, cnvHiTSeq offers a complete solution to sequencing-based CNV detection and genotyping, 
aiming to further our understanding of CNV impact on disease and evolution. 
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3.6 Summary 
This chapter presented the implementation and benchmarking of a novel algorithm to detect 
and genotype CNVs using WGS data. By combining evidence from various sequencing features, 
cnvHiTSeq offers a substantial improvement in CNV detection sensitivity over existing methods, while 
maintaining a low FDR. The population modelling aspects of cnvHiTSeq also allow it to achieve a high 
genotyping accuracy even from low-coverage data. Therefore, our method is especially well-suited for 
low-coverage WGS re-sequencing cohorts and can provide valuable insights into CNV prevalence and 
importance. Despite its advantages, WGS remains uneconomical for certain research applications and 
is thus being supplanted by targeted sequencing technologies. In the next chapter we describe the 
distinct properties of targeted sequencing datasets as well as the challenges they pose for CNV 
detection. Then we present an extension to our statistical framework that was developed to address these 
challenges.   
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Chapter 4 
Chapter 4 Extended framework for targeted sequencing 
Extended framework for targeted 
sequencing 
 
In the preceding chapters we have detailed our statistical methodology for detecting and 
genotyping CNVs in whole-genome sequencing datasets. WGS relies on the principles of shotgun 
fragmentation to interrogate genomic samples in their entirety. The all-encompassing nature of WGS 
renders it ideal for elucidating the full spectrum of genomic diversity. However, when aiming to achieve 
high coverage, the breadth of WGS translates into cost- and time-efficiency concerns. As a result, there 
has been an increased interest in the development of more targeted approaches that sacrifice 
comprehensiveness on the altar efficiency. Such approaches operate under certain assumptions that 
allow for an a priori selection of genomic targets, which constitute the focal point of downstream 
analyses. This process involves an intermediate experimental step that aims to capture the desired 
targets ahead of sequencing. Various techniques have been designed to facilitate target enrichment, each 
presenting with a unique set of benefits and drawbacks. The common thread connecting all capture 
protocols is the fact that they invariably introduce non-uniformity in sequencing coverage. This 
enrichment-specific bias is particularly problematic for CNV detection and renders WGS-based 
algorithms inapplicable to targeted sequencing datasets.  
This chapter explores the genesis of enrichment bias and delineates its role in obscuring CNV. 
It also describes the statistical strategies that we developed to overcome the obstacles posed by 
enrichment bias. Concepts from this chapter have been published in the following article: 
E. Bellos, V. Kumar, C. Lin, J. Maggi, Z. Y. Phua, C. Y. Cheng, C. M. Cheung, M. L. Hibberd, T. Y. Wong, L. J. 
Coin and S. Davila (2014). "cnvCapSeq: detecting copy number variation in long-range targeted 
resequencing data." Nucleic Acids Res. 
 
We begin with a brief discussion of targeted sequencing applications. Then, we present the most popular 
enrichment techniques and their confounding effects on individual alignment features. Finally, we detail 
the theoretical extensions of our statistical framework that serve to mitigate the enrichment bias and 
enable CNV investigation in targeted sequencing datasets. Existing CNV algorithms specifically 
developed for targeted sequencing are also reviewed in this chapter.  
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4.1 Targeted sequencing applications 
Both the advantages and the adverse aspects of WGS stem from its breadth of scope. By 
examining genomic samples in toto, WGS offers an unbiased view into human genotypic variation. 
However, this holistic approach results in large amounts of data from intergenic regions that are often 
difficult to interpret at the phenotypic level. Furthermore, intergenic data contributes significantly to 
the cost of WGS, which remains a limiting factor for large-scale population studies. Targeted 
sequencing was devised as a more tractable alternative to WGS, focusing on a predetermined subset of 
the genome. Thus, targeted sequencing constitutes a substantially more economical solution that 
prioritizes sample size and statistical power over exhaustiveness. The choice of targets and overall 
proportion of the genome to be interrogated depends highly on the research application. 
The design of targeted sequencing assays is usually motivated by prior hypotheses that 
demarcate specific genomic regions of interest. The most popular targeted approach is whole-exome 
sequencing (WES), which aims to capture the full complement of human protein-coding sequence. 
WES has largely superseded both WGS and more traditional linkage studies for investigating 
undiagnosed disorders. This is based on the assumption that coding mutations are more likely to cause 
the severe phenotypic effects commonly observed in rare genomic disorders. As a result, WES has led 
to a renaissance in the field of Mendelian genetics [128-130]. In contrast, targeted sequencing is also 
commonly used to capture large contiguous genomic regions. Unlike WES, which is primarily 
exploratory, contiguous target sequencing is more suitable for thorough examination of loci previously 
implicated in a disease or trait. This strategy is especially powerful for dissecting the results of genome-
wide association studies and linkage analyses to pinpoint elusive causative variants. 
Whether designed to capture contiguous or dispersed regions, targeting platforms employ the 
same set of enrichment strategies that are ultimately responsible for most of the systematic bias present 
in the final sequencing data. 
4.2 Target enrichment 
Multiple approaches have been developed to selectively enrich for specific genomic loci prior 
to sequencing. The most widely used enrichment protocols are based on two main techniques: PCR and 
hybrid capture. Each of these techniques possesses distinct properties and is thus more suitable for 
different applications. 
4.2.1 PCR-based enrichment 
PCR has been extensively used for sample preparation since the days of Sanger sequencing 
and was thus the earliest method to be adapted for NGS target enrichment. By utilizing unique 
oligonucleotide primers flanking the regions of interest, PCR can selectively amplify the intended 
targets with unmatched specificity. The resulting amplicons, corresponding to the enriched targets, are 
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then used to construct shotgun libraries, which are eventually sequenced using standard NGS protocols. 
The success of PCR-based enrichment is largely contingent on the primer design, which can itself be 
problematic in the presence of repetitive sequence or SNPs. Furthermore, traditional PCR is difficult to 
multiplex and thus suffers from scalability issues. Recent advancements pioneered by RainDance 
Technologies [131] have enabled an unprecedented degree of multiplexing, rendering PCR feasible on 
a near-exome level. Nevertheless, PCR remains impractical for targeting larger portions of the genome, 
and is therefore primarily reserved for sequencing gene panels and short contiguous regions. 
4.2.2 Hybridization-based enrichment 
Hybrid capture enrichment relies on the principles of hybridization that have been long-
established for selective isolation of genomic fragments [132, 133]. In this technique, the sample 
genome is first randomly sheared and the resulting fragments are hybridized to oligonucleotide probes 
designed to match the sequence of the target regions. Successfully hybridized fragments are 
subsequently eluted from the probes, PCR amplified and sequenced. 
The earliest enrichment protocols to couple hybrid capture with NGS were based on solid-
phase hybridization [134, 135]. This constitutes a conceptual extension to traditional DNA microarray 
technologies, in which the hybridization products are not used as quantifiers of biological signal, but as 
substrate for sequencing. To that end, the microarrays are washed after hybridization to remove non-
targeted sequence and the remaining fragments are extracted and processed into sequencing libraries. 
Array-based capture can readily interrogate exome-sized targets on a single chip and thus offers a 
distinct advantage over PCR. Nevertheless, microarray experiments remain relatively laborious and 
require specialised equipment. As a result, solid-phase capture has been largely superseded by newer 
solution-based hybridization technologies [136] that were devised to address the weaknesses of 
microarrays.  
Solution-based enrichment involves the hybridization of whole-genome fragments to 
oligonucleotide probes that are suspended in solution instead of being immobilized on a solid surface. 
The probes themselves are biotinylated and can therefore be pulled down from the solution using 
streptavidin-coated magnetic beads. The beads are then washed to minimize contamination and the 
hybrid-selected DNA is eluted and prepared for sequencing. Due to favourable hybridization kinetics, 
in-solution capture requires a smaller amount of starting DNA sample than microarrays. Furthermore, 
it improves upon the scalability of array-based platforms, while eliminating the need for dedicated 
infrastructure.  
Overall, hybrid capture exhibits lower specificity than PCR, but compensates with improved 
target coverage. The high degree of multiplexing achievable by hybrid capture allows for higher bait 
tiling redundancy that increases the probability of capturing a target even if individual baits fail. 
Furthermore, compared to PCR, hybrid capture can efficiently target a much higher proportion of the 
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genome, which renders it ideal for WES. As a result, in-solution capture is the technology behind the 
two leading enrichment platforms (NimbleGen’s SeqCap and Agilent’s SureSelect), having established 
itself as the most widespread targeting approach. 
4.3 Effects of enrichment on CNV detection 
Target enrichment, whether PCR- or hybridization-based, involves a number of steps 
interposed between sample preparation and actual sequencing. Thus, the inherent bias of the enrichment 
process confounds downstream analyses and unavoidably introduces an added level of complexity in 
data normalization. The most severely impacted aspect of targeted sequencing is the coverage 
uniformity. Enrichment-induced coverage heterogeneity affects all alignment features and poses 
significant obstacles to CNV detection.  
4.3.1 Exploratory dataset 
We explored the effects of enrichment on individual alignment features using hybrid capture 
platforms, which are currently prevalent in targeted sequencing applications. Specifically, we examined 
a contiguous target region in a cohort of 285 control samples. The target region spans ~350kb on 
chromosome 1 and was enriched with a custom NimbleGen SeqCap assay. It contains six paralogous 
genes and is known to harbour a common deletion. This capture dataset was used to substantiate our 
observations regarding enrichment bias. However, it also provided the means to assess our extended 
CNV detection framework and is thus described in more detail in the chapter 5.  
4.3.2 RD variability 
One of the main drawbacks of target enrichment lies in the uneven coverage across the regions 
of interest. In WGS, every genomic region is theoretically equally represented in the sequencing results, 
which allows us to draw inferences regarding the absence of a region by examining the local read depth. 
In capture sequencing, however, the genomic dosage of the target region is “decoupled” from the 
observed read depth, due to implicit enrichment biases. This translates into highly variable RD that is 
not directly proportional to the underlying copy number, as assumed by most CNV detection methods 
developed for WGS.  
4.3.2.1 Sequence composition 
An important source of RD bias in targeted sequencing arises from variability in the capture 
efficiency of different baits. Capture efficiency depends primarily on the base composition of the target 
sequence and on the enrichment strategy. 
GC content contributes significantly to RD variability through two distinct mechanisms. In 
hybrid capture technologies, GC content has a direct effect on hybridization efficiency. For example, 
AT-rich probes tend to form weaker, less stable hybrids and are thus under-represented in the 
enrichment products. This ultimately leads to a local decrease in sequencing coverage, which resembles 
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the RD signature of a deletion. Moreover, if the enrichment process involves PCR, the GC content has 
a strong effect on the amplification and thus introduces further RD bias [72]. 
Another sequence property that influences targeted RD is alignability. Low alignability 
manifests as repetitive or low-complexity regions that cannot be captured by unique baits. The inclusion 
of non-unique baits leads to artificially inflated RD or off-target capture. The exclusion of such baits 
results in decreased RD or gaps within a target. 
Most aspects of sequence composition, including GC content and alignability, are well 
described and can thus be modelled appropriately [119]. Sequence properties, however, can only 
account for a fraction of the noise present in capture datasets (FIGURE 4.1). 
 
FIGURE 4.1 Effects of GC and alignability correction on targeted RD. 
Read depth profile of sample CHH1030 (exploratory cohort) across the target region, before and after correcting for GC-
content and alignability using linear regression. The coefficient of determination (R2, ratio of explained variation to the total 
variation) is used to determine the variance explained by each variable. GC explains only a small fraction of the read depth 
variance, while alignability explains 57%. 
4.3.2.2 Bait design 
Another aspect of the enrichment protocol that plays an essential role in the resulting RD 
pattern is the design of the capture baits. Bait design is a complex process that aims to achieve the best 
possible coverage across targets by determining two basic parameters: bait length and tiling density. 
Especially in hybridization-based enrichment, bait arrangement can have a pronounced effect on the 
local RD, thus contributing considerably to coverage irregularity (Figure 4.2). For example, a denser 
tiling of the capture probes in a sub-segment of the target can lead to its over-representation in the 
enrichment results and to a subsequent regional increase in RD that appears like a duplication.
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FIGURE 4.2 Effects of bait design and tiling on read depth of simulated locus 
We designed 3 alternative ways to cover a target locus (chr6:139,582,000-139,627,000) with hybridization probes. By varying the probe length and the amount of overlap among probes we 
demonstrate how bait design can influence the resulting read depth pattern. The red dashed lines denote a known region of low alignability. (a-c) Each experiment (panel) has a unique probe tiling 
design that was generated by simulating random overlaps between probes, drawn from a uniform distribution over the interval [30%, 70%]. These tilings were used to simulate sequence data for 
3 different samples, denoted by different colour shades. The read depth patterns show a very high degree of similarity within experiments. (d) Representative samples from each tiling design are 
compared to each other. The noise patterns don’t appear to be consistent across experiments. 
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Bait design bias can be explicitly modelled and corrected, if the probe coordinates are 
available. However, with the exception of some commercial WES platforms, bait design is considered 
proprietary and thus remains undisclosed. This is particularly pertinent to custom enrichment assays 
that are designed to capture novel genomic regions. Thus, despite the fact that it explains a large 
proportion of the RD variability, bait design is generally considered a “black box” for normalization 
purposes. 
Although the individual RD confounders may remain unknown, it is apparent that the noise 
pattern is consistent among samples (FIGURE 4.2). This can be largely explained by the fact that bait 
design is specific to the enrichment assay and thus constant for each targeted sequencing experiment. 
As a result, the RD appears to be highly correlated across samples, with an average pair-wise Pearson’s 
correlation coefficient of 0.97 (FIGURE 4.3). Therefore, RD measurements are highly amenable to data-
driven normalization, which is especially powerful for large-scale population resequencing projects.  
 
FIGURE 4.3 Correlation of RD across samples in a targeted sequencing experiment. 
Correlogram for the read depth of 10 randomly chosen samples from the exploratory cohort. The lower left panel represents 
the pair-wise scatterplot for all possible sample combinations. The upper right panel represents the color- and intensity-coded 
Pearson’s correlation (r2) for all possible sample combinations. The minimum reported r2 is 0.93. 
 
4.3.3 RP & SR 
Read pair inconsistencies and split reads provide distinct CNV signatures that are largely 
complementary to RD. Unlike RD, however, these signatures only arise when the breakpoints of a CNV 
happen to be flanked by a read pair or spanned by a single read. This is commonplace in WGS datasets, 
which provide a comprehensive representation of the entire sample genome. Targeted sequencing, on 
the other hand, is a more sparse approach that is less likely to capture CNV breakpoints. 
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Even if the breakpoints of a CNV come to be targeted, the bait sequence, which is obtained 
from the reference genome, will differ substantially from the sequence of fragments spanning the 
variant. As a result, such fragments will hybridize poorly to the capture probes and thus fail to be 
enriched. This effectively eliminates split reads from capture sequencing results, leading us to omit the 
SR feature from our targeted CNV detection framework. 
The RP feature is more dependable than SR, but tends to provide more sporadic CNV 
evidence than RD. The scarcity of informative RPs is more pronounced in WES datasets, due to the 
highly discontiguous and sparse nature of exonic targets. Furthermore, as previously discussed, capture 
probes tend to be less reliable in the presence of repeats. This results in a large proportion of multi-
mapped RPs with ambiguous distances that are not readily interpretable. However, the same repetitive 
elements that confound targeted RP also mediate CNV genesis. Thus, by mitigating the ambiguity of 
RP alignments, we can recover valuable, if auxiliary, CNV signal. 
4.4 Existing approaches to enrichment bias correction 
To overcome the obstacles introduced by the enrichment process, a few CNV detection 
methods have been specifically developed for targeted resequencing. These methods focus on 
alleviating the effects of coverage non-uniformity in RD, but disregard RP evidence altogether. The 
vast majority of existing algorithms employ two basic strategies to deal with RD variability: control-
based normalization or data-driven normalization. 
4.4.1 Control-based RD normalization 
Control-based normalization was developed to take advantage of case-control study designs, 
such as WES of paired tumour/normal samples. This strategy attempts to counteract enrichment bias by 
considering only relative RD changes between cases and controls, instead of absolute RD 
measurements. This is usually achieved by dividing the RD of a case sample by a control depth to 
generate a log-ratio type metric. Thus, assuming that the confounders are shared all samples, RD ratios 
should theoretically adjust for local RD variability that is due to enrichment bias. This approach is 
inspired by microarray-based CNV detection and relies on significant deviations of the log-ratio from 
the baseline to assign copy numbers to each target. 
Notable methods in this category include ExomeCNV [137], EXCAVATOR [138] and 
CONTRA [139]. Most of these methods require an explicitly matched control population that is usually 
not available in targeted sequencing experiments. CONTRA also implements the use of a pseudo-
control, which is calculated from population average RD values. This pseudo-control, however, can be 
highly unrealistic, especially in the presence of CNVs with high population frequency. 
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4.4.2 Data-driven RD normalization 
Data-driven normalization attempts to identify and eliminate high-variance components in the 
RD signal that are likely dominated by noise. This strategy essentially constitutes a dimensionality 
reduction that can be achieved either using Singular Value Decomposition (SVD), or the equivalent 
Principal Component Analysis (PCA). Instead of relying on control samples, data-driven approaches 
leverage population-level information to mitigate the effects of enrichment. By concurrently analysing 
multiple samples, SVD- and PCA-based transformations can be used to determine the dominant modes 
of RD variation, which represent the portion of the signal that is shared among samples. These modes 
account for most of the enrichment bias that confounds CNV detection and are therefore removed from 
the signal. In addition to sequence composition biases, this process corrects RD for latent enrichment 
attributes, such as bait design. To achieve optimal results, data-driven normalization presupposes the 
existence of large sample sizes, which is becoming standard practice for targeted sequencing 
experiments. 
Popular methods in this category include CoNIFER [140] and xHMM [141]. All the existing 
data-driven algorithms focus on detecting exon-spanning CNVs in WES datasets and are based on the 
assumption that read depth correlation across distal regions reflects sample batch artifacts. As a result, 
they require exome-wide data and cannot accurately resolve CNV breakpoints outside exons, which 
makes them unsuitable for long-range contiguous capture sequencing.  
4.4.3 CNV calling 
Post-normalization, both control-based and data-driven approaches draw from the existing 
repertoire of CNV detection algorithms. The simplest methods employ crude thresholding to assign 
copy numbers to the normalized RD [140]. More sophisticated methods use established CNV 
segmentation algorithms such as circular binary segmentation (CBS) [139], shifting level models [138] 
and hidden Markov models [141]. Regardless of normalization strategy, the ability to call absolute copy 
number genotypes is currently limited and requires the use of a control population. 
4.5 Custom framework for targeted sequencing 
As previously discussed, the targeting process introduces unique challenges to CNV 
detection. Although our original CNV framework was designed to deal with sequence composition bias, 
it was ill-equipped to address the complex effects of target enrichment on alignment-based CNV 
signatures. Therefore, we set out to extend our framework with custom normalization techniques, 
designed to “salvage” alignment features that are rendered uninformative by enrichment bias. This 
includes new pre-processing strategies for both RD and RP, which are subsequently modelled as per 
our standard framework. We have also calibrated our HMM to accommodate the adjusted features and 
conform to the distinct properties of targeted sequencing. 
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4.5.1 SVD normalization for RD 
The SVD has been proposed as a robust mathematical framework for detecting high-order 
structure in complex biological datasets [142]. Moreover, SVD has been previously employed to 
normalize targeted RD [140], albeit with certain limitations. The most restrictive aspect of existing 
approaches lies in their propensity to aggregate RD counts at the target level. This strategy achieves 
sufficient resolution for WES, where targets coincide with exons, but proves inadequate for custom and 
contiguous target regions. To overcome these restrictions and harness the full potential of data-driven 
normalization, we have implemented a more general-purpose version of SVD-based correction. 
First, our read depth measurements are extracted from the BAM alignment files as described 
in chapter 2. Assuming our RD is sampled in non-overlapping windows of user-defined length (default 
100bp), normalized by the average per-sample coverage and arranged into a position-by-sample matrix 
M, SVD provides the following factorization: 
𝑀𝑀 = 𝑈𝑈𝑈𝑈𝑉𝑉∗ (4.1) 
The columns of matrix U represent the left singular vectors of M which can be interpreted as 
uncorrelated eigen-windows. Similarly, the rows of V* represent the right singular vectors of M and can 
be thought of as uncorrelated eigen-samples. Σ is a diagonal matrix containing the singular values of 
M, in decreasing order. The magnitude of each singular value corresponds to the relative importance of 
each combination of eigen-window and eigen-sample and is largely dependent on the number of 
samples being processed in parallel.  
Existing methods that apply SVD or PCA for RD normalization in WES datasets [140, 141] 
use heuristics to determine how many components need to be removed. In our exploratory dataset, 
however, it was evident that the first singular value is dominated by the systematic noise (FIGURE 4.4). 
 
FIGURE 4.4 Relative variance for the first 5 singular components of our exploratory dataset. 
The relative variance of component k is defined as sk2/Σisi2. The first singular component dominates with a relative variance 
of 93%, while the remaining components have minor contributions. 
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Thus, by removing only the first singular component and reconstructing the M matrix, we essentially 
remove the baseline coverage, making CNV signal stand out (FIGURE 4.5a,b). Nevertheless, we offer 
the option to eliminate more components as a user-definable parameter. 
 
FIGURE 4.5 SVD normalization results for two samples in our target capture cohort. 
(a) Read depth profile for sample CHH1008 with up to 4 singular components removed. This sample is copy-neutral (as 
validated by qPCR). (b) Read depth profile for sample CHH1039 with up to 4 singular components removed. This sample 
contains a PCR-validated heterozygous deletion (with breakpoints marked by the orange dashed lines). 
Also, unlike other SVD-based methods, we don’t convert our reconstructed data into z-scores, 
since that eliminates all scale information and allows only relative copy number estimation. Instead, we 
add the mean coverage back to the normalized data, thus restoring its original properties. The shifted, 
normalized RD can then be treated like its unnormalized counterpart, providing an intuitive basis for 
absolute copy number genotyping. 
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4.5.2 RP realignment 
Despite its important role in controlling specificity, the RP feature has been entirely 
overlooked in targeted CNV detection. This is mainly due to the fact that current approaches were 
designed to analyse WES datasets, which are unlikely to capture CNV breakpoints. However, as the 
enrichment paradigm has started shifting towards longer targets, RP-based CNV evidence has re-
established its relevance in capture sequencing experiments. 
The analysis of RP data is generally challenging in repeat-rich regions. The enrichment 
process further compounds the issue, resulting in complex and abstruse RP patterns, as evidenced in 
our test dataset (FIGURE 4.6). This due to ambiguous RP alignments, which are essentially 
uninformative for CNV calling, and thus usually discarded by CNV algorithms. However, by entirely 
excluding such reads from our contiguous capture results, all RP information appears to be lost. Instead, 
we attempt to rescue non-unique mappings using sensitive local realignment. This allows us to unveil 
weak read pair signatures that support the absence (FIGURE 4.6a) or presence of CNV (FIGURE 4.6b). 
       
FIGURE 4.6 RP realignment results for two samples in our target capture cohort 
(a) Read Pair Distance profile for copy-neutral sample CHH1008 with various strategies for dealing with multi-mapped reads. 
(b) Read Pair Distance profile for sample CHH1039. By locally realigning multi-mapped reads we manage to unmask a 
relatively weak read pair signal that supports the known deletion. 
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To that end, we extract discordant multi-mapped read pairs and perform very sensitive local 
realignment using Bowtie2 [143]. To increase alignment sensitivity we adjust Bowtie’s multiseed 
heuristic by reducing the length of seeds and the inter-seed distance, while increasing the number of 
permitted mismatches per seed. Thus, we obtain multiple alternative mappings with detailed alignment 
properties, which may have been sacrificed by the original aligner in favour of speed. We then rank the 
alternative mappings according to the alignment scores assigned to each possible pairing (reported as 
AS for the read under consideration and YS for its opposite mate). Subsequently, we select the 
combination that maximizes the sum of these alignment scores, while minimizing the overall amount 
of soft-clipping. Pairs with alternative mappings of indistinguishable quality are filtered out from further 
analysis. The rest are used to calculate the average distance of all spanning pairs at any given position 
(RPS), along with a count of such pairs (RPC). In accordance with our general framework, possible 
differences in library design among samples are addressed by quantile-normalizing the insert size 
distributions to a Gaussian reference with a mean of 200bp and 15bp variance. Finally, these metrics 
are sampled at the same resolution as the read depth. 
4.5.3 HMM fine-tuning 
Considering the potentially contiguous nature of capture targets, we incorporated both RD 
and RP into our extended framework. CNV detection and genotyping is achieved using the hidden 
Markov model described in chapter 2. As per our original strategy, the observed variables (RD, RPS 
and RPC) are analysed at the population level to achieve optimal results. 
For WGS, the HMM emission probabilities of RD and RPC were modelled using the negative 
binomial distribution, whereas a normal distribution was used for the read pair distance (RPS). Given 
that our pre-processing strategies reduce the dynamic range of both RD and RP, we tailored the 
distributions for capture sequencing datasets. Thus, we established a fine-tuned set of initial emission 
parameters for both the NB and the normal distribution, to allow for the detection of more subtle CNV 
signatures. We also adopted a higher initial transition rate than WGS, to increase the sensitivity of the 
model without affecting its specificity. 
Another important addition to the CNV calling framework is the ability to a priori exclude 
regions that correspond to failed target probes or intentional gaps. If there is information on loci that 
were not captured during the enrichment step, our algorithm will downweight all evidence arising from 
these loci, thus avoiding spurious CNV calls. 
4.6 Summary 
In this chapter we have presented an extension of our CNV calling framework for targeted 
sequencing datasets. We have developed customized pre-processing and normalization techniques to 
alleviate the effects of enrichment bias. These techniques were designed to be generic and independent 
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of particular target sets. Thus, unlike existing methods, our framework is not restricted to whole-exome 
sequencing analysis and can readily accommodate contiguous capture data. To take advantage of 
contiguous targets and maximize detection specificity, our approach considers evidence from both RD 
and RP. Furthermore, by utilizing information at the population level and preserving the scale of the 
normalized data, our method can ascertain absolute copy numbers without the need for matched control 
samples. In the next chapter we describe an application of our extended framework to long-range 
contiguous target sequencing. This is implemented as the cnvCapSeq algorithm, which was 
exhaustively benchmarked using both simulated and real datasets. A detailed discussion of 
cnvCapSeq’s performance evaluation is presented in chapter 5. 
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Chapter 5 
Chapter 5 Application to contiguous targeted sequencing: cnvCapSeq 
Application to contiguous targeted sequencing: 
cnvCapSeq 
 
Despite the ever decreasing cost of sequencing, it remains economically infeasible to employ 
WGS strategies in sample sizes large enough to identify rare variants of small effect or incomplete 
penetrance. Thus, targeted sequencing has emerged as an efficient and cost-effective alternative for 
investigating specific regions of interest. Targeted approaches have been used to elucidate both 
monogenic [130, 144, 145] and complex disorders [146-148], including some cancers [149-151]. These 
studies, however, have primarily focused on investigating SNPs and indels, essentially disregarding 
copy number variation. 
The scarcity of CNV findings obtained from capture sequencing can be largely attributed to 
systematic biases that arise from the target enrichment process. These biases, which were detailed in 
chapter 4, render traditional, whole-genome CNV detection algorithms inapplicable. Thus, various 
methods have been developed to mitigate the effects of enrichment in whole-exome datasets. However, 
none of the existing methods can accommodate contiguous targets, despite their increasing importance 
in clinical and research applications. Here, we present cnvCapSeq, a novel algorithm for accurate and 
sensitive CNV discovery and genotyping in long-range contiguous target resequencing.  
cnvCapSeq constitutes an implementation of our extended CNV framework, which was 
described in the previous chapter. It is the first algorithm specifically designed to address the challenges 
of capture sequencing, while reaping the benefits that come with contiguous targets. To demonstrate 
cnvCapSeq’s advantage over existing approaches, we conducted thorough benchmarking under various 
conditions. Concepts and results from this chapter have been published in the following article: 
E. Bellos, V. Kumar, C. Lin, J. Maggi, Z. Y. Phua, C. Y. Cheng, C. M. Cheung, M. L. Hibberd, T. Y. Wong, L. J. 
Coin and S. Davila (2014). "cnvCapSeq: detecting copy number variation in long-range targeted 
resequencing data." Nucleic Acids Res. 
 
Chapter 5 begins with a description of the datasets that were used in our benchmark. It continues with 
a brief discussion on the technical aspects of our algorithm’s implementation. The chapter concludes 
with a detailed account of cnvCapSeq’s performance, including the results of experimental validation.  
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5.1 Materials and datasets 
In lack of a true gold standard, cnvCapSeq was developed and benchmarked using an 
extensive multi-locus simulation dataset. This dataset was designed to explore CNV in its authentic 
genomic context, while covering a wide range of experimental scenarios. Our approach was then 
validated using a real cohort of 285 Chinese Singaporean control samples. This cohort comprises 
contiguous capture sequence data of the Regulation of Complement Activation (RCA) locus on 
chromosome 1. 
5.1.1 Simulation dataset 
To obtain a comprehensive benchmark for cnvCapSeq, we generated a synthetic dataset that 
spans multiple CNV lengths and population frequencies. For that purpose, we only considered genomic 
loci on chromosomes 1 and 6 (APPENDIX TABLE 3) that were shown to harbour recurrent deletions by 
Phase 1 of the 1000 Genomes Project [152]. These deletions were then cross-referenced with the DGV 
to ensure that they overlapped the results of at least one independent study. Based on the deletions that 
fulfilled the aforementioned criteria, we selected our final simulation set of 21 loci. 10 of the loci overlap 
RefSeq genes, while 14 loci contain segmental duplications or dispersed repeat elements. The sizes of 
the candidate deletions are evenly distributed between 1kb and 115kb. To facilitate CNV calling, each 
locus was extended by 20kb on either side of the candidate deletion.  
We used Wessim [153] to perform in silico simulations of contiguous capture sequencing 
reads in the 21 candidate loci. Although Wessim was originally designed for exome sequencing 
simulations, it can be generalized for any type of capture sequencing experiment. By emulating a probe-
hybridization step, Wessim generates very realistic synthetic capture data that cannot be obtained with 
traditional NGS simulators. To take advantage of this feature, we computationally fragmented the 
candidate loci into unevenly spaced 120bp-long probes, and queried the reference genome (GRCh37) 
for the corresponding probe sequences. These sequences constitute the input for Wessim and are used 
to model the hybridization properties of each probe. The amount of overlap between each pair of 
consecutive probes was drawn from a uniform distribution ranging from 30% to 70%. However, the 
probe design itself is obscured from later analysis, as it would be in real capture experiments. The 
random overlap of the hybridization probes approximates the custom probe tiling that is necessary for 
comprehensive coverage of a target region and is largely responsible for the observed uneven coverage. 
The second source of RD bias within capture targets is the presence of repetitive genomic sequence that 
exhibits low alignability. Such non-unique sequence has been shown to mediate CNV formation, and 
may therefore be overrepresented in copy number variable regions. This type of artifact can only be 
reproduced by considering candidate loci with known CNVs, instead of simulating under ideal 
conditions. The complex structure of our 21 loci, poses alignability challenges and renders our synthetic 
dataset more realistic (an example was presented in FIGURE 4.2). 
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In each locus we simulated 100 copy-neutral samples to aid in specificity and precision 
calculations and 30 samples with heterozygous deletions to evaluate sensitivity. An empirical error 
model was used to simulate paired-end reads from Illumina HiSeq IIx sequencing runs. The reads were 
100bp long with a mean insert size of 200bp, and were aligned to the reference using BWA [80]. The 
average coverage was kept constant at 200x across samples with 94.5% of all bases (across loci) covered 
at least 10x. Bases with coverage below 10x were excluded from further analysis, as they correspond 
to targets that failed to capture. This is most likely due to low alignability of the underlying probes. 
Finally, the deletion-carrying samples were combined with the copy-neutral samples to obtain 
pseudo-populations of varying deletion frequencies (1%-30%) in each locus. These pseudo-populations 
form the basis for evaluating the performance of cnvCapSeq against existing methods. 
5.1.2 RCA cohort 
The RCA cohort comprises capture sequence data of a 358kb locus on chromosome 1q31.3 
that contains the Complement Factor H (CFH) gene and 5 CFH-related (CFHR) genes. Although this 
region is known to harbour a common deletion and has been previously associated with Age-related 
Macular Degeneration (AMD) [154] and susceptibility to meningococcal disease [155], it remains 
difficult to characterize due to its high degree of macrohomology. The cohort is composed of 285 
Singaporean individuals of Chinese descent that were recruited as controls for a large AMD study. 
Given the contiguous nature of the target region and the relatively high frequency of the deletion allele 
in the population (previously reported between 6% and 9% for Han Chinese [156]), this cohort is ideal 
for exploring the utility of cnvCapSeq in real datasets. 
The target region was enriched using a custom Nimblegen SeqCap assay. Despite the highly 
repetitive nature of the RCA locus, the assay successfully captured ~90% of the intended 358kb region 
(chr1:196,620,597-196,978,814). In each assay 24 samples were captured, all of which were uniquely 
barcoded. Due to the relatively small size of the target region, two 24-sample capture libraries could be 
multiplexed to allow sequencing of 48 samples per flow cell on Illumina HiSeq2000, using a paired-
end protocol. The sequencing libraries consisted of 100bp reads with a mean insert size of 200bp. The 
sequencing reads were aligned to the human reference genome (GRCh37) using CASAVA, which is 
part of Illumina’s data analysis pipeline. Duplicate reads were removed using Picard followed by local 
realignment and recalibration with GATK [157, 158]. The average depth of coverage across samples is 
~650x and more than 90% of bases were covered at least 14x. This is expected since the assay did not 
contain baits to capture the remaining 10%. 
5.2 cnvCapSeq implementation 
cnvCapSeq is implemented as a collection of Java tools and helper shell scripts for UNIX 
systems. It takes BAM alignment files as input and offers the option to exclude target regions that are 
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known to have failed the capture step (in a standardized BED format). The BAM files are pre-processed 
using SAMtools [159] to extract the necessary RD and RP features. The RD measurements are then 
sampled and normalized using a custom implementation of SVD. For RP, we follow the same strategy 
as in WGS to normalize and combine sequencing libraries. However, instead of discarding multi-
mapped RPs, we realign them using Bowtie2 and incorporate the newly rescued pairs into our dataset. 
Summarized distance (RPS) and count (RPC) measurements are obtained by sampling the combined 
RP dataset. 
cnvCapSeq generates normalized RD files in binary and text format that can be used 
independently of our CNV calling component. Thus, cnvCapSeq also offers a standalone normalization 
tool that can be used in conjunction with third party segmentation algorithms. When our HMM 
framework is employed to integrate the normalized features, cnvCapSeq produces CNV calls in text 
format and optional segmentation plots.  
The sampling density of RD & RPC is a user-specified parameter that determines the CNV 
breakpoint resolution and the computational requirements of the algorithm. The performance of the 
normalization algorithm scales linearly with the population size and the length of the target region, 
while the feature pre-processing also depends on the depth of coverage. Thus, at the default high-
resolution setting of 100bp, the analysis of a ~350kb region in 100 samples (sequenced at 50x), requires 
4GB of memory and one CPU hour.  
5.3 cnvCapSeq performance evaluation 
A systematic evaluation of cnvCapSeq’s performance was obtained using our extensive 
simulation dataset. This dataset can serve as a general benchmark for contiguous capture sequencing 
algorithms and was thus made publicly available. We also investigated our framework’s behaviour in 
real capture sequencing data, by applying cnvCapSeq to samples from the RCA cohort. Since the true 
copy number status of these samples was unknown, we performed qPCR validation on a random but 
demonstrative subset of cnvCapSeq’s results. 
To establish a baseline for comparison, we included 3 representative WES CNV methods in 
our assessment: CONTRA, CoNIFER and xHMM. However, the applicability of these methods to 
contiguous targets is limited by their explicit requirement for capture target coordinates. The first 
obstacle for obtaining such coordinates is the proprietary nature of bait design for custom capture 
assays. Furthermore, the assumption of contiguity is contrary to the distinct nature of exons and genes 
spread across the genome. We attempted to overcome these constraints by generating “pseudo-targets” 
that cover our loci. This was achieved by partitioning each locus into non-overlapping 100bp windows. 
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5.3.1 Simulation benchmark 
Our simulation dataset explores numerous conditions and experimental scenarios. Before 
proceeding with the detailed performance assessment, however, we investigated how the normalization 
process itself affects our synthetic RD data. 
5.3.1.1 Normalization considerations 
We begin our analysis by examining the impact of RD normalization on our ability to detect 
known CNV patterns in simulated data. To that end, we applied the Singular Value Decomposition on 
RD measurements and observed that most of the variance that is due to unmeasurable sources of 
experimental bias can be captured by the first and largest singular value (FIGURE 5.1). In most cases, 
the absence of CNV in copy-neutral samples only becomes apparent after removing the first singular 
component (FIGURE 5.1a,d). Conversely, true CNVs are masked by an overlapping reduction in read 
depth that is present in all samples (FIGURE 5.1b,e). Removing more than one singular component masks 
all evidence of CNV (FIGURE 5.1c,f) and renders RD uninformative. Thus, we opted to normalize our 
simulated data by eliminating just the first singular component. The other data-driven methods in our 
benchmark (xHMM & CoNIFER) employ heuristics to determine the number of components to remove, 
which results invariably in over-correction. Therefore, we decided to override the default behaviour of 
these methods, forcing them to discard only the first singular component. This creates bias in favour of 
xHMM and CoNIFER, but allows for meaningful comparison with cnvCapSeq. 
5.3.1.2 Overall performance 
To obtain a broad view across simulated conditions, we calculated overall performance 
metrics for the four algorithms in our benchmark. In this assessment, cnvCapSeq outperforms all other 
methods by a wide margin (TABLE 5.1), with an overall sensitivity of 92.0% versus 48.3% for the next 
best method (xHMM) and an overall specificity of 99.8% versus 70.5%. cnvCapSeq also has a clear 
advantage in positive prediction value (PPV), as it achieves 98.4% versus 12.3% for xHMM. This 
disparity is due to the fact that all 3 WES CNV methods make considerably more false positive calls 
than true positive calls. In fact, CoNIFER detected almost none of the simulated deletions (0.02% 
sensitivity) and it was thus excluded from further comparisons.  
 Sensitivity Specificity PPV NPV Accuracy 
cnvCapSeq 92.08% 99.77% 98.37% 98.80% 98.75% 
xHMM 48.27% 70.47% 12.29% 94.08% 68.71% 
CONTRA 17.24% 46.24% 2.84% 85.98% 43.82% 
CoNIFER 0.02% 95.29% 0.07% 86.08% 82.57% 
TABLE 5.1 Overall performance comparison across methods in the simulated capture dataset. 
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FIGURE 5.1 SVD normalization results for 2 representative simulated loci. 
Each column represents a single locus where a deletion was simulated. 4 samples are depicted in each plot: 1 copy-neutral and 
3 harbouring heterozygous deletions. The red dashed lines denote the breakpoints of the simulated deletion. Removing the 
first singular component separates the copy-neutral from the deletion-bearing samples. When further components are 
eliminated all useful signal appears to be lost. (a-c) 5kb deletion simulated on chromosome 6 (chr6:139,582,000-139,627,000). 
(d-f) 115kb deletion simulated on chromosome 1 (chr1:12,879,000-13,033,000) 
 
5.3.1.3 Performance versus CNV length 
Next, we set out to explore the relationship between the length of the simulated CNV and 
method performance. Our synthetic dataset comprises 21 genomic loci, each harbouring a deletion of 
different size. The deletions range from 1014bp to 114,663bp, with an approximate increment of 5kb. 
cnvCapSeq remains consistently specific and precise across lengths while exhibiting small variations  
in sensitivity. xHMM and CONTRA, however, appear to deteriorate significantly with increasing CNV 
size. The effect is more pronounced for CNVs larger than 70kb, which both xHMM and CONTRA fail 
entirely to detect (FIGURE 5.2a; APPENDIX FIGURE 2). This can be largely explained by the fact that 
WES methods were designed for small- to medium-sized CNVs, spanning neighbouring exons. Thus, 
they resort to heuristics for calling larger events, which tend to restrict their functionality. 
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 FIGURE 5.2 Performance comparison for 3 methods on our synthetic capture dataset. 
Parallel coordinates plot represent combinations of sensitivity, specificity, accuracy and positive predictive value (PPV). (a) 
Simulated deletions were divided into 3 size groups and the performance metrics were averaged across frequencies. The denser 
the dash pattern the larger the underlying deletions. The best results for all methods are achieved for shorter CNVs. 
 
5.3.1.4 Effects of CNV population frequency 
In capture sequencing datasets, CNV detection is contingent on the ability to generate a robust 
RD baseline that represents the copy-neutral state across targets. Whether explicitly required (as in 
control-based normalization) or indirectly estimated (as in data-driven approaches), this baseline is 
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largely affected by the population frequency of the underlying CNV. We tested this effect by simulating 
a wide range of CNV population frequencies (1%-30%), while maintaining a constant overall 
population size of 100. As expected, higher frequencies pose challenges for all methods, with xHMM 
more severely affected (FIGURE 5.2b). cnvCapSeq maintains 100% sensitivity for frequencies up to 
15%, while specificity and PPV only start to decline at frequencies higher than  27%. On the other hand, 
xHMM and CONTRA start deteriorating for frequencies as low as 6% (FIGURE 5.3). 
 
FIGURE 5.3 Method performance versus simulated population frequencies. 
Sensitivity, specificity and positive predictive value (PPV) across population frequencies. The cohort size was kept constant 
at 100 samples and frequencies up to 30% were simulated. The performance metrics were averaged across simulated deletion 
sizes. Performance declines with increasing frequency for all methods, but xHMM and CONTRA deteriorate earlier and faster 
than cnvCapSeq. 
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5.3.1.5 Effects of cohort size 
Finally, we investigated how the size of the cohort influences CNV detection. Small cohorts 
may be economically preferable, but tend to suffer from higher variance, which leads to unreliable 
estimates of the RD baseline. This is especially problematic for dimensionality-reducing techniques, 
which attempt to compensate by eliminating more singular (or principal) components and discarding 
high-variance probes. This comes at the expense of true CNV signal, which often lies in regions with 
unstable read depth. In contrast, cnvCapSeq employs a conservative filtering approach, which confers 
enhanced performance for smaller datasets and increased robustness to sample size. This was 
demonstrated by simulating various cohort sizes (5-100 samples), while keeping the CNV population 
frequency approximately equal to 30%. In this challenging scenario, cnvCapSeq is shown to outperform 
the next best method (xHMM) by a wider margin for small datasets than for the full-size cohort (FIGURE 
5.4). Moreover, cnvCapSeq reaches stability for cohorts comprising as few as 40 samples, while xHMM 
requires twice as many samples for optimal results. 
 
FIGURE 5.4 Method performance across simulated cohort sizes. 
Sensitivity, specificity, accuracy and positive predictive value (PPV) across cohort sizes. The CNV population frequency was 
kept constant at approximately 30%, while cohort sizes from 5 to 100 samples were simulated. The dashed lines denote the 
performance for the full-sized cohort. cnvCapSeq outperforms xHMM across cohort sizes, with the difference being more 
pronounced for smaller cohorts. Also, cnvCapSeq achieves saturation faster than xHMM and thus requires smaller cohorts for 
optimal performance. 
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5.3.1.6 Conclusion 
We have demonstrated that in the simulated dataset, cnvCapSeq is superior to methods 
designed for exome CNV detection under a variety of conditions. cnvCapSeq also overcomes a major 
limitation of existing data-driven normalization methods, which can only detect rare variants, while 
requiring concurrent analysis of large sample numbers. 
5.3.2 RCA cohort benchmark 
cnvCapSeq was also evaluated in a real cohort comprising targeted resequencing data from 
the ~350kb RCA locus in 285 healthy control samples. The RCA locus lies on chromosome 1q and 
contains the Complement Factor H (CFH) gene along with 5 ancestrally related genes that arose through 
duplication of CFH. The samples were normalized in 3 batches, corresponding to the flow cells they 
were sequenced on, and then pooled for CNV analysis. 
5.3.2.1 RD normalization results 
We normalized the read depth using our SVD framework and investigated how the results 
differ from our simulated dataset. We verified our previous observation regarding the contribution of 
singular components to the RD noise profile. As in our simulated data, we observe a highly correlated 
RD pattern across samples, which swamps the true CNV signal. Both the absence (FIGURE 4.5a) and 
the presence of CNV (FIGURE 4.5b) are elucidated when the first singular component is removed and 
suppressed when removing higher-order components. Therefore, by filtering out only the first singular 
component we eliminate the noise pattern, exposing relatively weaker read depth perturbations caused 
by CNV. 
5.3.2.2 RP considerations 
Discordant read pairs provide orthogonal evidence for the presence of CNV and can greatly 
improve the specificity of CNV detection algorithms when combined with RD. Nevertheless, RPs 
remain underutilized in targeted resequencing experiments, since they are only relevant when the size 
of the target is larger than the insert size and the CNV breakpoints are captured. Although these 
conditions are met in the RCA cohort, RP distance profiles are strongly confounded by multi-mapped 
reads. Thus, we applied our sensitive realignment strategy in an effort to recover information from 
ambiguously mapped RPs. Rescuing such pairs is especially important in this cohort, since the common 
deletion in the RCA gene cluster is facilitated by nonallelic homologous recombination between the 
same repeat elements that also give rise to the multi-mappings [160]. Therefore, excluding such 
alignments would eliminate all read pair evidence for the deletion we are aiming to detect (FIGURE 4.6). 
5.3.2.3 CNV discovery 
Following normalization and realignment, we performed CNV segmentation using our 
integrative HMM. In the RCA cohort, cnvCapSeq detected 42 CNVs in 41 samples (FIGURE 5.5). Most 
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 FIGURE 5.5 Graphical representation of cnvCapSeq’s results. 
The UCSC genome browser was used to plot the CNVs detected by cnvCapSeq along with the affected genes. Red color 
denotes heterozygous deletion, pink denotes homozygous deletion and green corresponds to 3 copies. 
of the identified variants are consistent with the common ~80kb deletion that has been previously 
described in the RCA locus [154, 160] and results in a single copy loss of CFHR1 and CFHR3. We also 
report a ~90kb duplication that affects CFHR4 in 2 samples. Finally, we identified a 120kb 
heterozygous deletion that overlaps both the common deletion and the duplication, in 8 samples 
(APPENDIX TABLE 4). The identification of recurrent variants in our control population confirms prior 
observations regarding the susceptibility of the RCA region to CNV. 
5.3.2.4 qPCR validation 
cnvCapSeq’s results on the RCA cohort were validated using qPCR on a randomly chosen 
subset of the samples with predicted CNVs, in duplicates and whenever possible in triplicates. We 
designed four sets of primers distributed across the entire 358kb region (APPENDIX TABLE 5). Using all 
sets of primers for each CNV gave a reasonable estimate on its length. For instance, the most frequently 
detected CNV overlaps through two primer sets, located in the beginning and the end of the CNV, but 
not the remaining two sets. To confirm that the primers were targeting the intended region, we 
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performed PCR followed by Sanger sequencing for one sample. For internal control a fifth set of primers 
for PRKG1 (a house keeping gene) was also created. Following qPCR, copy number estimates were 
obtained using the ΔΔCt method of relative quantification.  
Thus, we set out to validate 13 out of the 41 samples in which a CNV was detected. This 
subset contains at least one sample for each identified CNV pattern. qPCR was also performed on 10 
additional samples that were predicted to be copy-neutral by cnvCapSeq. cnvCapSeq achieved a perfect 
concordance (13 out of 13 CNV calls) with PCR results, indicating very high precision (TABLE 5.2a).  
 Sample 
 
Sets of primers 
CFHR3 CFHR1 LOC100996886 CFHR4 
a CHH1039 1✓ 1✓ 2✓ 2✓ 
CHH1130 1✓ 1✓ 2✓ 2✓ 
CHH1141 1✓ 1✓ 2✓ 2✓ 
CHH1159 1✓ 1✓ 2✓ 2✓ 
CHH1164 1✓ 1✓ 2✓ 2✓ 
CHH1192 1✓ 1✓ 2✓ 2✓ 
CHH1193 1✓ 1✓ 2✓ 2✓ 
CHH1201 1✓ 1✓ 2✓ 2✓ 
CHH1236 1✓ 1✓ 2✓ 2✓ 
CHH1240 1✓ 1✓ 2✓ 2✓ 
CHH1190 2✓ 1✓ 1✓ 1✓ 
CHH1232 1✓ 0✓ 1✓ 1✓ 
CHH1045 2✓ 3✗ 3✓ 3✓ 
 
 
b CHH1008 2✓ 2✓ 2✓ 2✓ 
 
CHH1037 2✓ 2✓ 2✓ 2✓ 
CHH1137 2✓ 2✓ 2✓ 2✓ 
CHH1163 2✓ 2✓ 2✓ 2✓ 
CHH1179 2✓ 2✓ 2✓ 2✓ 
CHH1183 2✓ 2✓ 2✓ 2✓ 
CHH1186 2✓ 2✓ 2✓ 2✓ 
CHH1197 2✓ 2✓ 2✓ 2✓ 
CHH1227 2✓ 2✓ 2✓ 2✓ 
CHH1230 2✓ 2✓ 2✓ 2✓ 
TABLE 5.2 qPCR validation results. 
The copy numbers presented are the qPCR estimates, the green check marks represent concordance, while the red crosses 
represent discordance with cnvCapSeq. We validated (a) 13 samples with CNVs and (b) 10 copy-neutral samples. 
Furthermore, no false positives were detected in the copy-neutral samples, corresponding to 
high specificity (TABLE 5.2b). In addition, all the CNV lengths were predicted to be accurate at the 
locus level, except for a duplication which was predicted to be shorter by cnvCapSeq than the qPCR 
estimate. This corresponds to an average genotyping accuracy of 99% across the 4 primer sets. 
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5.3.2.5 Comparison to existing methods 
To put cnvCapSeq’s results into perspective, we also performed CNV segmentation on the 
RCA cohort using CONTRA, CoNIFER and xHMM. Since these methods require target coordinates as 
input, we divided our 358kb capture region into non-overlapping 100bp windows, which serve as 
pseudo-targets. 
We run CONTRA on our pseudo-target dataset using the entire population to create the 
required pseudo-control. CONTRA has a special set of parameters for predicting large CNVs using 
CBS. Even using these parameters, however, CONTRA identified 28 short CNVs (300bp – 5kb) that 
overlap neither the PCR results nor any of the remaining cnvCapSeq calls. By increasing the 
significance threshold we were able to recover 3 of the PCR-validated deletions at the expense of 4 
validated false positives (and 134 CNVs in samples that were deemed copy-neutral by cnvCapSeq). 
xHMM applies a strict filtering approach to exclude samples and target probes that exhibit 
high variance. It also employs an empirical rule to select how many principal components to eliminate. 
Using the default parameters, most samples failed quality control and the subsequent removal of 8 
components produced no CNV calls. When we omitted the variance filtering step and forced the 
removal of a single principal component, xHMM detected 24 CNVs. These CNVs overlap 19% of 
cnvCapSeq callset and include only 2 out 13 qPCR validated results and 1 validated false positive. 
CoNIFER, has a similar recommendation for high-variance samples, which we ignored as it 
would have eliminated more than half of our dataset. CoNIFER’s fundamental difference from xHMM 
is that it requires visual inspection of the scree plot to determine the number of components to be 
removed. Based on this empirical approach we identified 8 components for elimination, which again 
failed to produce any CNVs. When we relaxed this criterion to the minimum recommended value of 3 
components, CoNIFER identified 58 variants, consisting mostly of duplications. Out of the 13 PCR-
validated CNVs, CoNIFER successfully detected only 3 and had 1 false positive. When we forced 
CoNIFER to remove only the first singular component, the overall number of calls doubled, the number 
of validated CNVs rose to 4, but the number of false positives also increased to 3. 
5.3.2.6 Effects of sequencing depth 
Finally, we wanted to investigate how the sequencing depth of coverage affects our method’s 
performance. Our original RCA dataset had highly variable coverage, ranging from 300x to 1400x 
across samples. To establish a minimum threshold for coverage, we randomly downsampled our data 
to 50x and 10x and rerun the analysis. The results for 50x were almost indistinguishable from the 
original, except for minor breakpoint differences. Using a 50% reciprocal overlap criterion, 100% of 
the downsampled CNV calls agreed with the unconstrained analysis. Even at 10x, which is on the lowest 
end for targeted resequencing experiments, cnvCapSeq correctly identified most CNVs, albeit with 
slightly underestimated lengths. The only exceptions were the misclassification of a PCR-validated 
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nested, homozygous deletion as heterozygous and the fragmentation of a large deletion into two smaller 
ones. This led to 93% of the 10x CNV results overlapping the original callset. 
5.4 Discussion 
Targeted resequencing technologies offer a cost- and time-efficient alternative to whole-
genome sequencing and are thus rapidly gaining in popularity. Exome sequencing is the most common 
form of targeted resequencing, as it focuses on the genome-wide analysis of protein-coding variants. 
However, when the biological hypothesis instructs a more focused approach, larger contiguous regions 
are targeted in an effort to identify intronic and regulatory variants. CNVs in particular, can be detected 
more reliably and in higher resolution with larger targets, but there’s been a paucity of compatible 
algorithms. To that end, we have presented cnvCapSeq, a dedicated framework for discovery and 
genotyping CNVs in large-target capture resequencing datasets. 
cnvCapSeq has distinct advantages compared to existing CNV detection methods for capture 
sequencing. Since it was designed for large contiguous regions, our algorithm doesn’t require a priori 
knowledge of capture target coordinates. Furthermore, it is the only capture-specific method to 
incorporate evidence from discordant read pairs, which become relevant as the target size increases. 
cnvCapSeq doesn’t standardize or transform the underlying data and can thus generate absolute copy 
numbers without a reference panel. We have demonstrated that cnvCapSeq achieves a high accuracy 
along with high precision, without the need for matched control samples. Our method is also robust to 
high allele frequencies, low depths of coverage and to high coverage variability within datasets. 
As with all dimension-reducing techniques, cnvCapSeq gains power by concurrently 
analysing multiple samples. Unlike current methods, however, cnvCapSeq avoids eliminating true 
signal by removing only a single singular component from read depth. The potential trade-off is higher 
residual noise, which is counterbalanced using read pairs for increased specificity and hidden Markov 
modelling for spatial smoothing. Thus, cnvCapSeq can be used to analyse smaller datasets and genotype 
both rare and more common variants. 
cnvCapSeq was tested on a Nimblegen SeqCap assay, but remains agnostic to the enrichment 
technique, requiring only BAM alignment files as input. Thus, our method’s data-driven normalization 
approach is applicable in principle to all hybridization-based targeted sequencing of contiguous regions, 
regardless of platform. Enrichment protocols that don’t rely on hybrid capture may exhibit distinct 
properties and biases beyond the scope of cnvCapSeq. 
5.5 Summary 
In this chapter we have described a novel algorithm to detect and genotype CNV in long-
range contiguous capture sequencing data. cnvCapSeq employs customized normalization strategies to 
counteract the effects of enrichment bias and augment the underlying CNV signal. Since it was 
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specifically designed to take advantage of target contiguity, cnvCapSeq is the only capture-based 
method that considers CNV evidence from both read depth and discordant read pairs. Our algorithm 
was benchmarked on both simulated and real capture data and was shown to outperform the existing 
exome CNV methods by a wide margin both in terms of sensitivity and specificity. Therefore, 
cnvCapSeq constitutes a powerful and unique tool for analysing contiguous capture sequencing 
datasets, which are increasingly popular in both clinical and research applications. In the next chapter, 
we shift our focus to off-target data inadvertently generated by capture experiments. This data can be a 
rich source of CNV evidence in untargeted regions, but is affected by heterogeneous noise patterns that 
cannot be corrected using existing techniques. Thus, in chapter 6 we present a new statistical approach 
for mitigating off-target heterogeneity that relies on the principles of data-driven normalization. This 
normalization strategy was implemented as the cnvOffSeq algorithm and benchmarked using exome 
sequencing data from the 1000 Genomes Project.  
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Chapter 6 
Chapter 6 Application to off-target capture sequencing: cnvOffSeq  
Application to off-target capture sequencing: 
cnvOffSeq 
 
In the previous chapters we have introduced the methodological basis for identifying CNV in 
capture sequencing data. Our framework was designed to analyse genomic regions that were 
deliberately targeted and enriched prior to sequencing. The enrichment process, however, is inherently 
imperfect and results in large amounts of sequence data outside the designated target regions. This off-
target data can span the entire genome, albeit with low and heterogeneous coverage. The highly irregular 
nature of this data renders it difficult to interpret in its raw form. As a result, off-target reads are usually 
flagged during quality control and eliminated from all downstream analyses of capture sequencing 
experiments. We posit that off-target read depth is a rich source of information that can be mined to 
detect CNV on a nearly genome-wide level. This, however, requires specialized normalization 
techniques that lie beyond the capabilities of existing CNV detection methods. To that end, we have 
developed a dedicated algorithm called cnvOffSeq, which counteracts the heterogeneity of off-target 
data by disentangling its formative mechanisms. Our method relies on the principles of data-driven 
normalization and allows for accurate and precise CNV detection and genotyping in off-target regions. 
In this chapter we discuss the two distinct aspects of the enrichment process that give rise to 
off-target data in capture sequencing. This duality is largely responsible for the coverage fluctuations 
that are observed in off-target regions and therefore needs to be modelled appropriately. cnvOffSeq 
implements a novel statistical framework that achieves the required flexibility by adapting the 
normalization strategy to inferred local enrichment patterns. Our algorithm was extensively 
benchmarked using publicly available WES data from the 1000 Genomes Project. Concepts and results 
from the following chapter have been published in the following article: 
E. Bellos and L. J. Coin (2014). "cnvOffSeq: detecting intergenic copy number variation using off-target 
exome sequencing data." Bioinformatics 30(17): i639-645. 
 
Chapter 6 begins by describing the off-target enrichment properties that motivated an adaptive 
normalization approach. Then, we present the statistical foundations of our framework followed by 
details of its algorithmic implementation. Finally, we report the results of cnvOffSeq’s performance 
assessment against standard methods.  
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6.1 Motivation 
Target enrichment technologies have transformed sequencing from an economically 
impracticable novelty into a universally accessible research tool. The deeper coverage and lower cost 
offered by capture sequencing has sparked renewed interest in elucidating rare diseases. In particular, 
the advent of WES has led to a renaissance in the field of Mendelian genomics [128-130, 144]. Exome 
sequence analysis typically focuses on detecting previously unobserved (or very low-frequency) coding 
SNPs and small frame-shift indels that are absent from a reference set. A number of studies have also 
identified exonic CNV as the underlying genetic basis for various Mendelian disorders [161, 162]. 
6.1.1 On-target CNV detection 
Capture-based CNV detection is generally complicated by the presence of strong batch effects 
introduced by the enrichment process. Various approaches have been developed for investigating on-
target CNV in WES datasets [137, 140, 163]. Exome CNV methods attempt to mitigate enrichment bias 
either through control-based normalization or by identifying and removing the strongest components of 
variation across the population. In chapter 5 we presented an algorithm that extends the principles of 
data-driven normalization to long contiguous targets. Since all the existing approaches were designed 
to analyse on-target capture data, they operate under the assumption that most of the variation in 
sequence coverage is driven by systematic bias which swamps the real signal in global noise.  
6.1.2 Origins of off-target data 
As discussed previously, the most popular targeted sequencing platforms rely on hybrid 
capture to enrich for DNA fragments arising from a predetermined set of genomic targets. Hybridization 
is a sensitive but imperfect process that captures large amounts of off-target fragments along with the 
intended regions. Although hybridization efficiency is highly variable and platform-dependent, off-
target sequence has been consistently shown to comprise as much as 50% of whole-exome datasets 
[164]. The mechanisms behind off-target enrichment are highly complex and contingent on both 
sequence properties and stochastic processes. For the most part, however, off-target results can be 
attributed to two experimental aspects of enrichment assays: hybridization stringency and probe 
sequence uniqueness. 
In hybrid capture experiments, genomic fragments of interest are enriched using 
oligonucleotide probes that are complementary to the target sequence. After the fragments have been 
allowed to hybridize with the probes, the capture products are subjected to a washing step. This 
treatment is designed to remove non-specific hybrids before recovering the selected fragments. The 
overall stringency of the capture process is largely determined by experimental parameters of the 
washing scheme, such as the number of washing cycles and the choice of detergent in the wash buffer. 
Rigorous washing conditions eliminate uncaptured and poorly hybridized fragments, but can have 
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adverse effects on sensitivity and target coverage. Conversely, milder conditions result in better 
coverage at the expense of specificity, leading to non-selective enrichment in off-target regions. In this 
trade-off, capture platforms tend to favour sensitivity, which unavoidably generates low-coverage 
sequence data distributed randomly across the genome (FIGURE 6.1). 
On the other hand, as we discussed in chapter 4, hybridization efficiency is affected by probe 
sequence properties. Probes with higher GC content exhibit stronger affinity both for their actual targets 
and for off-target sequence. The most important aspect of probe design, however, lies in their 
uniqueness. The shorter the probe, the lower its ability to discriminate between its intended target and 
fragments of similar sequence. Under certain conditions, even longer probes will hybridize to off-target 
sequence that exhibits a high degree of homology to the target. Thus, non-unique probe sequence leads 
to highly specific enrichment of distinct untargeted regions that may be unavoidable if the target 
contains repetitive elements or segmental duplications. This manifests as localized increases in off-
target coverage as opposed to the dispersed coverage due to low hybridization stringency (FIGURE 6.1). 
 
FIGURE 6.1 Mechanisms of off-target enrichment. 
The dual nature of off-target data has proved unconducive to conventional analysis. Thus, 
despite their documented potential to generate high-quality SNP genotypes in non-coding regions [165], 
off-target reads are almost always treated as a contaminant and ignored by capture sequencing pipelines. 
Nevertheless, we postulate that off-target read depth can provide valuable evidence for CNV detection, 
when examined in the proper light. 
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6.1.3 Challenges for off-target CNV detection 
The off-target sequence coverage from a typical capture experiment can range from 0.5x to 
3x. As we have shown in chapter 3, it is possible to accurately identify and genotype CNVs from low-
coverage WGS data with as little as twofold redundancy. Despite the similar levels of coverage, the 
investigation of off-target sequence is confounded by the disparate aspects of its generative mechanism. 
As a result, different parts of the untargeted genome are subject to distinct biases that cannot be 
determined a priori. Furthermore, off-target RD appears to behave like a combination of WGS and on-
target capture data and is thus incompatible with CNV methods designed for either of these platforms. 
To address these challenges, we propose a novel data-driven normalization framework that builds on 
the principles of singular value decomposition.  
6.2 Off-target CNV detection framework 
The heterogeneity of off-target sequencing coverage poses a major hurdle for CNV detection. 
To overcome this hurdle, we have developed a dynamic RD normalization framework called 
cnvOffSeq. Our algorithm leverages information at the population level to unravel the enrichment 
patterns responsible for off-target data without explicitly modelling them. cnvOffSeq is based on a 
modified version of SVD that allows for flexible, region-specific noise reduction and signal 
enhancement. Global SVD has been established as a robust framework for on-target RD normalization 
and CNV calling in both WES and contiguous capture data. Here we present a local adaptive SVD 
approach for detection and genotyping of CNVs based solely on off-target reads of capture experiments.  
6.2.1 Local adaptive SVD 
The enrichment step that is essential for targeted sequencing technologies gives rise to biases 
that heavily affect the depth of coverage. The resulting RD is highly variable across target regions, 
rendering CNV detection problematic. As we have previously shown, global SVD can alleviate the 
effects of enrichment bias and has thus formed the basis of our contiguous capture normalization 
strategy. Similar global data-driven approaches are also employed by popular WES-based CNV 
detection methods [140, 141]. In this paradigm, the noise is assumed to be non-random and highly 
correlated across samples since the confounders (such as enrichment specificity and capture probe 
design) are shared among them. Therefore, by target-wide application of SVD and elimination of the 
strongest singular components, CNV methods can effectively de-noise RD and achieve accurate 
segmentation. 
Contrary to on-target exome data, off-target reads are unintentional by-products of the 
enrichment technologies and are thus subject to a mixture of sequencing biases that are highly variable 
and dependent on genomic context. Due to the repetitive nature of the human genome, some non-
targeted regions may be enriched if they are paralogous to the target. Such off-target regions will share 
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properties with on-target data and exhibit a similar pattern of highly correlated noise. The incomplete 
washing of uncaptured and poorly hybridized fragments can also introduce varying amounts of off-
target sequence into the enrichment results. In this case, the off-target noise is expected to be random 
and decorrelated among samples due to the stochastic nature of its origin. Consequently, off-target data 
is highly diverse and not amenable to global normalization approaches that treat noise as either entirely 
random or entirely correlated. 
To that end, we introduce a localized variant of the SVD, which segments the non-coding 
genome according to the observed RD noise pattern (FIGURE 6.2). To maintain contiguity and facilitate  
 
FIGURE 6.2 Flowchart describing the local adaptive SVD normalization process. 
(a) Iterative segmentation process (b) Differential normalisation of each segment according to the observed RD pattern. 
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CNV calling, we retain the target regions in our analysis but substitute their RD with the genome-wide 
off-target coverage. Our normalization framework divides the non-coding genome into regions with 
distinct RD noise profiles through an iterative application of SVD to genomic windows of varying size. 
Using big-R notation [166] we can express this repetitive computational process as follows:  
 
   𝐹𝐹 𝑅𝑅  𝜎𝜎1>𝜎𝜎1𝑛𝑛𝑚𝑚𝑚𝑚=𝛵𝛵 �𝑅𝑅𝐷𝐷𝑤𝑤𝑝𝑝𝑛𝑛𝑚𝑚𝑜𝑜𝑤𝑤𝑟𝑟𝑝𝑝𝑠𝑠𝑛𝑛×𝑟𝑟𝑚𝑚𝑛𝑛𝑚𝑚𝑙𝑙𝑛𝑛𝑟𝑟 = 𝑈𝑈𝑈𝑈𝑉𝑉∗ = 𝑈𝑈 �𝜎𝜎1 ⋯  ⋮ ⋱ ⋮ ⋯  � 𝑉𝑉∗� , ↓ (𝑟𝑟𝑝𝑝𝑠𝑠𝑛𝑛) (6.1) 
 
The columns of matrix U represent the left-singular vectors, the rows of V* represent the right-singular 
vectors and Σ is a diagonal matrix that contains the singular values in decreasing order. Each 
normalization window shrinks repeatedly by 100bp and the SVD is re-applied, until we detect a local 
maximum for the largest singular value, 𝜎𝜎1. When such a maximum has been detected, we have 
identified the most “singular” or degenerate region and the window shifts forward by the size of the 
shrunken window and repeats the process until the whole genome is covered. A stepwise description of 
the segmentation process is outlined in BOX 6.1. 
 
 
INITIALIZE maxWindowSize, minWindowSize, windowShrinkage 
Move currentWindow to the beginning of the genome 
REPEAT 
  
 maxσ1 ← 0 
 Set size of currentWindow to maxWindowSize 
 Calculate SVD for RDcurrentWindow and extract σ1 
 REPEAT 
   
  maxσ1 ← σ1 
  Shrink currentWindow by windowShrinkage   
  Calculate SVD for RDcurrentWindow and extract σ1 
 
 UNTIL σ1≤maxσ1 OR currentWindow≤minWindowSize 
 Calculate relative contribution of maxσ1 
 Normalize RDcurrentWindow 
 Shift currentWindow to the right 
 
UNTIL end of genome 
  
BOX 6.1 Pseudocode for local adaptive SVD. 
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The resulting segmentation provides the means for differentiating between regions of correlated and 
random noise. This can be achieved by examining the relative contribution of each region’s maximum 
singular value as defined by  
𝑅𝑅𝐷𝐷𝜎𝜎1 = 𝜎𝜎12 ∑ 𝜎𝜎𝑖𝑖2𝑖𝑖�  (6.2) 
The larger the contribution the more likely the region resembles an intended target with a highly 
consistent noise pattern across samples. The lower the contribution, the more randomly distributed the 
noise will tend to be across samples. We applied heuristic thresholds of 30% and 70% for the 𝑅𝑅𝐷𝐷𝜎𝜎1  to 
define 3 region classes: 
• If 𝑅𝑅𝐷𝐷𝜎𝜎1 < 30%, then the noise appears to be random and highly represented in the lower singular 
components. Thus, we normalize these regions by keeping the first singular component and 
eliminating the rest. 
• If 30% ≤ 𝑅𝑅𝐷𝐷𝜎𝜎1 ≤ 70%, the noise remains mostly random but there appear to be some signs of 
systematic bias. Thus, we eliminate all but the first two singular components. 
• If 𝑅𝑅𝐷𝐷𝜎𝜎1 > 70%, then the RD is dominated by systematic bias and is therefore normalized by 
removing the first singular component following the paradigm of on-target normalization. 
The local RD matrices are then reconstructed using either the truncated or the modified Σ matrix to 
obtain the filtered signal that can now be used for CNV detection. 
6.2.2 HMM calibration 
Our approach to off-target CNV detection focuses on read depth, since the sporadic coverage 
in untargeted regions renders both read pairs and split reads less reliable. Following RD normalization, 
we employ our general HMM framework to perform CNV segmentation and genotyping. Like its 
predecessors, cnvOffSeq analyses RD at the population level to achieve optimal results. Off-target RD 
exhibits the same tendency towards overdispersion as observed in other sequencing datasets. Therefore, 
its emission distribution is again modelled using the NB distribution, albeit with stricter initial 
parameters. The transition probabilities of our HMM are determined by the combination of a global 
transition rate matrix and a local transition rate, to capture the overall transition between copy number 
states across the region as well as position-specific changes. Despite the substantial de-noising achieved 
through our local adaptive SVD, the very low off-target coverage combined with the high RD variability 
informs a more stringent prior on the transition rate than both WGS and on-target capture data. As 
previously described, the parameters of the HMM are estimated using a generalized expectation-
maximization algorithm and the most likely CNV segmentation for the trained model is obtained by the 
Viterbi algorithm. 
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6.3 Samples and datasets 
Given the popularity of whole-exome sequencing, there is a trove of public off-target data 
that can be used to elucidate CNV patterns in non-exonic regions. Thus, cnvOffSeq was developed and 
tested using WES data from the 1000 Genomes Project. We evaluated our method’s performance using 
a set of gold standard intergenic CNV calls that was generated by the 1000 Genomes as part of the low-
coverage WGS study.  
6.3.1 1000 Genomes whole-exome data 
Phase 1 of the 1000 Genomes Project generated deep exome sequence data for ~700 
individuals using the Illumina platform. In most phase 1 samples, however, the exome was enriched 
using early capture platforms that exhibited relatively low target specificity. These platforms have been 
superseded by newer technologies that achieve substantially improved performance and thus minimize 
the amount of off-target enrichment. To ensure that our conclusions can be extrapolated to modern 
capture datasets, we eliminated samples that were enriched solely using legacy platforms. Furthermore, 
we only considered samples for which the consortium has also generated genome-wide CNV calls, 
based on the low-coverage dataset. Finally, samples that exhibited off-target coverage less than 1x were 
excluded, as most of their genome would not be covered by any reads. In such instances, RD is only 
informative when averaged over large genomic windows, which would render our local segmentation 
framework inapplicable. The aforementioned criteria were fulfilled by 50 samples spanning 7 
populations (APPENDIX TABLE 6). 
Our final WES dataset comprises individuals that were sequenced either by the Broad Institute 
(BI) or Washington University, Genome Sequencing Center (WUGSC). For target enrichment, BI used 
the Agilent SureSelect All Exon assay, while WUGSC also used the NimbleGen SeqCap EZ Exome 
assay. The samples were sequenced either on Illumina Genome Analyzer II or HiSeq2000 using a 
paired-end protocol, with the insert size varying between 100bp and 400bp across samples. Sequencing 
reads were aligned to the human reference genome (assembly GRCh37) using BWA. Since we are 
interested only in off-target data, we excluded regions that were reported as captured by either 
enrichment assay along with the surrounding 5kb to avoid possible contamination. In our 50 samples, 
the resulting on-target coverage ranges from 49x to 248x with a mean of 96x, while the off-target 
coverage ranges from 1.07x to 2.66x with a mean of 1.97x.  
6.3.2 Gold standard CNV calls 
Our off-target CNV calls were compared against a set of genotyped deletions that was 
generated by the Structural Variation Analysis Group of the 1000 Genomes Project [152]. This set was 
created by combining the predictions of 5 computational methods on low-coverage WGS data. 
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Experimental validation was performed on ambiguous and contradictory predictions to produce the 
definitive CNV callset for the 1000 Genomes. In our systematic benchmark, we focused on 
chromosome 6 gold standard deletions. We excluded variants located less than 5kb from the nearest 
exon target as well as variants overlapping regions that were blacklisted by the ENCODE project for 
anomalous RD patterns. We also eliminated gold standard deletions for which none of our 50 WES 
samples passed quality control. Our CNV detection resolution is limited by the low off-target coverage, 
so we only considered events larger than 500bp. The final gold standard dataset consisted of 104 deleted 
regions harbouring 497 confident calls across all samples (APPENDIX TABLE 7). These deletions range 
from 606bp to 69,281bp with a median length of 2,375bp. 
6.4 cnvOffSeq implementation 
cnvOffSeq is implemented as a collection of JAR-packaged Java tools and UNIX shell scripts. 
The main input of the algorithm is BAM alignment files, which are then pre-processed using SAMtools. 
cnvOffSeq also requires the coordinates of target regions to be excluded from further analyses in BED 
format. Such files are typically provided by capture assay vendors. cnvOffSeq produces normalized RD 
files in text and binary format that can be disentangled from our CNV calling pipeline and used by third 
party segmentation algorithms. When used in conjunction with our HMM framework, cnvOffSeq 
generates CNV calls in text format and optional segmentation plots. The sampling density of RD is a 
user-specified parameter that determines the CNV breakpoint resolution and the computational 
requirements of the algorithm. At the default high-resolution setting of 100bp, the normalization of a 
single chromosome in 50 samples required 4GB of memory and one CPU hour. 
6.5 cnvOffSeq performance assessment 
cnvOffSeq’s performance was evaluated using chromosome 6 data in 50 WES samples. First, 
we explore the overall effects of our normalization approach and demonstrate the benefits of the 
adaptive framework. Then, we provide an extensive benchmark of cnvOffSeq on 104 intergenic loci 
that have been independently genotyped by the 1000 Genomes Project. Since no other CNV methods 
have been specifically designed for off-target analysis, our benchmark includes representative 
algorithms intended for WGS and on-target capture datasets. We also compared cnvOffSeq to its 
conceptual antecedents, cnvHiTSeq and cnvCapSeq, to demonstrate the necessity for a dedicated off-
target algorithm. 
6.5.1 Normalization results 
We began our analysis by sampling the RD data every 100bp and calculating the off-target 
coverage for each sample. Then we applied the local adaptive SVD with a starting window size of 50kb 
and a minimum window of 2.5kb. Our dynamic normalization framework divides chromosome 6 into 
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5354 segments with an average length of 32.5kb. 582 of these segments, amounting to almost 1Mb of 
sequence, exhibit highly correlated RD patterns across samples. These segments resemble on-target 
data and are dominated by systematic bias, which can be mitigated by removing the first singular 
component (FIGURE 6.3b). The remaining segments are affected by varying degrees of random noise 
and would suffer from loss of actual signal if normalized the same way (FIGURE 6.3b). Instead, such 
segments are de-noised by eliminating low-order singular components (FIGURE 6.3c). Consequently, 
global SVD methods developed for capture sequencing tend to over-correct off-target RD, while low-
order component filtering tends to under-correct the most outlying observations. Depending on the local 
RD profile our adaptive SVD algorithm applies either first component filtering or low-order component 
filtering, thus combining the best of both worlds (FIGURE 6.3d). 
 
FIGURE 6.3 Comparison of normalization techniques for two samples on chr6. 
The red dashed lines denote the breakpoints of a gold standard deletion that is present only in sample NA06989. (a) Raw RD 
data. The noisy nature of unnormalized RD makes the deletion difficult to detect in NA06989. The two regions denoted by the 
yellow dashed lines, show highly correlated RD profiles that most likely correspond to systematic bias. (b) Removing the first 
singular component mitigates the systematic bias, but also suppresses the signal of the true deletion. (c) Filtering low-order 
singular components de-noises the signal and enhances the true deletion but leaves systematic bias unaffected. (d) Our local 
adaptive SVD algorithm achieves the best results by combining the two approaches in one cohesive framework. The yellow 
shaded regions were normalized by filtering the first singular component (as in b) while the red shaded region was normalized 
by filtering low-order components (as in c). 
6.5.2 Benchmark 
cnvOffSeq was benchmarked, under different scenarios, against multiple competing 
approaches. These comprise WGS-specific algorithms (CNVnator [98] and cnvHiTSeq), targeted CNV 
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detection methods (CoNIFER [140] and cnvCapSeq) as well as an ad hoc non-adaptive variant of 
cnvOffSeq (hereinafter referred to as local static SVD). In each case, we present standard performance 
metrics, including sensitivity, specificity and false discovery rate. We also utilise the absolute copy 
numbers generated by the 1000 Genomes Project to assess cnvOffSeq’s genotyping accuracy. Finally, 
we investigate our method’s ability to detect variants across the size spectrum. 
6.5.2.1 Comparison to WGS CNV methods 
Since off-target regions comprise the majority of the genome in typical capture experiments, 
we first set out to compare cnvOffSeq with CNV methods designed for whole-genome sequencing. 
WGS approaches largely rely on accurate depth of coverage estimations to obtain a baseline for 
comparison. This is problematic in our case, since the on-target coverage is at least an order of 
magnitude higher than the off-target. Thus, the genome-wide coverage calculation is confounded by the 
on-target read depth, leading to coverage estimates that are too high for off-target regions and too low 
for on-target regions. One plausible solution is to exclude exome target regions from the calculations, 
but this is not trivial for most existing WGS methods. In fact, when we applied CNVnator to our whole-
exome dataset, the results reflected the skewed coverage estimation since most of the genome was 
deemed either deleted or duplicated in every sample. Therefore, to ensure an accurate and fair 
comparison we modified our previously described WGS framework, cnvHiTSeq, to accommodate 
discontiguous RD datasets, such as those represented by whole-exome off-target analyses. cnvHiTSeq 
utilizes LOESS smoothing and GC/alignability correction to mitigate sequencing biases, but relies on 
the same HMM framework as cnvOffSeq. Thus, by comparing cnvHiTSeq with cnvOffSeq we provide 
a benchmark of “naïve” smoothing versus local adaptive SVD. Although cnvHiTSeq detects only 26 
gold standard deletions fewer than cnvOffSeq (55.0% vs. 57.5% sensitivity), it suffers from much 
higher rates of false positive calls (82.7% vs. 5.0% false discovery rate), resulting in considerably lower 
accuracy (TABLE 6.1). 
 cnvOffSeq cnvHiTSeq CoNIFER cnvCapSeq Local Static SVD 
Sensitivity 57.5% 55.0% 7.6% 31.1% 49.4% 
Specificity 99.2% 79.1% 99.9% 99.5% 97.4% 
PPV 95.0% 17.3% 96.0% 91.5% 82.2% 
NPV 89.8% 95.7% 81.1% 88.5% 88.7% 
FPR 0.8% 20.9% 0.1% 0.5% 2.6% 
FDR 5.0% 82.7% 4.0% 8.5% 17.8% 
Accuracy 90.4% 77.4% 81.3% 88.7% 88.0% 
TABLE 6.1 cnvOffSeq performance comparison. 
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This demonstrates the advantage of local adaptive SVD in minimizing aberrant CNV calls while 
enhancing the true RD signal (FIGURE 6.4). 
 
FIGURE 6.4 Normalization results for seven gold standard regions. 
These seven demonstrated regions account for 30% of the total deletion calls. The top panels in each plot represent LOESS 
smoothed RD. The bottom panels represent RD that is normalized using local adaptive SVD. Each colour corresponds to a 
different sample while the red dashed lines denote the breakpoints of the deletions as determined by the 1000 Genomes Project. 
 
6.5.2.2 Comparison to targeted CNV methods 
Next, we examined the performance of CoNIFER, as a representative of the global SVD 
approaches for whole-exome CNV detection. Like all exome CNV methods, CoNIFER requires an 
explicit list of target coordinates to function. In order to expand CoNIFER’s functionality to off-target 
data, we created pseudo-targets spanning the 104 gold standard regions (extended by 50kb on either 
side). These pseudo-targets were then broken down into pseudo-probes of 100bp and 1000bp to allow 
for higher resolution. The best results were obtained by using 1000bp-long pseudo-probes and removing 
only the first singular component. However, CoNIFER’s performance falls far short of cnvOffSeq’s in 
terms of sensitivity. CoNIFER detects only 12 of the gold standard calls (corresponding to a sensitivity 
of 7.6%), most of which were genotyped as homozygous deletions by the 1000 Genomes Project 
(TABLE 6.1). For completeness, we also included cnvCapSeq in the assessment of targeted CNV 
108 
 
methods. Like CoNIFER, cnvCapSeq is based on a global implementation of SVD. cnvCapSeq, 
however, is better suited for off-target analysis, since it was designed for large contiguous targets. As a 
result, cnvCapSeq achieves a significant improvement over CoNIFER in terms of sensitivity, but still 
trails behind cnvOffSeq (31.1% vs 57.5%). This highlights the highly stringent nature of global SVD 
normalization, which renders it unsuitable for off-target CNV detection. 
6.5.2.3 Comparison to local static SVD normalization 
cnvOffSeq uses low-order singular component filtering to de-noise a large portion of the off-
target RD. To demonstrate why low-order filtering alone is not sufficient for optimal results we also 
developed a variation of our normalization algorithm called local static SVD. Like its adaptive 
counterpart, static SVD segments the genome using patterns of RD, but then applies low-order filtering 
to every segment. This approach achieves a sensitivity of 49.4%, which is comparable with cnvOffSeq. 
As expected, however, the non-adaptive normalization does not cope well with segments dominated by 
systematic bias and is therefore more prone to false positives (FIGURE 6.3). Thus static SVD exhibits 
an elevated FDR of 17.8% compared to 5% for adaptive SVD (TABLE 6.1). 
6.5.2.4 Genotyping accuracy 
We also investigated the genotyping performance of cnvOffSeq as compared with 
cnvHiTSeq, cnvCapSeq and local static SVD. CoNIFER was excluded from this comparison since it 
doesn’t provide absolute copy numbers. All methods in this analysis generate posterior probabilities for 
each CNV call, which were used to exclude results of low confidence (designated as missing). 
cnvOffSeq achieved an overall genotyping accuracy of 96.3% versus 73.0% for cnvHiTSeq, 88.6% for 
cnvCapSeq and 90.8% for local static SVD (TABLE 6.2). 
Method Genotyping Accuracy 
Missing 
rate 
cnvOffSeq 96.3% 10.4% 
cnvHiTSeq 73.0% 19.0% 
Local Static SVD 90.8% 8.3% 
cnvCapSeq 88.6% 7.3% 
TABLE 6.2 Genotyping accuracy across methods. 
Furthermore, all methods designed for targeted sequencing exhibited comparable missing rates, while 
cnvHiTSeq’s was almost twice as high, signifying a higher proportion of low quality genotype calls. 
6.5.2.5 Comparison to results from WGS data 
Finally, we set out to explore how our off-target results compare to those obtained using 
whole-genome data. To that end, we applied cnvHiTSeq and CNVnator to low-coverage WGS data 
(3x-16x) for the same 50 samples. The higher and more even coverage of the WGS dataset leads to 
higher overall sensitivity (75.5% for cnvHiTSeq and 62.6% for CNVnator vs. 57.5% for cnvOffSeq). 
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The improvement was more pronounced in CNVs smaller than 3kb for which cnvHiTSeq achieves a 
sensitivity of 41.8% compared to 19.5% for cnvOffSeq. The FDR does not appear to benefit and remains 
comparable between WGS and off-target results (5.5% for cnvHiTSeq and 11.1% for CNVnator vs. 5% 
for cnvOffSeq). 
6.5.2.6 Performance vs. CNV length 
The inherently irregular nature of off-target RD may pose limits in the attainable resolution 
for CNV detection. Therefore, we investigated cnvOffSeq’s performance as a function of the gold 
standard CNV length, by only considering events larger than a certain (variable) threshold. The results 
indicate that both the sensitivity and the accuracy improve significantly for longer CNVs (TABLE 6.3). 
Specifically, the sensitivity exceeds 90% for deletions above 5kb, while the specificity reaches 97%. 
False positives appear to be evenly distributed across CNV lengths as the FDR remains consistent 
throughout. The performance deteriorates for lengths higher than 25kb, simply because there are only 
two deletions in the gold standard that exceed this threshold. Thus we conclude that cnvOffSeq is 
especially well suited for longer deletions (>5kb) which are detected with very high sensitivity and 
consistently low false discovery rate. 
CNV length 
threshold (bp) 
Sensitivity Specificity FDR Accuracy 
Number of 
CNV loci 
>500 57.5% 99.2% 5.0% 90.4% 104 
>2000 70.2% 99.1% 5.0% 93.2% 89 
>3000 73.5% 98.9% 5.0% 93.5% 67 
>4000 83.4% 98.6% 5.4% 95.3% 58 
>5000 90.4% 98.4% 5.8% 96.7% 49 
>6000 89.9% 98.3% 6.8% 96.6% 39 
>7000 88.5% 99.0% 4.4% 96.8% 36 
>8000 87.4% 98.9% 4.9% 96.6% 31 
>9000 94.2% 99.0% 4.0% 98.0% 25 
>10000 93.9% 98.9% 4.2% 97.8% 22 
>11000 94.4% 98.7% 5.6% 97.8% 20 
>13000 95.7% 98.4% 5.7% 97.8% 16 
>14000 98.5% 98.1% 5.7% 98.2% 13 
>15000 100.0% 98.2% 4.3% 98.7% 11 
>22000 100.0% 97.7% 3.9% 98.5% 5 
>25000 100.0% 97.3% 9.5% 97.8% 2 
TABLE 6.3 cnvOffSeq performance across CNV lengths. 
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6.6 Discussion 
Targeted sequencing is a relatively nascent technology that has nevertheless achieved near 
ubiquity due to its cost- and time-effectiveness. Exome sequencing, in particular, has largely superseded 
both whole-genome sequencing and more traditional linkage studies for investigating rare genetic 
disorders. Furthermore, exome sequencing has proven to be a powerful diagnostic tool that has 
revolutionized clinical genetics. By elucidating disorders of unknown genetic aetiology, exome 
sequencing can inform custom treatment options, thus ushering in a new era of truly personalized 
medicine. 
Off-target data is an integral but overlooked component of capture sequencing. Regardless of 
the underlying technology, enrichment strategies attempt to strike a balance between on-target 
stringency and coverage maximization. The fortunate side effect of this delicate equilibrium is off-target 
reads, which are often regarded as wasteful and dispensable. As capture sequencing is maturing, it will 
continue to generate increasing amounts of off-target data that represent an unexplored treasure of 
genomic information. cnvOffSeq is the first method to tap into this valuable resource for the purpose 
of CNV detection. 
Off-target enrichment arises through various processes leading to highly heterogeneous off-
target coverage. Off-target read depth is affected by a mixture of deterministic biases and random noise 
that require individualized treatment, but are difficult to determine a priori. As a result off-target data 
pose a significant challenge for CNV detection that prompted the development of a tailored data-driven 
normalization approach, implemented in cnvOffSeq. 
We have demonstrated that our local adaptive SVD approach provides a flexible and robust 
framework for off-target read depth normalization that can enhance true signal while eliminating 
capture artifacts. cnvOffSeq clearly outperforms CNV detection methods that were designed for whole-
genome sequencing. Furthermore, it was shown to improve upon both high-order and low-order 
singular component filtering, thus amounting to more than the sum of its parts. 
cnvOffSeq was tested on data from both Agilent and Nimblegen hybrid capture assays but 
remains platform-agnostic. Like all SVD-based techniques, cnvOffSeq’s ability to mitigate systematic 
bias improves with larger sample sizes. However, even in the absence of sufficiently large datasets, 
cnvOffSeq retains some of its de-noising capacity by essentially reverting to low-order singular 
component filtering. Finally, the modular nature of our pipeline allows for the RD normalization to be 
separated from the CNV calling and incorporated into future applications as a pre-processing step. 
6.7 Summary 
In this chapter, we have presented the challenges involved in identifying off-target CNV and 
described a novel normalization framework to address them. Our approach is based on a localized 
111 
 
adaptive application of SVD, which was implemented in the cnvOffSeq algorithm. cnvOffSeq alleviates 
the observed heterogeneity in off-target read depth and thus enables sensitive and specific CNV 
detection. Our method was benchmarked on whole-exome sequencing samples from the 1000 Genomes 
Project and was shown to substantially outperform both whole-genome and targeted CNV detection 
algorithms. Thus, cnvOffSeq offers a new perspective on capture sequencing analysis and provides the 
tools for repurposing previously discarded surplus into meaningful data. Given the abundance of exome 
datasets, cnvOffSeq constitutes a powerful, novel method for investigating intergenic CNV and 
exploring its contribution to disease and phenotypic variation. In the next and final chapter, we discuss 
the overall conclusions drawn in the course of this project and contemplate on future directions of CNV 
research.   
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Chapter 7 
Chapter 7 Conclusion  
Conclusion 
 
The work presented in this thesis was conducted in an era of rapid technological advancement 
that redefined the field of genomics. In the beginning of the project, multiple next-generation 
sequencing platforms were vying to secure their long-term viability. This sequencing arms race drove 
innovation at an unprecedented pace and precipitated a paradigm shift in the study of genomic variation. 
The vast potential of high-throughput sequencing was demonstrated by the 1000 Genomes Project in 
its ground-breaking pilot study. In the course of a few years, the 1000 Genomes consortium generated 
and publicized a trove of sequencing data that offered a tantalising glimpse into the capacity of HTS to 
elucidate copy number variation. 
A single sequencing experiment comprises multifaceted and complementary features that 
attest to the presence of CNV. Soon, it became apparent that analysing single features in isolation or 
sequentially was insufficient to uncover the full spectrum of CNV. Thus, our project embarked upon a 
quest to identify, model and integrate sources of CNV evidence into an all-encompassing statistical 
framework. This framework represented the first truly holistic approach to CNV detection and was 
originally attuned to whole-genome applications of HTS. 
Despite its undisputed technical merits, HTS was initially economically prohibitive for most 
practical research purposes. In addition to a dramatic decrease in the per-genome cost, recent years have 
witnessed the widespread adoption of targeted HTS implementations that aim to maximize efficiency 
by limiting the scope to subgenomic regions. The ascendency of targeted HTS, however, raised new 
challenges with respect to CNV investigation that prompted us to extend and reshape our framework. 
In this thesis we have presented the theoretical underpinnings behind three novel statistical 
methods designed to unveil CNV in a wide range of HTS studies. Furthermore, we have explored the 
algorithmic aspects of these methods and compared their performance against the state-of-the-art. This 
chapter summarizes our findings and ties together the conclusions drawn from our analyses. We proceed 
with a discussion of the overarching themes and implications of our project. Lastly, we consider future 
directions for our framework and reflect on its applicability to emerging sequencing technologies.  
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7.1 Summary of findings 
Despite its pervasiveness in the human genome, CNV has been historically more elusive to 
uncover than other forms of genomic variation. This can be largely attributed to technological 
limitations that imposed a choice between detection accuracy and comprehensiveness. In chapter 1, we 
chronicled the advent of high-throughput sequencing and detailed its substantial advantages over pre-
existing experimental techniques. The 1000 Genomes Project demonstrated the practicability of next-
generation sequencing platforms on a population scale and facilitated the dissemination of HTS datasets 
to a wide audience. Furthermore, HTS was shown to provide the means for a genome-wide investigation 
of CNV at an unprecedented resolution. 
HTS generates three distinct alignment features that can be harnessed for CNV detection. 
Chapter 2 explored the properties of these features and described the statistical modelling components 
that we developed to extract the underlying CNV signatures. Although the features can be used 
individually to perform CNV segmentation, each of them exhibits a distinguishable set of qualities that 
is better suited for detecting different subsets of variants. Therefore, we reasoned that only through 
feature synthesis can we obtain a comprehensive view across the CNV landscape. A few tools have 
been developed to consider more than one feature, but they invariably adopt step-wise strategies that 
don’t allow different features to contribute equally. To that end, we presented the first truly integrative 
framework for HTS-based CNV identification. By jointly analysing all available evidence, our model 
reconciles copy number differences among features to generate the most reliable segmentation. Our 
framework also benefits from population-level modelling to mitigate sample-independent variation that 
is unlikely to arise from CNV. 
The earliest practical application of our theoretical framework was implemented in the 
cnvHiTSeq tool, which was designed to analyse whole-genome sequencing data. In chapter 3 we 
discussed the particular characteristics of WGS along with the strategies developed to remedy their 
effects. cnvHiTSeq was thoroughly benchmarked using low-coverage WGS samples from the 1000 
Genomes Project. In this assessment, our method was shown to be considerably more sensitive than 
other approaches without sacrificing specificity. The unifying approach adopted by cnvHiTSeq allows 
it to detect variants across a broad range of sizes. Moreover, cnvHiTSeq excelled at determining 
absolute copy numbers by leveraging information across samples. Overall, our method maintained a 
high level of accuracy and precision, while detecting more variants than the competition. Thus, we 
concluded that cnvHiTSeq represents a valuable asset in the study of CNV that could help expose 
variants missed by other tools. 
The exhaustive nature of WGS renders it ideal for interrogating the role of CNV across the 
entire genome. Furthermore, ongoing improvements in HTS technology have translated into increased 
efficiency and dwindling sequencing costs. Nevertheless, population-wide applications of deep WGS 
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remain unfeasible in many research contexts. Therefore, in recent years, the focus has shifted towards 
more targeted approaches that pre-select a subset of the genome to be sequenced in higher coverage and 
across many samples. In chapter 4, we explored the effects of the enrichment process that is required to 
isolate the regions of interest prior to sequencing. We demonstrated that this process introduces bias 
into the alignment features and thus poses substantial challenges for CNV detection. To address these 
challenges, we presented a fundamental extension to our statistical framework that involves customized 
pre-processing components and a novel data-driven normalization strategy. Our extended framework 
was developed as a universal CNV solution for capture sequencing datasets and is thus not constrained 
to pre-established target regions. 
Targeted sequencing can be configured to capture disjoint regions, as in whole-exome 
datasets, or large contiguous loci. Although multiple methods have been designed to perform CNV 
calling on WES, none of them are directly applicable to contiguous targets. To fill this gap, we 
implemented an application of our extended framework for long-range contiguous capture sequencing. 
The resulting cnvCapSeq algorithm was explicated in chapter 5. cnvCapSeq takes advantage of our 
customized normalization approach to mitigate the enrichment bias while enhancing true CNV signal. 
Our method’s performance was evaluated under a wide variety of conditions using both simulated and 
real capture data. In our extensive benchmark, cnvCapSeq was found to substantially outperform 
methods intended for WES in every aspect. Additionally, it exhibited robustness to variation in CNV 
length, population frequency and cohort size. Through experimental validation of cnvCapSeq’s results 
on the real cohort, we also demonstrated its exceptional genotyping accuracy. Overall, we established 
cnvCapSeq’s unique position as the only algorithm capable of sensitive and specific CNV detection in 
contiguous target datasets. 
Capture sequencing experiments also generate large amounts of data outside the designated 
target regions. Although off-target data can be a valuable source of CNV evidence, it is subject to 
complex enrichment biases that confound its interpretation. As a result, it is typically discarded from 
targeted sequencing analyses and entirely disregarded by existing CNV detection algorithms. Chapter 
6 discussed the disparate mechanisms that give rise to off-target data and demonstrated the need for a 
dedicated normalization framework that can adjust to localized enrichment patterns. Thus, we presented 
a customized approach that borrows from the principles of data-driven normalization, but performs 
adaptive correction depending on the observed noise context. This approach was implemented in the 
cnvOffSeq algorithm and benchmarked using WES data from the 1000 Genomes Project. cnvOffSeq 
was compared against methods developed for WGS and targeted sequencing, and was shown to achieve 
significantly better performance in every respect. Furthermore, we demonstrated that our method 
exhibits enhanced sensitivity for larger CNVs, which rivals that of cnvHiTSeq on WGS data. Therefore, 
we concluded that cnvOffSeq offers a sui generis approach to CNV analysis that allows targeted 
sequencing results to be repurposed as low-coverage whole-genome datasets. 
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7.2 Perspective and future directions 
At the heart of this work lies the exploration of statistical models that can elucidate latent 
CNV signatures in HTS datasets. The algorithms we presented compose a generalized toolset for 
detecting and genotyping CNV across established genome resequencing platforms. In whole-genome 
and off-target capture datasets, this toolset can uncover variants that were previously undetectable and 
thus provide valuable information about the prevalence and distribution of CNV in the human genome. 
Our strategies can also be used to gain insight into the role of CNV in disease aetiology and progression, 
especially when applied to targeted sequencing results.  
The intrinsic characteristics of sequencing technology have played a defining role in the 
design and implementation of our algorithms. Thus, the performance of our toolset has mirrored the 
evolution of Illumina NGS platforms. Over the course of this project, virtually every technical aspect 
of sequencing has witnessed marked improvement: error rates have plummeted, read lengths have 
quintupled and throughput has soared. Moreover, the ever-decreasing cost of HTS has rendered deep 
sequencing of whole genomes routine. As a result, present-day HTS datasets have little in common with 
those generated by the 1000 Genomes pilot phase, on which our framework was based. In many 
respects, these developments have been beneficial to our algorithms. Long error-free reads can be 
unambiguously mapped to the reference genome, thus alleviating the alignability bias. Also, higher 
coverage of the genome with longer reads increases the probability that a CNV breakpoint will be 
spanned. This elevates the importance of split reads, which are known to provide the most compelling 
evidence for CNV, but have been elusive in older iterations of the sequencing platforms. 
At the same time, there are certain caveats that are associated with the escalating pace of 
sequencing. Our original framework was developed in the era when population genomics was 
constrained to low-coverage WGS. The relatively low footprint of low-coverage data allowed us to pool 
information across many samples, while sampling the genome at a very high resolution. This approach 
achieves optimal results but is computationally intensive and may become intractable when analysing 
ultra-deep genome-wide experiments at the population scale. Furthermore, as coverage increases, data 
storage and manipulation becomes excessively burdensome. In its current form, our WGS-based 
algorithm would require high-performance computing infrastructure to accommodate this type of study 
without sacrificing on resolution. Therefore, to future-proof our toolset, we need to consider efficient 
algorithmic implementations that minimize memory consumption and intermediate file storage. 
Computational efficiency is of less concern in targeted sequencing datasets due to their non-
comprehensive nature. Nevertheless, our targeted CNV framework is also dependent on the underlying 
technology, particularly in terms of the capture process. Both our on-target and off-target algorithms 
were devised for current hybridization-based platforms and are thus not immune to technical 
developments that may alter the basic properties of enrichment. As hybrid capture matures, both the 
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sensitivity and the specificity of oligonucleotide probes will improve. This will lead to more uniform 
on-target coverage and more sporadic off-target enrichment, thus directly affecting our tools’ 
performance. A potential increase in capture efficiency will have a pronounced impact on our off-target 
algorithm, which relies on a certain degree of non-selective enrichment. Lastly, the utility of our 
methods on alternative enrichment strategies, such as PCR-based techniques, has yet to be assessed. 
Although our algorithms were developed and evaluated using human cohorts, they are 
analogously applicable to HTS-based datasets arising from other species. Large-scale plant 
resequencing projects, such as the 1001 Arabidopsis Genomes [125], are particularly amenable to our 
analysis methods, as they can reap the benefits of the population modelling component. Furthermore, 
our framework was designed to explicitly account for increased levels of ploidy and can thus readily 
accommodate recently sequenced polyploid plant genomes. These include important crops, such as the 
tetraploid potato [167], the hexaploid species of bread wheat [168] and the tetraploid species of 
cultivated cotton [169]. However, the analysis of allopolyploid genomes may pose challenges for CNV 
detection and necessitate adaptations to our framework. Specific strategies to address these challenges 
remain to be explored. Nevertheless, plant genomics offer an exciting avenue to examine the effects of 
CNV on crop yield and disease susceptibility. 
Despite the relatively recent advent of NGS platforms, we seem to be on the cusp of yet 
another sequencing revolution. After years in development, third generation sequencing technologies 
have left the prototype stage and are now demonstrating their potential in a wide range of research 
applications. Third generation platforms have distinct advantages over NGS, mainly in terms of read 
length. By routinely generating kilobase-long reads, TGS overcomes many of the alignability 
limitations of short-read sequencing and greatly facilitates de novo genome assembly. Furthermore, 
such long reads are especially informative for CNV detection, as they are more suitable for split read 
analysis. However, TGS remains relatively low throughput and thus doesn’t yet allow for the high 
degree of redundancy that is required for a systematic exploration of genomic variation. As a result, 
hybrid strategies have been proposed to combine the advantages of NGS and TGS for the purposes of 
both assembly and polymorphism detection [170, 171]. Our CNV detection framework would benefit 
considerably from such mixed datasets, as they enhance split read evidence without neglecting the 
importance of read depth and read pairs. Thus, adapting our algorithms for TGS-based experiments 
constitutes an exciting prospect that will ensure our toolset’s relevance for years to come. 
 
 
  
117 
 
References 
1. Wang, D.G., et al., Large-scale identification, mapping, and genotyping of single-nucleotide 
polymorphisms in the human genome. Science, 1998. 280(5366): p. 1077-82. 
2. Sachidanandam, R., et al., A map of human genome sequence variation containing 1.42 million 
single nucleotide polymorphisms. Nature, 2001. 409(6822): p. 928-33. 
3. Freeman, J.L., et al., Copy number variation: new insights in genome diversity. Genome Res, 
2006. 16(8): p. 949-61. 
4. Conrad, D.F., et al., Origins and functional impact of copy number variation in the human 
genome. Nature, 2010. 464(7289): p. 704-12. 
5. Jacobs, P.A., et al., The somatic chromosomes in mongolism. Lancet, 1959. 1(7075): p. 710. 
6. Bobrow, M., L.F. Joness, and G. Clarke, A complex chromosomal rearrangement with 
formation of a ring 4. Journal of Medical Genetics, 1971. 8(2): p. 235-9. 
7. Lubs, H.A., A marker X chromosome. Am J Hum Genet, 1969. 21(3): p. 231-44. 
8. Scherer, S.W., et al., Challenges and standards in integrating surveys of structural variation. 
Nat Genet, 2007. 39(7 Suppl): p. S7-15. 
9. Itsara, A., et al., De novo rates and selection of large copy number variation. Genome Res, 
2010. 20(11): p. 1469-81. 
10. Stankiewicz, P. and J.R. Lupski, Genome architecture, rearrangements and genomic disorders. 
Trends Genet, 2002. 18(2): p. 74-82. 
11. Gu, W., F. Zhang, and J.R. Lupski, Mechanisms for human genomic rearrangements. 
Pathogenetics, 2008. 1(1): p. 4. 
12. Hastings, P.J., G. Ira, and J.R. Lupski, A microhomology-mediated break-induced replication 
model for the origin of human copy number variation. PLoS Genet, 2009. 5(1): p. e1000327. 
13. Parra, I. and B. Windle, High resolution visual mapping of stretched DNA by fluorescent 
hybridization. Nat Genet, 1993. 5(1): p. 17-21. 
14. Kallioniemi, A., et al., Comparative genomic hybridization for molecular cytogenetic analysis 
of solid tumors. Science, 1992. 258(5083): p. 818-21. 
15. Zhao, X., et al., An integrated view of copy number and allelic alterations in the cancer genome 
using single nucleotide polymorphism arrays. Cancer Res, 2004. 64(9): p. 3060-71. 
16. Weksberg, R., et al., A method for accurate detection of genomic microdeletions using real-
time quantitative PCR. BMC Genomics, 2005. 6: p. 180. 
17. Stranger, B.E., et al., Relative impact of nucleotide and copy number variation on gene 
expression phenotypes. Science, 2007. 315(5813): p. 848-53. 
18. de Cid, R., et al., Deletion of the late cornified envelope LCE3B and LCE3C genes as a 
susceptibility factor for psoriasis. Nat Genet, 2009. 41(2): p. 211-5. 
19. Molokhia, M., et al., FCGR3B copy number variation is associated with systemic lupus 
erythematosus risk in Afro-Caribbeans. Rheumatology (Oxford), 2011. 50(7): p. 1206-10. 
20. Perry, G.H., et al., Diet and the evolution of human amylase gene copy number variation. Nat 
Genet, 2007. 39(10): p. 1256-60. 
21. Caspersson, T., L. Zech, and C. Johansson, Differential binding of alkylating fluorochromes in 
human chromosomes. Exp Cell Res, 1970. 60(3): p. 315-9. 
22. Forozan, F., et al., Genome screening by comparative genomic hybridization. Trends Genet, 
1997. 13(10): p. 405-9. 
23. Knuutila, S., et al., DNA copy number amplifications in human neoplasms: review of 
comparative genomic hybridization studies. Am J Pathol, 1998. 152(5): p. 1107-23. 
24. Lichter, P., et al., Comparative genomic hybridization: uses and limitations. Semin Hematol, 
2000. 37(4): p. 348-57. 
25. Sebat, J., et al., Large-scale copy number polymorphism in the human genome. Science, 2004. 
305(5683): p. 525-8. 
118 
 
26. Iafrate, A.J., et al., Detection of large-scale variation in the human genome. Nat Genet, 2004. 
36(9): p. 949-51. 
27. Pinkel, D., et al., High resolution analysis of DNA copy number variation using comparative 
genomic hybridization to microarrays. Nat Genet, 1998. 20(2): p. 207-11. 
28. Pollack, J.R., et al., Genome-wide analysis of DNA copy-number changes using cDNA 
microarrays. Nat Genet, 1999. 23(1): p. 41-6. 
29. Davies, J.J., I.M. Wilson, and W.L. Lam, Array CGH technologies and their applications to cancer 
genomes. Chromosome Res, 2005. 13(3): p. 237-48. 
30. Fanciulli, M., et al., FCGR3B copy number variation is associated with susceptibility to systemic, 
but not organ-specific, autoimmunity. Nat Genet, 2007. 39(6): p. 721-3. 
31. Greshock, J., et al., A comparison of DNA copy number profiling platforms. Cancer Res, 2007. 
67(21): p. 10173-80. 
32. Mei, R., et al., Genome-wide detection of allelic imbalance using human SNPs and high-density 
DNA arrays. Genome Res, 2000. 10(8): p. 1126-37. 
33. Altug-Teber, O., et al., A rapid microarray based whole genome analysis for detection of 
uniparental disomy. Hum Mutat, 2005. 26(2): p. 153-9. 
34. Diskin, S.J., et al., Copy number variation at 1q21.1 associated with neuroblastoma. Nature, 
2009. 459(7249): p. 987-U112. 
35. Cook, E.H., Jr. and S.W. Scherer, Copy-number variations associated with neuropsychiatric 
conditions. Nature, 2008. 455(7215): p. 919-23. 
36. Walters, R.G., et al., A new highly penetrant form of obesity due to deletions on chromosome 
16p11.2. Nature, 2010. 463(7281): p. 671-675. 
37. Redon, R., et al., Global variation in copy number in the human genome. Nature, 2006. 
444(7118): p. 444-54. 
38. Conrad, D.F., et al., Origins and functional impact of copy number variation in the human 
genome. Nature, 2010. 464(7289): p. 704-12. 
39. D'Haene, B., J. Vandesompele, and J. Hellemans, Accurate and objective copy number profiling 
using real-time quantitative PCR. Methods, 2010. 50(4): p. 262-70. 
40. Chiang, P.W., et al., Use of a fluorescent-PCR reaction to detect genomic sequence copy 
number and transcriptional abundance. Genome Res, 1996. 6(10): p. 1013-26. 
41. Charbonnier, F., et al., Detection of exon deletions and duplications of the mismatch repair 
genes in hereditary nonpolyposis colorectal cancer families using multiplex polymerase chain 
reaction of short fluorescent fragments. Cancer Res, 2000. 60(11): p. 2760-3. 
42. Armour, J.A., et al., Measurement of locus copy number by hybridisation with amplifiable 
probes. Nucleic Acids Res, 2000. 28(2): p. 605-9. 
43. Lander, E.S., et al., Initial sequencing and analysis of the human genome. Nature, 2001. 
409(6822): p. 860-921. 
44. Collins, F.S., et al., A vision for the future of genomics research. Nature, 2003. 422(6934): p. 
835-47. 
45. Wu, R. and A.D. Kaiser, Structure and base sequence in the cohesive ends of bacteriophage 
lambda DNA. J Mol Biol, 1968. 35(3): p. 523-37. 
46. Watson, M., Illuminating the future of DNA sequencing. Genome Biol, 2014. 15(2): p. 108. 
47. Sanger, F. and H. Tuppy, The amino-acid sequence in the phenylalanyl chain of insulin. 2. The 
investigation of peptides from enzymic hydrolysates. Biochem J, 1951. 49(4): p. 481-90. 
48. Sanger, F. and H. Tuppy, The amino-acid sequence in the phenylalanyl chain of insulin. I. The 
identification of lower peptides from partial hydrolysates. Biochem J, 1951. 49(4): p. 463-81. 
49. Watson, J.D. and F.H. Crick, Molecular structure of nucleic acids; a structure for deoxyribose 
nucleic acid. Nature, 1953. 171(4356): p. 737-8. 
50. Holley, R.W., et al., Structure of a Ribonucleic Acid. Science, 1965. 147(3664): p. 1462-5. 
51. Smith, H.O. and K.W. Wilcox, A restriction enzyme from Hemophilus influenzae. I. Purification 
and general properties. J Mol Biol, 1970. 51(2): p. 379-91. 
119 
 
52. Sanger, F. and A.R. Coulson, A rapid method for determining sequences in DNA by primed 
synthesis with DNA polymerase. J Mol Biol, 1975. 94(3): p. 441-8. 
53. Sanger, F., et al., Nucleotide sequence of bacteriophage phi X174 DNA. Nature, 1977. 
265(5596): p. 687-95. 
54. Sanger, F., S. Nicklen, and A.R. Coulson, DNA sequencing with chain-terminating inhibitors. 
Proc Natl Acad Sci U S A, 1977. 74(12): p. 5463-7. 
55. Sanger, F., et al., Nucleotide sequence of bacteriophage lambda DNA. J Mol Biol, 1982. 162(4): 
p. 729-73. 
56. Baer, R., et al., DNA sequence and expression of the B95-8 Epstein-Barr virus genome. Nature, 
1984. 310(5974): p. 207-11. 
57. Smith, L.M., et al., Fluorescence detection in automated DNA sequence analysis. Nature, 1986. 
321(6071): p. 674-9. 
58. Edwards, A., et al., Automated DNA sequencing of the human HPRT locus. Genomics, 1990. 
6(4): p. 593-608. 
59. Fleischmann, R.D., et al., Whole-genome random sequencing and assembly of Haemophilus 
influenzae Rd. Science, 1995. 269(5223): p. 496-512. 
60. Fraser, C.M., et al., The minimal gene complement of Mycoplasma genitalium. Science, 1995. 
270(5235): p. 397-403. 
61. Venter, J.C., et al., The sequence of the human genome. Science, 2001. 291(5507): p. 1304-51. 
62. Lander, E.S., et al., Initial sequencing and analysis of the human genome. Nature, 2001. 
409(6822): p. 860-921. 
63. Gregory, S.G., et al., The DNA sequence and biological annotation of human chromosome 1. 
Nature, 2006. 441(7091): p. 315-21. 
64. Margulies, M., et al., Genome sequencing in microfabricated high-density picolitre reactors. 
Nature, 2005. 437(7057): p. 376-80. 
65. Bentley, D.R., et al., Accurate whole human genome sequencing using reversible terminator 
chemistry. Nature, 2008. 456(7218): p. 53-9. 
66. Shendure, J., et al., Accurate multiplex polony sequencing of an evolved bacterial genome. 
Science, 2005. 309(5741): p. 1728-32. 
67. Genomes Project, C., et al., An integrated map of genetic variation from 1,092 human 
genomes. Nature, 2012. 491(7422): p. 56-65. 
68. Cancer Genome Atlas Research, N., et al., The Cancer Genome Atlas Pan-Cancer analysis 
project. Nat Genet, 2013. 45(10): p. 1113-20. 
69. Eid, J., et al., Real-time DNA sequencing from single polymerase molecules. Science, 2009. 
323(5910): p. 133-8. 
70. Clarke, J., et al., Continuous base identification for single-molecule nanopore DNA sequencing. 
Nat Nanotechnol, 2009. 4(4): p. 265-70. 
71. Schadt, E.E., S. Turner, and A. Kasarskis, A window into third-generation sequencing. Hum Mol 
Genet, 2010. 19(R2): p. R227-40. 
72. Aird, D., et al., Analyzing and minimizing PCR amplification bias in Illumina sequencing 
libraries. Genome Biol, 2011. 12(2): p. R18. 
73. Zerbino, D.R. and E. Birney, Velvet: algorithms for de novo short read assembly using de Bruijn 
graphs. Genome Res, 2008. 18(5): p. 821-9. 
74. Butler, J., et al., ALLPATHS: de novo assembly of whole-genome shotgun microreads. Genome 
Res, 2008. 18(5): p. 810-20. 
75. Adams, M.D., et al., The genome sequence of Drosophila melanogaster. Science, 2000. 
287(5461): p. 2185-95. 
76. Altschul, S.F., et al., Basic local alignment search tool. J Mol Biol, 1990. 215(3): p. 403-10. 
77. Li, H., J. Ruan, and R. Durbin, Mapping short DNA sequencing reads and calling variants using 
mapping quality scores. Genome Res, 2008. 18(11): p. 1851-8. 
120 
 
78. Li, R., et al., SOAP: short oligonucleotide alignment program. Bioinformatics, 2008. 24(5): p. 
713-4. 
79. Ferragina, P. and G. Manzini, Opportunistic data structures with applications. 41st Annual 
Symposium on Foundations of Computer Science, Proceedings, 2000: p. 390-398. 
80. Li, H. and R. Durbin, Fast and accurate short read alignment with Burrows-Wheeler transform. 
Bioinformatics, 2009. 25(14): p. 1754-60. 
81. Langmead, B., et al., Ultrafast and memory-efficient alignment of short DNA sequences to the 
human genome. Genome Biol, 2009. 10(3): p. R25. 
82. Li, R., et al., SOAP2: an improved ultrafast tool for short read alignment. Bioinformatics, 2009. 
25(15): p. 1966-7. 
83. Chang, S.W., C.Y. Ni, and S.L. Chuang, Theory for bowtie plasmonic nanolasers. Opt Express, 
2008. 16(14): p. 10580-95. 
84. project, r.g., The 3,000 rice genomes project. Gigascience, 2014. 3: p. 7. 
85. Wetterstrand, K. DNA Sequencing Costs: Data from the NHGRI Genome Sequencing Program 
(GSP). 2014  [cited 2014 October 31]; Available from: www.genome.gov/sequencingcosts. 
86. Choi, M., et al., Genetic diagnosis by whole exome capture and massively parallel DNA 
sequencing. Proc Natl Acad Sci U S A, 2009. 106(45): p. 19096-101. 
87. Genomes Project, C., et al., A map of human genome variation from population-scale 
sequencing. Nature, 2010. 467(7319): p. 1061-73. 
88. Alkan, C., et al., Personalized copy number and segmental duplication maps using next-
generation sequencing. Nat Genet, 2009. 41(10): p. 1061-7. 
89. Medvedev, P., M. Stanciu, and M. Brudno, Computational methods for discovering structural 
variation with next-generation sequencing. Nat Methods, 2009. 6(11 Suppl): p. S13-20. 
90. Coin, L.J., et al., cnvHap: an integrative population and haplotype-based multiplatform model 
of SNPs and CNVs. Nat Methods, 2010. 7(7): p. 541-6. 
91. Li, H., et al., The Sequence Alignment/Map format and SAMtools. Bioinformatics, 2009. 25(16): 
p. 2078-9. 
92. Yoon, S., et al., Sensitive and accurate detection of copy number variants using read depth of 
coverage. Genome Res, 2009. 19(9): p. 1586-92. 
93. Saha, K. and S. Paul, Bias-corrected maximum likelihood estimator of the negative binomial 
dispersion parameter. Biometrics, 2005. 61(1): p. 179-185. 
94. Lee, Y. and J.A. Nelder, Hierarchal generalised linear models: A synthesis of generalised linear 
models, random-effect models and structured dispersions. Biometrika, 2001. 88(4). 
95. Brent, R.P., Algorithms for minimization without derivatives. Prentice-Hall series in automatic 
computation. 1972, Englewood Cliffs, N.J.,: Prentice-Hall. xii, 195 p. 
96. Consul, P.C. and G.C. Jain, Generalization of Poisson Distribution. Technometrics, 1973. 15(4): 
p. 791-799. 
97. del Castillo, J. and M. Perez-Casany, Weighted Poisson distributions for overdispersion and 
underdispersion situations. Annals of the Institute of Statistical Mathematics, 1998. 50(3): p. 
567-585. 
98. Abyzov, A., et al., CNVnator: an approach to discover, genotype, and characterize typical and 
atypical CNVs from family and population genome sequencing. Genome Res, 2011. 21(6): p. 
974-84. 
99. Lee, S., et al., MoDIL: detecting small indels from clone-end sequencing with mixtures of 
distributions. Nat Methods, 2009. 6(7): p. 473-4. 
100. Sheather, S.J. and J.S. Marron, Kernel Quantile Estimators. Journal of the American Statistical 
Association, 1990. 85(410): p. 410-416. 
101. Hörmann, W., J. Leydold, and G. Derflinger, Automatic Nonuniform Random Variate 
Generation. 2004: Springer. 
102. Volik, S., et al., End-sequence profiling: sequence-based analysis of aberrant genomes. Proc 
Natl Acad Sci U S A, 2003. 100(13): p. 7696-701. 
121 
 
103. Tuzun, E., et al., Fine-scale structural variation of the human genome. Nat Genet, 2005. 37(7): 
p. 727-32. 
104. Eichler, E.E., et al., Combinatorial algorithms for structural variation detection in high-
throughput sequenced genomes. Genome Research, 2009. 19(7): p. 1270-1278. 
105. Chen, K., et al., BreakDancer: an algorithm for high-resolution mapping of genomic structural 
variation. Nat Methods, 2009. 6(9): p. 677-81. 
106. Morgulis, A., et al., A fast and symmetric DUST implementation to mask low-complexity DNA 
sequences. J Comput Biol, 2006. 13(5): p. 1028-40. 
107. Bennett, E.A., et al., Natural genetic variation caused by transposable elements in humans. 
Genetics, 2004. 168(2): p. 933-51. 
108. Ye, K., et al., Pindel: a pattern growth approach to detect break points of large deletions and 
medium sized insertions from paired-end short reads. Bioinformatics, 2009. 25(21): p. 2865-
71. 
109. Pei, J., et al., Mining sequential patterns by pattern-growth: The PrefixSpan approach. Ieee 
Transactions on Knowledge and Data Engineering, 2004. 16(11): p. 1424-1440. 
110. Holmes, I. and G.M. Rubin, An expectation maximization algorithm for training hidden 
substitution models. J Mol Biol, 2002. 317(5): p. 753-64. 
111. Klosterman, P.S., et al., XRate: a fast prototyping, training and annotation tool for phylo-
grammars. BMC Bioinformatics, 2006. 7: p. 428. 
112. Mills, R.E., et al., Mapping copy number variation by population-scale genome sequencing. 
Nature, 2011. 470(7332): p. 59-65. 
113. International HapMap, C., The International HapMap Project. Nature, 2003. 426(6968): p. 789-
96. 
114. Mills, R.E., et al., An initial map of insertion and deletion (INDEL) variation in the human 
genome. Genome Res, 2006. 16(9): p. 1182-90. 
115. McCarroll, S.A., et al., Integrated detection and population-genetic analysis of SNPs and copy 
number variation. Nat Genet, 2008. 40(10): p. 1166-74. 
116. Kidd, J.M., et al., Mapping and sequencing of structural variation from eight human genomes. 
Nature, 2008. 453(7191): p. 56-64. 
117. Cooper, G.M., et al., Systematic assessment of copy number variant detection via genome-
wide SNP genotyping. Nat Genet, 2008. 40(10): p. 1199-203. 
118. Bentley, D.R., et al., Accurate whole human genome sequencing using reversible terminator 
chemistry. Nature, 2008. 456(7218): p. 53-59. 
119. Benjamini, Y. and T.P. Speed, Summarizing and correcting the GC content bias in high-
throughput sequencing. Nucleic Acids Res, 2012. 40(10): p. e72. 
120. Consortium, E.P., et al., Identification and analysis of functional elements in 1% of the human 
genome by the ENCODE pilot project. Nature, 2007. 447(7146): p. 799-816. 
121. 1000 Genomes Project Consortium, A map of human genome variation from population-scale 
sequencing. Nature, 2010. 467(7319): p. 1061-73. 
122. Marioni, J.C., et al., Breaking the waves: improved detection of copy number variation from 
microarray-based comparative genomic hybridization. Genome Biology, 2007. 8(10): p. -. 
123. Handsaker, R.E., et al., Discovery and genotyping of genome structural polymorphism by 
sequencing on a population scale. Nat Genet, 2011. 43(3): p. 269-76. 
124. Li, R., et al., Building the sequence map of the human pan-genome. Nat Biotechnol, 2010. 
28(1): p. 57-63. 
125. Cao, J., et al., Whole-genome sequencing of multiple Arabidopsis thaliana populations. Nat 
Genet, 2011. 43(10): p. 956-63. 
126. Xu, X., et al., Resequencing 50 accessions of cultivated and wild rice yields markers for 
identifying agronomically important genes. Nat Biotechnol, 2011. 30(1): p. 105-11. 
127. Lam, H.M., et al., Resequencing of 31 wild and cultivated soybean genomes identifies patterns 
of genetic diversity and selection. Nat Genet, 2010. 42(12): p. 1053-9. 
122 
 
128. Bamshad, M.J., et al., Exome sequencing as a tool for Mendelian disease gene discovery. Nat 
Rev Genet, 2011. 12(11): p. 745-55. 
129. Ng, S.B., et al., Exome sequencing identifies the cause of a mendelian disorder. Nat Genet, 
2010. 42(1): p. 30-5. 
130. Hoischen, A., et al., De novo mutations of SETBP1 cause Schinzel-Giedion syndrome. Nat Genet, 
2010. 42(6): p. 483-5. 
131. Tewhey, R., et al., Microdroplet-based PCR enrichment for large-scale targeted sequencing. 
Nat Biotechnol, 2009. 27(11): p. 1025-31. 
132. Lovett, M., J. Kere, and L.M. Hinton, Direct selection: a method for the isolation of cDNAs 
encoded by large genomic regions. Proc Natl Acad Sci U S A, 1991. 88(21): p. 9628-32. 
133. Parimoo, S., et al., cDNA selection: efficient PCR approach for the selection of cDNAs encoded 
in large chromosomal DNA fragments. Proc Natl Acad Sci U S A, 1991. 88(21): p. 9623-7. 
134. Okou, D.T., et al., Microarray-based genomic selection for high-throughput resequencing. Nat 
Methods, 2007. 4(11): p. 907-9. 
135. Albert, T.J., et al., Direct selection of human genomic loci by microarray hybridization. Nat 
Methods, 2007. 4(11): p. 903-5. 
136. Gnirke, A., et al., Solution hybrid selection with ultra-long oligonucleotides for massively 
parallel targeted sequencing. Nat Biotechnol, 2009. 27(2): p. 182-9. 
137. Sathirapongsasuti, J.F., et al., Exome sequencing-based copy-number variation and loss of 
heterozygosity detection: ExomeCNV. Bioinformatics, 2011. 27(19): p. 2648-54. 
138. Magi, A., et al., EXCAVATOR: detecting copy number variants from whole-exome sequencing 
data. Genome Biol, 2013. 14(10): p. R120. 
139. Li, J., et al., CONTRA: copy number analysis for targeted resequencing. Bioinformatics, 2012. 
28(10): p. 1307-13. 
140. Krumm, N., et al., Copy number variation detection and genotyping from exome sequence 
data. Genome Res, 2012. 22(8): p. 1525-32. 
141. Fromer, M., et al., Discovery and statistical genotyping of copy-number variation from whole-
exome sequencing depth. Am J Hum Genet, 2012. 91(4): p. 597-607. 
142. Alter, O., P.O. Brown, and D. Botstein, Singular value decomposition for genome-wide 
expression data processing and modeling. Proc Natl Acad Sci U S A, 2000. 97(18): p. 10101-6. 
143. Langmead, B. and S.L. Salzberg, Fast gapped-read alignment with Bowtie 2. Nat Methods, 
2012. 9(4): p. 357-9. 
144. Ng, S.B., et al., Exome sequencing identifies MLL2 mutations as a cause of Kabuki syndrome. 
Nat Genet, 2010. 42(9): p. 790-3. 
145. Semler, O., et al., A mutation in the 5'-UTR of IFITM5 creates an in-frame start codon and 
causes autosomal-dominant osteogenesis imperfecta type V with hyperplastic callus. Am J 
Hum Genet, 2012. 91(2): p. 349-57. 
146. O'Roak, B.J., et al., Exome sequencing in sporadic autism spectrum disorders identifies severe 
de novo mutations. Nat Genet, 2011. 43(6): p. 585-9. 
147. Xu, B., et al., De novo gene mutations highlight patterns of genetic and neural complexity in 
schizophrenia. Nat Genet, 2012. 44(12): p. 1365-9. 
148. Lehne, B., C.M. Lewis, and T. Schlitt, Exome localization of complex disease association signals. 
BMC Genomics, 2011. 12: p. 92. 
149. Wei, X., et al., Exome sequencing identifies GRIN2A as frequently mutated in melanoma. Nat 
Genet, 2011. 43(5): p. 442-6. 
150. Varela, I., et al., Exome sequencing identifies frequent mutation of the SWI/SNF complex gene 
PBRM1 in renal carcinoma. Nature, 2011. 469(7331): p. 539-42. 
151. Yan, X.J., et al., Exome sequencing identifies somatic mutations of DNA methyltransferase gene 
DNMT3A in acute monocytic leukemia. Nat Genet, 2011. 43(4): p. 309-15. 
152. Mills, R.E., et al., Mapping copy number variation by population-scale genome sequencing. 
Nature, 2011. 470(7332): p. 59-65. 
123 
 
153. Kim, S., K. Jeong, and V. Bafna, Wessim: a whole-exome sequencing simulator based on in silico 
exome capture. Bioinformatics, 2013. 29(8): p. 1076-7. 
154. Hughes, A.E., et al., A common CFH haplotype, with deletion of CFHR1 and CFHR3, is associated 
with lower risk of age-related macular degeneration. Nat Genet, 2006. 38(10): p. 1173-7. 
155. Davila, S., et al., Genome-wide association study identifies variants in the CFH region 
associated with host susceptibility to meningococcal disease. Nat Genet, 2010. 42(9): p. 772-
6. 
156. Sivakumaran, T.A., et al., A 32 kb critical region excluding Y402H in CFH mediates risk for age-
related macular degeneration. PLoS One, 2011. 6(10): p. e25598. 
157. McKenna, A., et al., The Genome Analysis Toolkit: a MapReduce framework for analyzing next-
generation DNA sequencing data. Genome Res, 2010. 20(9): p. 1297-303. 
158. DePristo, M.A., et al., A framework for variation discovery and genotyping using next-
generation DNA sequencing data. Nat Genet, 2011. 43(5): p. 491-8. 
159. Li, H., et al., The Sequence Alignment/Map format and SAMtools. Bioinformatics, 2009. 25(16): 
p. 2078-2079. 
160. Zipfel, P.F., et al., Deletion of complement factor H-related genes CFHR1 and CFHR3 is 
associated with atypical hemolytic uremic syndrome. PLoS Genet, 2007. 3(3): p. e41. 
161. Lango Allen, H., et al., Next generation sequencing of chromosomal rearrangements in 
patients with split-hand/split-foot malformation provides evidence for DYNC1I1 exonic 
enhancers of DLX5/6 expression in humans. Journal of Medical Genetics, 2014. 51(4): p. 264-
7. 
162. Rohrer, J.D., et al., Exome sequencing reveals a novel partial deletion in the progranulin gene 
causing primary progressive aphasia. J Neurol Neurosurg Psychiatry, 2013. 84(12): p. 1411-2. 
163. Coin, L.J., et al., An exome sequencing pipeline for identifying and genotyping common CNVs 
associated with disease with application to psoriasis. Bioinformatics, 2012. 28(18): p. i370-
i374. 
164. Hedges, D.J., et al., Comparison of three targeted enrichment strategies on the SOLiD 
sequencing platform. PLoS One, 2011. 6(4): p. e18595. 
165. Guo, Y., et al., Exome sequencing generates high quality data in non-target regions. BMC 
Genomics, 2012. 13: p. 194. 
166. Wang, Y.X., On the big-R notation for describing iterative and recursive behaviors. Proceedings 
of the Fifth IEEE International Conference on Cognitive Informatics, Vols 1 and 2, 2006: p. 132-
140. 
167. Potato Genome Sequencing, C., et al., Genome sequence and analysis of the tuber crop potato. 
Nature, 2011. 475(7355): p. 189-95. 
168. International Wheat Genome Sequencing, C., A chromosome-based draft sequence of the 
hexaploid bread wheat (Triticum aestivum) genome. Science, 2014. 345(6194): p. 1251788. 
169. Li, F., et al., Genome sequence of the cultivated cotton Gossypium arboreum. Nat Genet, 2014. 
46(6): p. 567-72. 
170. Koren, S., et al., Hybrid error correction and de novo assembly of single-molecule sequencing 
reads. Nat Biotechnol, 2012. 30(7): p. 693-700. 
171. Laszlo, A.H., et al., Decoding long nanopore sequencing reads of natural DNA. Nat Biotechnol, 
2014. 32(8): p. 829-33. 
  
124 
 
Appendix 
 
APPENDIX TABLE 1 Independent validation of cnvHiTSeq’s results 
using array-CGH data from the High Resolution CNV Discovery Project. 
 
Location (build37) 
CNV 
Length 
(bp) 
Copy 
Number 
Number of 
overlapping 
array probes 
Detected by 
Genome STRiP 
Validation 
status 
1:25647261-25665261 18000 1 12 0 1 
1:60048640-60049641 1001 0 10 1 1 
1:89475800-89478621 2821 1 10 1 1 
1:94288340-94291261 2921 0 9 0 1 
1:108733300-108737161 3861 1 10 1 1 
1:109572880-109574961 2081 1 12 0 1 
1:110187180-110191421 4241 0 10 0 1 
1:152760441-152770761 10320 0 9 0 1 
1:181057920-181058861 941 1 5 0 1 
1:185009640-185011721 2081 1 10 1 1 
1:187464840-187466381 1541 1 9 0 Excluded 
1:187716100-187722521 6421 0 10 1 1 
1:189704440-189780140 75700 1 10 0 1 
1:229812540-229820821 8281 0 10 1 1 
1:236919040-236920401 1361 0 8 0 1 
1:248728641-248739381 10740 1 5 0 1 
1:248739460-248740660 1200 0 7 0 1 
1:248748381-248795660 47279 0 9 0 1 
2:14704140-14710181 6041 1 10 1 1 
2:35976001-35993540 17539 0 10 1 1 
2:52749661-52761801 12140 0 5 1 1 
2:52764061-52785241 21180 0 5 1 1 
2:54565421-54567460 2039 0 5 1 1 
2:59623240-59624401 1161 1 10 1 1 
2:66505500-66507581 2081 1 10 1 1 
2:76773480-76775441 1961 0 10 1 1 
2:79076480-79081201 4721 0 10 1 1 
2:89132241-89159121 26880 0 10 1 1 
2:89160000-89185521 25521 1 13 0 1 
2:98140461-98158341 17880 1 16 0 1 
2:108855401-108856281 880 0 10 1 1 
2:110705821-110718421 12600 1 5 0 1 
2:129638400-129646221 7821 1 10 1 1 
2:130242080-130251401 9321 1 10 1 1 
2:130954920-130957381 2461 0 8 1 1 
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2:146862580-146876841 14261 0 10 1 1 
2:151031101-151037881 6780 1 9 1 1 
2:184085380-184091120 5740 1 10 1 1 
2:194689500-194696021 6521 0 10 1 1 
2:217955880-217957241 1361 0 10 1 1 
3:6649921-6654601 4680 1 10 1 1 
3:32101940-32107921 5981 1 10 1 1 
3:98410640-98414781 4141 0 10 0 1 
3:104278200-104278901 701 1 6 1 1 
3:156092160-156093661 1501 1 10 1 1 
3:159461140-159463441 2301 1 10 1 1 
3:162717300-162722221 4921 0 10 0 1 
3:186582960-186585381 2421 1 12 1 1 
3:189737260-189740561 3301 1 10 1 1 
3:192875621-192885481 9860 1 9 1 1 
3:196934261-196939281 5020 1 10 1 1 
4:9457280-9480941 23661 0 13 1 1 
4:10392301-10402320 10019 1 6 1 1 
4:34779841-34828921 49080 0 10 0 1 
4:69446461-69460781 14320 0 7 0 1 
4:69461961-69491081 29120 0 4 0 1 
4:86976321-86979841 3520 1 10 1 1 
4:161878880-161885321 6441 1 10 1 1 
4:166002500-166005040 2540 0 10 1 1 
4:173425040-173433541 8501 0 9 1 1 
4:186441581-186444081 2500 0 10 1 1 
5:1023521-1025821 2300 0 5 0 0 
5:1881060-1884321 3261 1 10 0 0 
5:1924561-1925181 620 0 10 0 1 
5:6712860-6714881 2021 0 4 0 0 
5:19375120-19376461 1341 1 7 1 1 
5:26796921-26801961 5040 1 10 1 1 
5:27524840-27526321 1481 1 8 1 1 
5:57323441-57333761 10320 0 10 1 1 
5:63698220-63701381 3161 1 10 1 1 
5:86115181-86117861 2680 1 10 1 1 
5:90499700-90502081 2381 0 10 1 1 
5:104432020-104478901 46881 1 7 1 1 
5:117387000-117393861 6861 1 10 1 1 
5:119380101-119382661 2560 0 10 1 1 
5:147553001-147554301 1300 0 8 0 1 
5:177225920-177240361 14441 1 7 0 Excluded 
6:128827521-128829680 2159 1 10 1 1 
6:132114121-132118601 4480 1 10 1 1 
6:132375080-132379020 3940 1 10 1 1 
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6:149198140-149199041 901 1 5 0 0 
6:165724580-165732121 7541 0 10 1 1 
7:13022001-13028761 6760 1 10 1 1 
7:22434761-22436741 1980 0 10 1 1 
7:31315461-31318961 3500 0 10 1 1 
7:38388140-38397381 9241 1 5 0 1 
7:51594300-51598701 4401 0 13 1 1 
7:64297660-64301261 3601 1 7 0 1 
7:64719140-64724641 5501 0 10 0 1 
7:70420941-70426181 5240 0 10 1 1 
7:81441660-81442341 681 0 7 1 1 
7:126048400-126051481 3081 0 7 1 1 
7:141767761-141786261 18500 1 6 0 1 
7:148072800-148076301 3501 0 10 1 1 
7:157880701-157882161 1460 1 4 0 1 
7:158126341-158134561 8220 1 5 1 1 
8:11245501-11247201 1700 0 10 1 1 
8:24985601-24991061 5460 1 4 1 1 
8:25587561-25588501 940 1 4 0 1 
8:26879380-26881061 1681 1 4 0 1 
8:32679940-32691261 11321 0 10 1 1 
8:39243841-39387220 143379 1 25 0 1 
8:40774500-40779761 5261 0 10 1 1 
8:112294001-112297121 3120 0 10 1 1 
9:23363420-23375001 11581 1 6 1 1 
9:71738081-71743421 5340 0 10 1 1 
9:101308981-101311661 2680 0 10 1 1 
9:131700921-131702181 1260 0 4 1 1 
9:136624700-136626301 1601 1 6 1 1 
10:4290021-4291661 1640 0 10 1 1 
10:46624540-46683381 58841 1 4 0 1 
10:46788560-46905381 116821 1 31 0 1 
10:78255540-78261001 5461 0 10 1 1 
10:95545500-95546481 981 0 4 1 1 
10:114112180-114116641 4461 0 10 1 1 
10:132909060-132912741 3681 1 10 1 1 
11:29007140-29012941 5801 0 10 0 1 
11:29967460-29968540 1080 1 10 1 1 
11:48600860-48602321 1461 0 9 1 1 
11:81857160-81863341 6181 1 10 1 1 
11:104267660-104273221 5561 0 10 1 1 
12:11225481-11250621 25140 1 15 0 1 
12:11506581-11546961 40380 1 9 0 1 
12:22571740-22582121 10381 1 10 0 0 
12:23939520-23940061 541 0 6 1 1 
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12:84593041-84596041 3000 0 10 1 1 
12:90488081-90490681 2600 1 8 0 1 
12:99793741-99802761 9020 1 10 1 1 
12:100287980-100291940 3960 1 10 0 1 
13:51069340-51075081 5741 0 10 1 1 
13:67174680-67177580 2900 1 10 1 1 
13:72477241-72480561 3320 0 10 1 1 
13:72807380-72812421 5041 1 10 1 1 
13:95363680-95366000 2320 1 9 0 Excluded 
13:110434080-110438361 4281 1 6 0 Excluded 
14:36417961-36418841 880 1 4 0 1 
14:73996921-74026481 29560 1 33 0 1 
14:80106600-80115041 8441 1 9 1 1 
14:82499021-82503321 4300 0 10 1 1 
14:103987320-103989661 2341 1 4 0 0 
14:106178060-106284401 106341 1 6 1 1 
15:74043960-74045121 1161 1 4 0 0 
15:98842140-98843841 1701 1 10 1 1 
15:99192260-99193400 1140 1 8 0 1 
16:76539041-76544061 5020 0 10 1 1 
16:88599700-88601181 1481 0 7 0 1 
17:35755600-35758741 3141 0 10 0 1 
17:39421880-39432061 10181 0 10 0 1 
17:44460720-44544820 84100 1 6 0 1 
17:61955921-61959961 4040 1 5 0 0 
18:5295060-5296481 1421 0 7 0 0 
18:30495740-30501261 5521 1 8 1 1 
18:38259780-38266461 6681 1 10 1 1 
18:47694941-47698421 3480 0 10 1 1 
18:63723540-63732381 8841 1 10 1 1 
18:63766700-63769361 2661 1 10 1 1 
18:66205060-66209260 4200 1 5 0 1 
18:76131000-76133241 2241 1 5 0 1 
18:76662340-76666341 4001 1 10 1 1 
19:38343500-38345001 1501 1 10 0 1 
20:1560941-1594181 33240 1 15 0 0 
20:52647140-52655021 7881 1 5 1 1 
20:61724661-61725641 980 0 7 1 1 
21:43349961-43353541 3580 1 10 1 1 
22:37143120-37147901 4781 0 10 1 1 
22:45624540-45625281 741 1 7 0 0 
 
Each row corresponds to a deleted locus detected by cnvHiTSeq in samples NA12878. A locus was only considered if there 
were at least 4 overlapping probes in the Agilent 105k array designed by the High Resolution CNV Discovery Project to 
genotype known CNV loci. The array-CGH data was analysed using cnvHap and the resulting CNV calls were compared 
against those obtained from cnvHiTSeq with a 50% reciprocal overlap criterion. 4 of the 166 cnvHap calls made on CGH data 
exhibited low posterior probabilities and were excluded as ambiguous after visual inspection.  
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APPENDIX TABLE 2 Genotyping accuracy on a subset of the HapMap CEU population. 
Location Predicted Location 
Predicted 
Length 
(bp) 
cnvHap SCIMM 
cnvHiTSeq 
cnvHiTSeq* cnvHiTSeq† 
r2 r2 r2 Accuracy Missing rate r
2 Accuracy Missing rate 
chr1:35098051-35115368 chr1:35100671-35112111 11440 1.00 1.00 0.77 0.88 0.23 1.00 1.00 0.00 
chr1:152759872-152770356 chr1:152760173-152770753 10580 0.90 0.94 0.85 0.82 0.23 1.00 1.00 0.00 
chr3:151625213-151657165 N/A N/A 0.00 N/A N/A N/A N/A N/A N/A N/A 
chr7:97395305-97402641 chr7:97395365-97402646 7281 1.00 1.00 0.66 0.81 0.05 1.00 1.00 0.00 
chr7:115930472-115941073 chr7:115931453-115941632 10179 1.00 1.00 N/A 0.95 0.00 1.00 1.00 0.00 
chr8:51030941-51038331 chr8:51031082-51038282 7200 0.92 0.93 0.63 0.94 0.11 1.00 1.00 0.00 
chr8:144700485-144714694 chr8:144700505-144714606 14101 1.00 0.97 0.54 0.67 0.00 1.00 1.00 0.00 
chr10:71280989-71291079 chr10:71280949-71291070 10121 0.90 0.82 0.58 0.86 0.05 0.89 0.95 0.00 
chr11:5783630-5809284 chr11:5784450-5809211 24761 1.00 1.00 0.61 0.83 0.00 0.94 0.94 0.00 
chr11:107238222-107244154 chr11:107238422-107244103 5681 0.94 0.97 0.83 0.90 0.00 1.00 1.00 0.00 
chr15:34694542-34817215 chr15:34701483-34817043 115560 0.80 1.00 0.69 1.00 0.05 1.00 1.00 0.00 
chr15:76884597-76907042 chr15:76884597-76896918 12321 0.56 N/A 0.96 0.95 0.00 1.00 1.00 0.00 
chr19:35851153-35861684 chr19:35851134-35863213 12079 1.00 1.00 0.81 0.90 0.05 1.00 1.00 0.00 
chr19:52132525-52148984 chr19:52132606-52149186 16580 0.96 0.96 0.88 0.86 0.00 1.00 1.00 0.00 
chr20:1558407-1585809 chr20:1561187-1585928 24741 0.90 N/A 0.95 0.94 0.00 1.00 1.00 0.00 
chr22:23154417-23243496 chr22:23186037-23241798 55761 0.22 N/A 0.61 0.73 0.00 0.77 0.80 0.09 
chr22:24323894-24418396 chr22:24343395-24397295 53900 0.00 N/A 0.91 0.86 0.00 1.00 1.00 0.00 
chr22:39366812-39386139 chr22:39358773-39383652 24879 1.00 0.96 0.46 0.85 0.00 1.00 1.00 0.00 
 
Genotyping accuracy as measured by the concordance between copy number estimates on 22 HapMap CEU samples from the low-coverage pilot of the 1000 Genomes Project and reference copy 
number estimates obtained using PCR. Concordance is quantified using two different metrics: the correlation coefficient r2 between the reference and the predicted genotypes as well as the fraction 
of calls with the correct genotype for both alleles. r2 measurements for SCIMM were obtained from Supp. Material of [117]. r2 measurements for cnvHap were obtained from Supp. Material of [90]. 
Two different versions of cnvHiTSeq were used: cnvHiTSeq*, which is a single-sample version of the algorithm that doesn’t take advantage of the population modelling capabilities, and cnvHiTSeq†, 
which trains the parameters of the model using the entire low-coverage HapMap CEU population from the 1000 Genomes Project (currently consisting of 94 samples). The genotyping accuracy 
was calculated using 22 of the 94 samples, since these were the only samples for which PCR copy number estimates were available. When all the samples are predicted to be copy neutral for a given 
location the accuracy and r2 are undefined and denoted by N/A. cnvHiTSeq calls with posterior probabilities lower than 80% were excluded and declared as missing. 
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APPENDIX FIGURE 1 Heatmap of cnvHiTSeq genotyping results 
 
 
 
Heatmap showing the genotyping concordance between cnvHiTSeq and the benchmark Conrad et al dataset. The 91 CEU 
samples are depicted on the x axis, while the 150 CNV regions are depicted on the y axis. Green corresponds to concordant 
results, blue corresponds to genotypes missing from either cnvHiTSeq or benchmark datasets and pink corresponds to 
discordant results. The shading is proportional to the posterior probability assigned to each CNV call by our method. The 
samples marked in red presented with high variability in depth of coverage among regions, in some instances dropping below 
1x. The regions marked in red presented with complex CNVs that could probably not be resolved by the array-CGH data. 
Specifically, all but chr2:56649400-56655700 were deletions flanked by duplications, which were miscalled as normal in the 
benchmark results. chr2:56649400-56655700 encompassed a nested homozygous deletion.  
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APPENDIX TABLE 3 21 genomic loci used in our simulations. 
Chr Outer Start Coordinate 
Outer End 
Coordinate 
Left CNV 
breakpoint 
Right CNV 
breakpoint 
CNV 
Length (bp) 
1 12,879,000 13,033,000 12,898,653 13,013,316 114663 
1 49,895,000 50,019,000 49,914,513 49,998,578 84065 
1 72,746,000 72,832,000 72,766,323 72,811,839 45516 
1 106,144,000 106,235,000 106,164,396 106,215,440 51044 
1 112,672,000 112,726,000 112,691,801 112,706,300 14499 
1 152,536,000 152,608,000 152,555,542 152,587,742 32200 
1 158,435,000 158,534,000 158,455,170 158,513,839 58669 
1 189,298,000 189,403,000 189,317,522 189,383,122 65600 
1 196,713,000 196,834,000 196,733,401 196,813,850 80449 
1 246,354,000 246,467,000 246,373,568 246,447,415 73847 
6 29,841,000 29,936,000 29,860,857 29,915,764 54907 
6 31,200,000 31,333,000 31,220,482 31,312,868 92386 
6 31,336,000 31,473,000 31,356,165 31,453,117 96952 
6 32,470,000 32,546,000 32,490,263 32,526,276 36013 
6 66,989,000 67,069,000 67,008,728 67,048,916 40188 
6 74,572,000 74,622,000 74,592,060 74,602,439 10379 
6 77,417,000 77,479,000 77,437,226 77,458,987 21761 
6 78,947,000 79,056,000 78,967,194 79,036,475 69281 
6 95,173,000 95,214,000 95,193,322 95,194,336 1014 
6 103,717,000 103,783,000 103,737,464 103,762,889 25425 
6 139,582,000 139,627,000 139,601,876 139,606,900 5024 
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APPENDIX TABLE 4 cnvCapSeq-generated CNV calls 
for the RCA cohort along with the genes affected. 
 
Sample Chr Start Coordinate 
End 
Coordinate Length 
Copy 
Number 
Overlaps 
CFHR3 CFHR1 CFHR4 
CHH1039 1 196,734,200 196,810,800 76,600 1 ● ●  
CHH1045 1 196,811,300 196,905,000 93,700 3   ● 
CHH1130 1 196,734,200 196,804,900 70,700 1 ● ●  
CHH1141 1 196,734,200 196,810,800 76,600 1 ● ●  
CHH1159 1 196,727,100 196,810,900 83,800 1 ● ●  
CHH1164 1 196,723,700 196,804,900 81,200 1 ● ●  
CHH1181 1 196,723,700 196,804,900 81,200 1 ● ●  
CHH1190 1 196,786,900 196,905,000 118,100 1  ● ● 
CHH1192 1 196,723,700 196,804,900 81,200 1 ● ●  
CHH1193 1 196,734,200 196,810,900 76,700 1 ● ●  
CHH1201 1 196,734,200 196,819,600 85,400 1 ● ●  
CHH1232 
1 196,723,700 196,790,800 
181,300 
1 ●   
1 196,790,900 196,804,900 0  ●  
1 196,805,000 196,905,000 1   ● 
CHH1236 1 196,723,700 196,804,900 81,200 1 ●   
CHH1239 1 196,723,700 196,804,900 81,200 1 ●   
CHH1240 1 196,726,800 196,804,900 78,100 1 ●   
CHH1249 1 196,786,900 196,905,000 118,100 1  ● ● 
CHH1278 1 196,786,900 196,905,000 118,100 1  ● ● 
CHH1285 1 196,727,100 196,811,000 83,900 1 ● ●  
CHH1420 1 196,723,700 196,804,900 81,200 1 ● ●  
CHH1424 1 196,723,700 196,804,900 81,200 1 ● ●  
CHH1437 1 196,732,500 196,804,900 72,400 1 ● ●  
CHH1443 1 196,734,200 196,819,600 85,400 1 ● ●  
CHH1465 1 196,734,200 196,804,900 70,700 1 ● ●  
CHH1478 1 196,734,200 196,804,900 70,700 1 ● ●  
CHH1489 1 196,786,900 196,905,000 118,100 1  ● ● 
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CHH1512 1 196,734,200 196,804,900 70,700 1 ● ●  
CHH1519 1 196,723,700 196,804,900 81,200 1 ● ●  
CHH1526 1 196,723,700 196,804,900 81,200 1 ● ●  
CHH1530 1 196,734,200 196,810,800 76,600 1 ● ●  
CHH1560 1 196,786,900 196,905,000 118,100 1  ● ● 
CHH1562 
1 196,734,200 196,783,100 48,900 1 ●   
1 196,819,800 196,905,000 85,200 3   ● 
CHH1564 1 196,723,700 196,804,900 81,200 1 ● ●  
CHH1583 1 196,723,700 196,804,900 81,200 1 ● ●  
CHH1584 
1 196,723,700 196,790,800 
181,300 
1 ●   
1 196,790,900 196,804,900 0  ●  
1 196,805,000 196,905,000 1   ● 
CHH1586 1 196,734,200 196,810,800 76,600 1 ● ●  
CHH1613 1 196,727,000 196,804,900 77,900 1 ● ●  
CHH1624 1 196,726,800 196,804,900 78,100 1 ● ●  
CHH1626 1 196,786,900 196,905,000 118,100 1  ● ● 
CHH1645 1 196,723,700 196,804,900 81,200 1 ● ●  
CHH1646 1 196,726,900 196,811,100 84,200 1 ● ●  
CHH2009 1 196,734,200 196,804,900 70,700 1 ● ●  
 
 
APPENDIX TABLE 5 qPCR primers used for the RCA validation. 
Gene Chr Coordinate (start) Strand Primer sequence (5'-3') 
CFHR3 1 
196,749,063 Forward GGAGAAAGGCTGGTCTCCTACT 
196,749,149 Reverse CTGAGACTGTCGTCCGTGTTAC 
CFHR1 1 
196,796,120 Forward AAATGCAGGTCCACTGGTAAGT 
196,796,340 Reverse GAGATGATGATGCTACCGGTTT 
LOC100996886 1 
196,842,723 Forward TGACTGGTGACTCATTCCTCTG 
196,842,826 Reverse TCAGATAGGGTTGGCCTTTCTA 
CFHR4 1 
196,865,825 Forward ACGATCCAAGTCATCCCTAGAA 
196,865,910 Reverse TGGAATCTGACTCCTCACCTTT 
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 APPENDIX FIGURE 2 Method performance versus simulated deletion size. 
 
 
 
Sensitivity, specificity and positive predictive value (PPV) across 21 deletion lengths. The performance metrics were averaged 
across simulated population frequencies. For xHMM and CONTRA performance deteriorates with increasing size, while 
cnvCapSeq remains consistent throughout. 
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APPENDIX TABLE 6 Whole-exome sequencing samples used to benchmark cnvOffSeq. 
 
Sample ID 
1000 
Genomes 
Population 
On-target 
coverage 
Off-target 
coverage 
NA06984 CEU 57.39 1.75 
NA06989 CEU 105.24 2.46 
NA07048 CEU 145.87 1.29 
NA07051 CEU 81.83 1.88 
NA07347 CEU 104.96 2.52 
NA11843 CEU 54.21 1.72 
NA11919 CEU 63.44 2.33 
NA11930 CEU 58.17 1.72 
NA12045 CEU 86.89 1.98 
NA12058 CEU 91.64 1.67 
NA12340 CEU 56.89 1.71 
NA12341 CEU 49.47 1.59 
NA12342 CEU 52.42 1.63 
NA12748 CEU 53.15 1.69 
NA12750 CEU 124.86 1.13 
NA12830 CEU 54.06 1.65 
NA12843 CEU 50.14 1.53 
NA18504 YRI 97.72 2.27 
NA18510 YRI 115.47 2.33 
NA18538 CHB 136.23 1.93 
NA18553 CHB 101.05 2.26 
NA18560 CHB 92.52 2.05 
NA18567 CHB 117.73 1.92 
NA18574 CHB 86.59 2.21 
NA18616 CHB 100 2.50 
NA18631 CHB 97.66 2.35 
NA18634 CHB 96.38 2.50 
NA18638 CHB 94.64 2.36 
NA18856 YRI 96.27 2.21 
NA18950 JPT 64.34 1.86 
NA19057 JPT 81.96 2.03 
NA19064 JPT 105.21 2.07 
NA19067 JPT 109.78 2.50 
NA19068 JPT 184.02 1.12 
135 
 
NA19137 YRI 139.48 1.08 
NA19213 YRI 131.63 1.73 
NA19236 YRI 113.37 1.82 
NA19331 LWK 248.29 1.14 
NA19350 LWK 108 2.32 
NA19472 LWK 90.13 2.22 
NA19473 LWK 74.55 1.90 
NA19625 ASW 96.45 2.04 
NA20796 TSI 102.39 2.33 
NA20798 TSI 90.12 2.27 
NA20801 TSI 101.01 2.00 
NA20802 TSI 120.11 2.67 
NA20803 TSI 88.4 2.01 
NA20804 TSI 89.38 2.33 
NA20805 TSI 80.71 2.11 
NA20806 TSI 109.62 2.04 
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APPENDIX TABLE 7 Set of Gold Standard Deletions used in benchmarking 
 
Chromosome Start Coordinate 
End 
Coordinate Length 
6 2,568,175 2,571,928 3753 
6 3,619,179 3,621,861 2682 
6 3,955,842 3,957,814 1972 
6 7,781,563 7,782,512 949 
6 8,336,551 8,342,450 5899 
6 12,370,753 12,371,801 1048 
6 12,393,279 12,394,188 909 
6 14,739,472 14,740,972 1500 
6 14,839,472 14,842,000 2528 
6 16,884,965 16,886,093 1128 
6 17,110,752 17,112,771 2019 
6 18,327,049 18,331,661 4612 
6 19,041,186 19,049,398 8212 
6 19,676,316 19,677,358 1042 
6 19,685,001 19,687,600 2599 
6 21,890,287 21,897,090 6803 
6 22,050,940 22,054,346 3406 
6 27,674,964 27,679,474 4510 
6 40,715,113 40,717,902 2789 
6 48,751,126 48,752,266 1140 
6 48,930,945 48,938,533 7588 
6 54,417,662 54,418,911 1249 
6 54,553,853 54,557,375 3522 
6 54,662,535 54,665,917 3382 
6 55,825,957 55,846,712 20755 
6 63,563,666 63,566,018 2352 
6 63,597,634 63,598,985 1351 
6 65,711,005 65,715,712 4707 
6 65,910,057 65,910,663 606 
6 66,399,045 66,404,686 5641 
6 67,008,728 67,048,916 40188 
6 67,325,062 67,326,021 959 
6 67,770,208 67,772,440 2232 
6 67,971,647 67,974,165 2518 
6 69,138,587 69,139,391 804 
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6 69,406,916 69,413,357 6441 
6 70,332,608 70,333,527 919 
6 73,221,940 73,222,765 825 
6 74,592,060 74,602,439 10379 
6 74,613,569 74,620,396 6827 
6 75,265,090 75,266,300 1210 
6 77,016,710 77,029,160 12450 
6 77,097,492 77,102,641 5149 
6 77,309,926 77,327,604 17678 
6 77,437,226 77,458,987 21761 
6 77,865,093 77,875,752 10659 
6 78,009,157 78,011,971 2814 
6 78,440,518 78,446,680 6162 
6 78,879,858 78,898,877 19019 
6 78,967,194 79,036,475 69281 
6 80,557,132 80,570,423 13291 
6 81,283,718 81,293,577 9859 
6 81,852,379 81,853,880 1501 
6 83,335,002 83,336,129 1127 
6 86,623,833 86,625,832 1999 
6 87,074,083 87,082,941 8858 
6 91,358,823 91,360,244 1421 
6 91,423,961 91,424,951 990 
6 93,469,481 93,472,966 3485 
6 93,596,329 93,599,180 2851 
6 94,546,351 94,553,601 7250 
6 98,416,730 98,418,537 1807 
6 98,595,583 98,598,033 2450 
6 99,142,464 99,143,333 869 
6 100,537,906 100,539,258 1352 
6 101,380,108 101,384,930 4822 
6 101,482,612 101,486,973 4361 
6 101,494,600 101,496,611 2011 
6 101,934,559 101,939,029 4470 
6 103,585,660 103,588,051 2391 
6 103,737,464 103,762,889 25425 
6 106,403,841 106,406,220 2379 
6 109,078,431 109,083,217 4786 
6 113,700,957 113,703,116 2159 
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6 114,865,764 114,870,658 4894 
6 115,703,958 115,718,359 14401 
6 119,039,465 119,040,407 942 
6 120,928,681 120,929,535 854 
6 121,849,993 121,851,916 1923 
6 121,957,522 121,958,326 804 
6 122,080,357 122,083,418 3061 
6 122,316,829 122,320,039 3210 
6 131,659,937 131,665,251 5314 
6 133,949,673 133,950,539 866 
6 136,817,519 136,821,253 3734 
6 141,377,695 141,380,209 2514 
6 141,548,624 141,550,030 1406 
6 142,110,603 142,114,941 4338 
6 145,705,466 145,706,520 1054 
6 147,438,391 147,444,429 6038 
6 148,001,686 148,003,348 1662 
6 153,226,752 153,227,739 987 
6 153,958,367 153,961,524 3157 
6 154,252,486 154,253,114 628 
6 154,962,605 154,964,587 1982 
6 155,386,352 155,391,615 5263 
6 155,918,172 155,919,665 1493 
6 159,313,923 159,318,649 4726 
6 161,276,240 161,281,599 5359 
6 162,738,024 162,740,306 2282 
6 163,425,770 163,426,837 1067 
6 164,688,747 164,691,816 3069 
6 166,497,640 166,502,589 4949 
6 169,271,377 169,273,907 2530 
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